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Abstract 
The polycistronic z-pJKAJL rpoBC mRNA of E. coli, 
encoding ribosomal proteins and the RNA polymerase 
subunits 13 and  13, is subject to RNase III dependent 
cleavage between the rplL and rpoB coding sequences. 
Under steady-state exponential growth conditions RNase 
III processing in this region is apparently unimportant 
for the regulation of rpoBC gene expression. However 
during a challenge with the drug rifampicin, the 
stimulation of 1313' synthesis is markedly delayed in a 
RNase 111-deficient strain, as compared with the wild-
type control. This is shown to be a post- 
transcriptional effect, which is probably normally 
concealed during steady-state growth by autogenous 
translational control. The construction of a z-poB - 
lacZ fusion plasmid, and RNase Ill-target site deletion 
mutant derivatives, allows a more direct analysis of the 
role of processing in rpoB expression. The results of 
detailed studies using these plasmids have led to the 
proposal of a model wherein deletions of the RNase III 
target site alter the translational efficiency of rpoB 
mRNA by altering the equilibrium between conformations at 
the translation initiation site. The evidence for, and 
implications of, this model are discussed. 
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CHAPTER 1 
1 . 1 E. COLI RIBONUCLEASES : INTRODUCTION 
Since my research work has focussed on regulation of 
the rpoBC operon by RNase III processing, I will give 
particular emphasis to the role of this enzyme in the 
cell's general RNA metabolism. However it should be 
remembered that the E. coli cell contains a battery of 
ribonucleases. The in vivo function of some of these 
enzymes is reasonably well defined, whereas for others it 
can only be guessed at from information obtained through 
in vitro studies. 
I will discuss the metabolism of each RNA species in 
turn: messenger RNA (mRNA), ribosomal RNA (rRNA) and 
transfer RNA (tRNA), and detail the ribonucleases 
involved in their processing. Of course, in the cell 
all species of RNA and all ribonucleases co-exist. 
Against that background the highly specific interaction 
between enzyme and substrate RNA is quite remarkable. 
Also noteworthy is the interplay between different 
ribonucleases involved in the cell's overall RNA 
metabolism and the way in which wholesale RNA degradation 
is avoided. Such considerations have led to the notion 
that RNases may be compartmentalised within the cell. 
For instance, a non-specific degradative enzyme, such as 
RNase I may, it is argued, be isolated from susceptible 
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RNA molecules by its localisation in the periplasmic 
space. Regulatory elements, or events, might then 
trigger its release into the cytoplasm and lead to RNA 
degradation (Deutscher 1988). 
Similarly the intriguing idea of a "processome" has 
been raised (Miczak et al 1989). Apparently the 
processing enzymes RMase III, RNase E and RNase P are 
"primarily located" in the E. coli inner membrane. 
Whether they are present there independently or are co-
localised (in some processing complex) is not known. 
Obviously the idea of colocalisation of these enzymes in 
a processing complex ("processome") is an interesting one 
in that this might confer greater processing efficiency. 
As well as being efficient, these enzymes are often 
highly specific as is clear from the range of precisely 
defined RNA processing reactions carried out in the cell. 
These reactions can be broadly divided into two classes. 
Firstly, there are those involved in degradation or 
turnover of RNA. 	The majority of mRNA processing 
reactions I will deal with are of this nature. 	The 
second type are those which are responsible for the 
conversion of a precursor RNA into its mature, functional 
form. Most stable RNA (i.e. rRNA and tRNA) processing, 
which I will discuss, is to this end. 
C] 
1.2 MESSENGER RNA PROCESSING AND STABILITY 
The cellular, steady-state level of any message is a 
balance between its synthesis and decay rates. 
Therefore regulating mRNA stability, and hence messenger 
levels, •col4 be a fundamental way of controlling gene 
expression in the cell. How messenger degradation is 
controlled is unclear, although there is a growing body 
of work on the subject. The number of ribonucleases 
known to be involved in the process is, to date, quite 
small. Of the six known E. coil exoribonucleases only 
two play a significant part in mRNA metabolism : RNase II 
and polynucleotide phosphorylase (PNPase) (Donovan and 
Kushner 1986). A third enzyme RNase B, whilst 
displaying the requisite exonuclease activity in vitro 
(Kasai et al 1977) has no identified role in messenger 
turnover in vivo. RNase II and PNPase like all known 
E. coil exoribonucleases - have processive 3' - 5' 
activities (No 5' - 3' exoribonucleases have yet been 
detected in E. coli). Mutants which lack both RNase II 
and PNPase are inviable and accumulate mRNA fragments 
between 100 and 1500 nucleotides in length. 
Surprisingly, strains lacking only one of these enzymes 
appear to degrade mRNA normally suggesting that, despite 
differences between the enzymes themselves, they are 
functionally complementary (Donovan and Kushner 1986). 
There is no evidence that these enzymes are targeted to 
specific messages; they appear, rather, to be involved 
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in bulk rnRNA degradation. 	Therefore, the susceptibility 
of the 3' end of a message to attack by these 
exonucleases could be a crucial factor in determining its 
stability. Studies with RNase II and PNPase suggest 
that RNA secondary structures provide some resistance to 
these processive exonucleases (Gupta et al 1977, 
Deutscher 1985). The finding of multiple, highly 
conserved, inverted repeats throughout the genomes of E. 
coli and Salmonella typhimurium, which have the potential 
to form stable, stem-loop structures in mRNA was 
therefore highly interesting (Higgins et al 1982, Stern 
et al 1984, Gilson et al 1984). These sequences - 
called either R.E.P. (repetitive extragenic palindromic) 
(Stern et al 1984) or P.U. (palindronic unit, Gilson et 
al 1984) are remarkably abundant about 25% of all E 
coli transcription units contain a REP/PU sequence 
(Newbury et al 1987a). 
In those operons which have been studied, the REP/PU 
sequences are either located in a transcribed intergenic 
region or in a 3' untranslated region upstream of the 
terminator. Both locations are, of course, consistent 
with the REP/PU sequence acting as a protective barrier 
against 3' - 5' exonucleolytic attack. 	It has been 
shown that in vitro 	(Higgins et al 1988) and in vivo 
(Newbury et al 1987a) REP/PU sequences can perform such a 
function. Whether examined in their normal, chromosomal 
locations (e.g. the Salmonella typhimurium his JQMF 
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operon) or artificial sites, created by cloning into 
multicopy 	plasmids, 	REP/PU 	sequences 	cause 	the 
stabilisation and accumulation of upstream RNA. 
Interestingly this stabilised RNA is in a translationally 
active form, thus hinting at the possibility that REP/PU 
sequences may play a physiologically significant role in 
controlling gene expression. 
Also suggestive is the observation that a Mu phage 
insertion at the distal end of the E. coli glyA gene 
reduces its expression. 	(Plamann and Stauffer 1985). 
This insertion separates the qlyA gene from a 3' REP/PU 
sequence (Newbury et al 1987a, Gilson et al 1987). 
Plamann and Stauffer (1985) suggest that this separation 
exposes the message at its 3' end, reducing its stability 
and hence lowering glyA expression in the mutant. 
Similarly deletion of a 3' REP/PU sequence reduces E. 
coli qdb mRNA stability (Merino et al 1987) and gene 
expression (Becerril et al 1985). 
Direct evidence for an in vivo role for REP/PU 
sequences in controlling gene expression is provided by 
the analysis of the ma1EFG operon in E. coli. This 
operon contains two REP/PU sequences between malE and 
malF. Normally the specific malE transcript has a 
longer half-life than the full-length ma1EFG message and 
correspondingly the MalE protein is present in excess 
compared with Ma1F and Ma1G (Newbury et al 1987a). 
n. 
Deletion of the REP/PU sequences from the intergenic 
region on the chromosome destabilises the upstream 
transcript, leading to reduced malE message 
accumulation. Moreover the deletion also causes a 
reduction in the level of MalE protein in the cell 
(Newbury et al 1987b). 
Clearly these REP/PU sequences are responsible for 
the differential mRNA stability in this operon which in 
turn is partly responsible for determining the relative 
levels of gene expression. The authors (Newbury et a] 
1987b) are careful to note, however, that other factors, 
such as translational efficiency, may also play a role in 
the differential gene expression from this operon, since 
the ratio of MalE to Ma1F proteins is 20 - 40 : 1 whereas 
differential mRNA stability accounts for only a nine-fold 
difference in expression. 
Despite the ability of REP/PU sequences to stabilise 
upstream RNA and in some cases influence relative gene 
expression, the overriding opinion (Gilson et al 1987, 
Higgins et al 1988) is that this is ipt the primary 
function of these sequences. It is felt that this alone 
would not impose the selective pressure to maintain the 
high degree of sequence conservation between REP/PU 
sequences. Alternative roles in chromosomal 
organisation, rearrangements and as "selfish DNA" are 
discussed in the two reviews. 
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Other stem-loop structures (not of the REP/PU 
family) can also act as barriers to 3' - 5' exonucleases. 
The mature 3' end of E. coli tryptophan operon mRNA has 
such a structure. Correct 3' end formation in vivo is 
mainly a result of 3' - 5' exonuclease processing from a 
distal rho-dependent terminator (trpt') being blocked at 
this stem-loop structure (trpt). trpt has features 
normally associated with a rho-independent terminator. 
As expected, RNase ii in vitro processes this transcript 
to the trpt hairpin, and no further. (Mott et al 1985). 
Therefore the 3' end location of such secondary 
structures may not only signify a role in transcriptional 
termination but also in messenger stability. This has 
been shown to be so for ribosomal protein S20 messenger 
RNA, where deletion of the rho-independent terminator 
accelerates the decay of upstream S20 mRNA (Parsons and 
Mackie 1983, Mackie 1987). Also the terminator region 
of the cry gene from Bacillus thuringiensis, when cloned 
downstream of foreign genes, stabilises their message (by 
preventing exonuclease digestion) and increases their 
expression (Wong and Chang 1986). Stem-loop structures 
inserted at the 3' end of OX174 gene B or gene D 
stabilise their specific mRNAs, causing increased 
production of these proteins. Exactly how this is 
achieved is unclear because mutations which disrupt the 
stem base-pairing do not always abolish this stabilising 
effect (Hayashi and Hayashi 1985). 
E] 
Interestingly a bacteriophage T7 RNase III site, 
when cloned downstream of a foreign gene, also confers 
message stability on the upstream transcript. It is 
proposed that a single cleavage of the RNase III target 
sequence does not destroy its secondary structure and 
hence produces a transcript with a 3' terminal hairpin 
(Panayotatos and Truong 1985). 
Hairpin-loop structures (other than REP/PU) also 
appear to stabilise upstream message when they are 
located within a polycistronic transcript. The proximal 
portion of the Rhodobacter capsulatis operon messenger 
RNA is nine times more abundant than the distal mRNA. 
These regions are separated by a stem-loop sequence which 
protects the upstream RNA from 3' - 5' exonucleolytic 
attack. The half-life of the upstream message (encoding 
putBA) is about 20 minutes whereas the longer transcript 
(encoding pufBALMX) has a half-life of about 3 - 5 
minutes (Belasco et al 1985). 	The puf operon also 
contains an upstream gene pufQ (Bauer et al 1988). 	If 
pufQ is part of the same transcription unit, there must 
be a very rapid endonucleolytic cleavage to separate it 
from pufB since no pufQBALMX full, operon-length 
transcript has been observed (Chen et al 1988, Belasco 
and Chen 1988). 
Oj 
Deletion of the pufA - pufL intercistronic sequence 
leads to instability of the upstream RNA and consequently 
alters the pattern of gene expression from the put operon 
(Kiug et al 1987). However, insertion of this sequence 
at the 3' end of the puf operon fails to stabilise the 
pufMLX segment of mRNA (Chen et al 1988). In other 
words, the intercistronic stem-loop is necessary to 
stabilise pufBA mRNA but is, in itself, insufficient to 
confer message stability when located elsewhere. 
Therefore, presumably, there are other features of pufBA 
and pufMLX messages which contribute to the longevity of 
the former species and relatively brief life of the 
latter. Chen et a] (1988) suggest that the pufMLX 
message is processed endonucleolytically and are 
currently investigating this process (Belasco and Chen 
1988, Chen and Belasco 1989). They argue that this 
would trigger degradation of this segment of RNA by 3' - 
5' exonucleases which would then be blocked on reaching 
the hairpin-loop structure between put/i and puffrf. 
Different susceptibilities of putBA and putMLX mRNA to 
this rate-limiting endonuclease could thus help explain 
their different stabilities. As a general model for 
mRNA stability this one of interacting endonucleases and 
exonucleases determining the rate of degradation is more 
attractive than the simple one whereby protection against 
3' - 5' exonucleases is the sole determinant; and indeed 
the more complex model has long been preferred. 
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Certainly complete degradation of mRNA requires the 
combined activities of endo- and exo-ribonucleases. 
Donovan and Kushner (1986) observed that without the 
activities of the exoribonuc leases RNase II and PNPase, 
mRNA fragments accumulate, demonstrating not only that 
these two enzymes are the major exoribonucleases involved 
in mRNA turnover, but also that no endonuclease is 
capable of extensive degradation. 
Pin-pointing the location of the endonucleolytic cut 
in the message is vital to explaining its role in mRNA 
degradation. For instance, an endonucleolytic cleavage 
near the 3' end of a message invariably exposes that RNA 
molecule to exonuclease attack. This is the model 
proposed by Chen et al (1988) (discussed above) for the 
degradation of the pufMLX mRNA segment. ,It has also 
been noted that in mutants where RNase II and PNPase are 
inactivated, S20 mRNA is cleaved by an endonuclease 
toward the 3' end of the transcript. This causes the 
downstream message to be stabilised relative to the 
upstream portion (Mackie 1989). Presumably those 
mutants have invoked some alternative pathway of mRNA 
degradation whereby the initial endonucleolytic 
processing triggers upstream decay, since in wild-type 
strains, S20 mRNA decays without accumulation of discrete 
intermediates. 
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Internal processing may also mediate differential 
gene expression from the multifunctional rpsU - dnaG - 
rpoD operon (see Fig. 1.3). Cleavage of this single 
transcript at the dnaG - rpoD intercistronic region 
separates rpofl message from the upstream RNA and could 
expose the 3' end of the dnaG message to exonucleases. 
This degradation may then be halted by a terminator 
structure tl at the 3' end of rpsU. In this way low-
level dnaG expression relative to rpsU and rpoD could be 
explained in terms of differential mRNA stability (Burton 
et al 1983). A similar mechanism could explain the 
regulation of E. coil pilin gene expression. 
Uropathogenic E. coil produce Pap pili (that facilitate 
adhesion to the urinary tract) from the pap gene cluster. 
Two genes of this cluster, papB and papA, are co-
transcribed to produce a 1300 nucleotide long papBA 
transcript (Baga et al 1985). Cleavage of the 
transcript, between the two genes, results in the 
production of a highly stable and abundant 800 nucleotide 
papA message, and rapid degradation of the upstream 500 
nucleotide papB segment (Baga et al 1988). A potential 
stem-loop structure at the 3' end of the papA message may 
contribute to its long half-life of approximately 27 
minutes (Baga et al 1988). 
One of the best known examples of processing 
destabilising upstream message is that of 	>, mt mRNA. 
The 	X mt gene encodes a protein involved in site- 
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specific recombination. 	Its expression is regulated 
differentially during successive phases of the 	), life 
cycle. 	mt mRNA can be produced from two promoters 
P1 or PL. 	In a lysogenic response to infection X cli 
protein stimulates transcription initiation from Pi 
(Schmeissner et al 1981). 	This transcript terminates 
277 nucleotides beyond 	mt at a rho-independent 
terminator T1 (Schmeissner et al 1984a), creating a 
relatively stable transcript from which high levels of 
mt proteins are made. This is yet another example of a 
terminator structure also serving to stabilise upstream 
message. 
In a lytic response, the anti-termination activity 
of > N protein allows FL initiated transcripts to pass 
through several genes including mt. Whilst this 
transcript can allow production of numerous polypeptides 
both proximal and distal to mt, it is incapable of 
directing the synthesis of mt protein. This is due to 
action at a regulatory element named sib located at the 
3' end of the mt gene transcript (Guarneros et al 1982) 
a process termed retroregulation (reviewed in Gottesman 
et al 1982). Sib is in fact an RNase III target site 
which is cleaved by the enzyme in vitro and in vivo 
(Schmeissner et al 1984b), thus explaining the earlier 
connections made between RNase III and mt expression 
(Belfort 1980, Schindler and Echols 1981, Guarneros et al 
1982). PI initiated transcripts do not contain this 
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RNase III target site as they terminate just upstream at 
T1. PL derived messages read through Ti (due to A N 
action) and hence contain the entire RNase III target 
site. Cleavage at this site is followed by 3' - 5' 
exonuclease degradation which is then blocked, at a 
region of potential mRNA secondary structure, withii. the 
mt coding region. (Plunkett and Echols 1989). This 
neatly explains why the mt gene alone is not expressed 
from PL derived transcripts. 
Interestingly, expression of the Ac II protein may 
also be regulated by RNase III processing at a site 
distal to the gene. Krinke and Wulff (1987) have 
proposed an elaborate model whereby anti-sense OOP RNA 
hybridises with complementary sequences at the 3' end of 
Ac II message to produce a double-stranded RNA structure 
which is sensitive to RNase III cleavage (Krinke and 
Wulff 1987, Krinke and Wulff 1989). Once cut, the 
assumption is that the 3' end of cli mRNA is attacked by 
exonucleases, leading to transcript degradation and the 
consequent inhibition of Xcii gene expression. 
RNase III also processes the major leftward "early" 
(Anevski and Lozeron 1981) and "delayed early" (Lozeron 
et al 1977, Wilder and Lozeron 1979) (including mt mRNA) 
and the "late" major rightward (Lozeron et al 1983, 
Daniels et al 1988) RNAs of bacteriophage A. Little is 
known about the significance of most of these cuts; many 
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may be superfluous. 	RNase III cleavage near the 
terminator of 	the N-antiterminated N gene mRNA, 
destabilises the upstream message (Wilder and Lozeron 
1979, Lozeron et al 1983). The position of the cut site 
in the "late major rightward, Q antiterminated, 6S RNA 
is also near a terminator, although there is no evidence 
to suggest that cleavage here alters the message 
stability (Daniels et al 1988). 
Internal cleavage of mRNA near the 5' end has been 
known about for some time. E. coli trp messenger RNA is 
degraded in a net 5' - 3' direction with 5' end turnover 
occurring even before transcription of the entire operon 
is complete (Morikawa and Imamoto 1969, Morse et al 
1969). Since it is widely held that no 5' - 3' 
exonuclease activity exists in E. coli, this implies that 
endonucleolytic cleavage must occur to liberate fragments 
which are then processed by the existing 3' - 5' 
exonucleases, giving rise to an apparent wave of 
degradation in the 5' - 3' direction (Morikawa and 
Imamoto 1969, Morse et a] 1969, Apirion 1973). 
Discrete endonucleolytic cleavage has been observed 
near the 5' end of trp operon mRNA (Kano and Imamoto 
1979) and, importantly, along its length (Lim and Kennell 
1980). Rather than defined sequential fragmentation 
from the 5' end (Schiessinger et al 1977) trp mRNA can be 
processed at specific internal sites in a less ordered 
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fashion (Lim and Kennell 1980). 	Nonetheless the general 
apparent directionality of degradation (5' - 3') is 
maintained. Specific internal cleavages also occur in 
the E. coli gal operon messenger RNA (Achord and Kennell 
1974) and Bacillus .subtjljs cat mRNA (Ambulos et al 
1987). Since neither 5' nor 3' terminal sequences 
determine the stability of E. coli cat mRNA, it too is 
assumed to initiate degradation via one or more 
endonucleolytic cleavages (DeFranco and Schottel 1989). 
Detailed analysis of this type of message decay has 
concentrated on the E. coli lac operon. This contains 
three genes : the lacZ gene (encoding t3 galactosidase), 
the lacY gene (encoding lactose permease) and the lacA 
gene (encoding galactoside acetyl transferase). They 
are produced from a single polycistronic mRNA in the 
order lacZYA, which is cleaved internally along its 
length (Blundell and Kennell 1974, Lim and Kennell 1979, 
Cannistraro et al 1986, Subbarao and Kennell 1988). The 
proximal lacZ message is twice as stable as the distal 
lacY and lacA portions of the transcript (Cannistraro et 
al 1986, Blundell et al 1972) and is degraded in a net 5' 
- 3' direction (Cannistraro and Kennell 1985a). 
A careful study using Si mapping and direct 
sequencing of the discrete RNA fragments produced during 
messenger decay showed the intergenic lacZY region, and 
considerable amounts of sequence on either side, to be 
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peppered with distinct cleavage sites (Cannistraro et al 
1986, Subbarao and Kennell 1988). 	These cleavage sites 
show some sequence similarity, the tetramer UUAU 
appearing to be especially vulnerable (Cannistraro et al 
1986). Recently a novel E. coli endoribonuc lease was 
discovered (RNase M) which has the capability to cut at 
such sites (i.e. it cleaves at pyrimidine - adenosine 
bonds) (Cannistraro and Kennell 1989). 
It is tantalising to draw a parallel between this 
tetramer (UUAU) and the pentamer AUUUA which is present 
in the 3' untranslated region of many labile eukaryotic 
mRNAs (Shaw and Kamen 1986, Brawerman 1987). This 
pentameric sequence is part of a larger AU rich region 
which, when cloned into the 3' untranslated region of 
stable messages, can render them unstable (Shaw and Kamen 
1986). Conversely, the removal of this region confers 
greater stability upon messages produced from transfected 
plasmid constructs (Greenberg et al 1986, Wilson and 
Triesman 1988). A cytosolic protein (termed adenosine - 
uridine binding factor AUBF) has been identified, which 
specifically binds to RNA molecules with this AUUUA 
sequence (Malter 1989). 
The finding of Cannistraro et al (1986) that E. coil 
iacZ mRNA is endonucleolytically cleaved at specific 
sites may be of general relevance to bacterial messenger 
breakdown. Internal cleavage is clearly not a random 
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process. 	This is consistent with work on several 
different transcripts which has demonstrated that 
bacterial message stab Llity is not related to transcript 
length, but rather is due to some specific sequence or 
region of the message (Gorski et al 1985, Belasco et a] 
1986, Petersen 1987, Belasco and Chen 1988). In 
contrast, there appears to be a general inverse 
relationship between mRNA length and stability in 
Saccharomyces cerevisiae (Santiago et al 1986), although 
this correlation does not apply to all the transcripts 
tested. The authors (Santiago et al 1986) therefore 
propose that some other major factor(s) is/are involved 
in determining messenger stability in yeast. 
The 	specific 	nature 	of 	bacterial 	mRNA 
endonucleolytic cleavage has led to speculation about the 
enzyme(s) involved. The number and variety of cut sites 
in lac mRNA suggests that an enzyme (or enzymes) of 
broad specificity (such as RNase M) may be at work. 
Perhaps secondary structure also plays a role in the 
definition of the target site. 
RNase E has been reported to be essential for the 
processing of bacteriophage T4 gene 32 mRNA (Mudd et a] 
1988, Carpousis et al 1989). This cleavage renders gene 
32 transcript stable, while the upstream messages decay 
(Belin et al 1987). Gorski et al (1985) provide 
evidence which suggests that binding of a bacteriophage 
T4 factor (or factors) at the 5' end of gene 32 mRNA may 
also confer stability to the transcript. This region of 
gene 32 mRNA is proposed to form a 'pseudoknot' structure 
which is part of the autogenous regulatory site on gene 
32 mRNA (McPheeters et al 1988). 
Besides RNase M and RNase E, the only other 
identified E. coil mRNA endoribonuc lease is RNase III. 
RNase III certainly has the ability to cut lacZ mRNA and 
also ti-p mRNA in vitro (Shen et al 1981, Shen et al 1982, 
Schiessinger et al 1983) but there is no evidence that it 
actually attacks either transcript in vivo; and since 
lac message is still inactivated in an RNase III-
deficient strain (Talkad et al 1979) it seems clear that 
other endonucleases play the major role in initiating lac 
mRNA decay. RNase III has target sites in the 
intercistronic region of the E. coli rpoBC operon (Barry 
et al 1980), the ribosomal protein S15 operon (Regnier 
and Portier 1986) and the mc operon (Bardwell et al 
1989), as well as multiple sites in several bacteriophage 
transcripts, all of which are processed in vivo. Whilst 
RNase III processing of the rpoBC operon has been clearly 
demonstrated, the functional significance of this 
event remains in doubt and will be dealt with, in depth, 
later. 
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What i •sestablished is that RNase III processing of 
the S15 and mc operon messenger RNAs does play a major 
role in controlling the expression of the encoded genes. 
The S15 operon is comprised of two genes : rpsO 
(encoding r-protein S15) and pnp (encoding polynucleotide 
phosphorylase). pnp mRNAs are synthesised from two 
promoters (P1 and P2 - see Fig. 1.1). All transcripts 
which encode PNPase are normally processed at the RNase 
III target site which lies between P2 and the pnp coding 
region. A portion of the transcripts initiated at P1 
(coding for S15) are also endonucleolytically cleaved 
downstream of rpsO (close to tj) at a site M. This 
processing is clearly n.otRNase 111-mediated, since it is 
seen in rnc1O5 mutant strains. 	(Regnier and Portier 
1986). 	The identity of the endonuclease which cuts at M 
is not known. 
The importance of RNase III cleavage at its target 
site in the S15 operon on expression of the distal pnp 
gene was first demonstrated by comparative studies on the 
rnclOS mutant (BL321) and its isogenic rnc partner 
(BL322) (Portier et al 1987). Similar studies were also 
made of an rnclO5 mutant (N2077) and its rnc partner 
(N2076). (Takata et al 1987). Differences in the 
magnitude of observed effects reported in these two 
papers may be due to the strain variations, or could be 
because the BL321/BL322 cells were grown in LB medium 
Structural organisation of the S15 operon. rpsO 
encodes r-protein S15. 	pnp encodes polynucleotide 
phosphorylase. 	P1 and P2 are promoters; ti and t2 are 
terminators. 	ms is the RNase III target site, M is a 
maturation site. 	Open boxes represent the structural 
genes. 
Fig 1.1 






whilst the N2076/N2077 cells were grown in M9 minimal 
medium. These workers observed that the rncl05 mutants 
had either two or three times (N2077) or eleven times 
(BL321) as much pnp mRNA as their respective rnc 
partners. This increased level is due to an increase in 
the stability of pnp mRNA in the rncl05 mutants. 
Portier et al (1987) showed that RNase Ill-processed pnp 
mRNA has an estimated half-life of 1.5 minutes, whilst 
that of the unprocessed message is over 40 minutes. 
Takata et al (1987) initially reported mRNA half-lives of 
1.2 minutes in their rnc strain and 2.5 minutes in the 
mc partner. However, in a recent detailed study of the 
degradation of pnp mRNA they revise their estimate of the 
half-life of unprocessed pnp mRNA to 8 minutes. (Takata 
et al 1989). In no case was the upstream rpsO mRNA 
stabilised. 
The stable, unprocessed message is functional, 
giving rise to a tenfold overexpression of PNPase in 
BL321 (relative to BL322) and a 4.4fold overexpression of 
PNPase in N2077 (relative to N2076). 
The common conclusion from these papers is that 
RNase III processing is normally involved in the 
functional inactivation of pnp mRNA, and triggers the 
destabilisation of the pnp message. RNase III cleavage 
gives the message a half-life of approximately 1.5 
minutes which is uniform along the length of pnp mRNA. 
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In contrast unprocessed mRNA has an estimated half-life 
of 8 minutes which is notuniform along the length of the 
mRNA. Sequences near the 5' end of the transcript are 
more stable than those in the middle, which are in turn 
more stable than those towards the 3' end of the mRNA. 
These observations are most easily explained by a 
mechanism involving progressive 3' - 5 exonuclease decay 
of the pnp mRNA. The RNase III endonucleolytic cleavage 
obviously greatly enhances the rate at which degradation 
of the entire pnp message can proceed. It is, however, 
not known exactly how this is achieved, particularly 
since the RNase III cleavage is at the 5' end of pnp 
mRNA. 
The effect of RNase III processing on messenger 
stability in the mc operon is very similar. 	This 
operon most likely contains three genes. 	Certainly two 
of them 	mc (encoding RNase III) and era (encoding Era 
protein) are co-transcribed from a single promoter 
upstream of mc (Bardwell et al 1989). They are so 
closely linked that the termination codon of mc overlaps 
the initiation codon of era (Ahnn et al 1986). 
Downstream of era lies a third gene : recO (Morrison et 
al 1989). Genetic studies suggest that all these are in 
a common operon since mutations in mc have polar effects 
on era expression and era mutants similarly affect mecO 
expression (Takiff et al 1989). Transcripts are 
processed by RNase III upstream of the mc gene, 
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producing an mc - era transcript with a half-life of 
0.75 minutes. Failure to process, in an rncl05 mutant, 
leads to the accumulation of mc - era message with a 
half-life of 4.8 minutes (Bardwell et al 1989). This in 
turn is responsible for the rncl05 mutant producing RNase 
III and Era proteins 3 - 5 times more rapidly than the 
mnc partner. Thus, as with pnp message, RNase III 
cleavage near the 5' end is responsible for accelerated 
turnover of the entire transcript. Besides apparently 
sharing a common mechanism of messenger decay, these 
operons are also related in that they both encode 
ribonucleases. RNase III controls its own level of 
expression, and that of polynucleotide phosphorylase, 
raising the intriguing possibility that ribonucleases can 
form a regulatory network in E. coil. 
This possibility has also been suggested by 
Claverie-Martin et al (1989). They have cloned the 
altered message stability (ams) gene of E. coil - the 
product of which is involved in mRNA decay (Arraino et al 
1988). Whether this gene encodes a ribonuclease or a 
regulator of nuclease activity is still unclear. 
Site-specific endonucleolytic cleavages at the 5' 
noncoding region of ompA mRNA also control the stability 
of that entire transcript. However in this case (unlike 
mc and pnp) the identity of the endonuclease is unknown. 
Interestingly these endonucleolytic cleavages seem to be 
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involved 	in 	the 	growth-rate-dependent 	degradation 
exhibited by ompA mRNA (Belasco et al 1986, Nilsson et al 
1988, Melefors and von Gabain 1988). Such cleavages are 
also seen in the 5' non-coding region of bla message 
(Nilsson et al 1988). 
One factor so far omitted from this discussion, 
which could play a major role in bacterial mRNA stability 
in vivo, is the translating ribosome. The association 
of ribosomes on mRNA may sterically protect the 
transcript from endonucleolytic attack. Conversely 
endonucleolytic cleavage at the 5' end of a message may 
prevent ribosome association with the transcript, 
rendering it functionally inactive, and hence alter 
message stability. A summary of this complex and 
controversial subject follows. 
Drug-induced translation inhibition has apparently 
contradictory effects on mRNA stability, depending upon 
which drugs are used. Blockage of translation by 
kasugamycin and puromycin cause messenger RNAs to be 
rapidly degraded (Schneider et al 1978, Carter and Newton 
1971, Imamoto 1973, Cremer et al 1974, Cremer and 
Schlessinger 1974) whereas the use of chloramphenicol 
results in messenger stabilisation (Imamoto 1973, Cremer 
et al 1974, Cremer and Schlessinger 1974, Schneider et al 
1978). 	This of course may reflect differences in the 
mechanisms of drug action. 	The action of kasugamycin 
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(which prevents translation initiation) or puromycin 
(which blocks translocation, releasing the ribosome from 
the message) could expose mRNA, whilst chloramphenicol-
induced slowing (or blockage) of ribosomes on the message 
may actually nçreasethe protection against 
endonucleases, particularly as only relatively short, 
specific segments of the transcript may be determinants 
of messenger stability. 
E. coli trp polar mutants (Yanofsky and Ito 1966) 
show accelerated degradation of messenger RNA distal to 
the nonsense codon (Morse and Yanofsky 1969, Hiraga and 
Yanof sky 1972). This was interpreted as demonstrating 
that the loss of ribosome association with this region of 
irp mRNA rendered it vulnerable to attack from 
degradative ribonucleases, which was initially assumed to 
be the primary mechanism of the polar effect. However 
an alternative explanation, now in favour, is that 
polarity is due primarily to premature transcription 
termination (Imamoto et al 1970) at a normally cryptic 
rho-dependent site(s), 	after the loss of ribosome 
association with the mRNA. 	(Richardson et al 1975, 
Ratner 1976, Korn and Yanof sky 1976 reviewed in Galloway 
and Platt 1986). Consistent with this explanation is the 
finding that, just as N-modification of RNA polymerase 
leads to antitermination in 
),, so too it abolishes 
polarity by causing transcriptional readthrough of the 
rho-dependent terminators. (Franklin 1974, Segawa and 
25 
Imamoto 1974). 	Moreover, polarity-suppressor mutations 
were isolated and found to be rho mutants (Ratner, 1976). 
The hyper-labile trp mRNA detected in polar mutants 
(Morse and Yanof sky 1969, Higara and Yanof sky 1972) is 
relatively short in length. It has been proposed that 
it represents the truncated transcript generated by rho-
dependent termination and is unstable because it has an 
exposed 3' end vulnerable to 3' - 5' exonucleases. 
(Yanofsky and Crawford 1987). If this exonucleolytic 
degradation continued through the gene carrying the 
nonsense mutation and into the next upstream gene, it 
could also explain the phenomenon of "anti-polarity". 
This term refers to the process whereby some polar 
mutants inhibit the expression of the gene just u.pstre,rn 
(Yanof sky and Ito 1967). In summary, however, the role 
of messenger degradation in polarity seems limited and of 
secondary importance to the role of premature 
transcription termination. 
As predicted by the above model for nonsense 
polarity inefficient translation initiation of lacZ mRNA 
(and hence increased ribosome spacing on the transcript) 
can also lead to rho-mediated transcription termination 
at a site in the lacZ gene (Stanssens et al 1986). 
In one case mutational inhibition of translation 
does seem to alter message stability without causing any 
premature transcriptional termination. Introduction of 
FM 
a translation stop signal at codon position 29 of the 
chromosornal ly located ompA gene results in a ten-fold 
increase in ti te rate of omp A mRNA degradation (Nilsson et 
al 1987). However this same study produced 
contradictory results with a different transcript (see 
later). 
The effect of translation blockage on the stability 
of messenger RNA can be studied in wild-type cells 
without the addition of drugs. Message "protection" 
afforded by translating ribosomes can be lost by mRNA-
protein interaction which inhibits ribosome loading or 
passage. For example, ribosomal protein messenger RNAs 
(r-protein mRNA) are subject to translational regulation 
by a specific repressor r-protein, which interacts with 
the transcript to the exclusion of ribosomes. (For 
general reviews of translational regulation of r-protein 
synthesis see:- Nomura et al 1984, Lindahl and Zengel 
1986, Nomura 1986 and Jinks-Robertson and Nomura 1987). 
Because r-protein genes are often clustered in 
polycistronic operons, translational repression can be 
used to control the synthesis of several r-proteins 
simultaneously. This is achieved by a process of 
"translational coupling", whereby the translation of 
distal genes in a polycistronic mRNA is reliant on prior 
translation of upstream genes. Binding of a repressor 
r-protein to the messenger RNA of a proximal gene in a 
polycistronic operon inhibits translation of that gene 
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directly, and, through the dependence on translational 
coupling, indirectly shuts down synthesis of distal r-
proteins. The exact mechanism of translational coupling 
is not known, although the hypothesis is that the 
translation initiation sites of the downstream genes may 
be masked by structural features of the polycistronic 
mRNA. Translation of the upstream gene may be required 
to 'unmask' the initiation site of the distal gene and 
allow its translation. This process could be repeated 
along the entire length of the polycistronic message. 
Translational coupling is the main way of linking 
the expression of proximal and distal genes in r-protein 
operons. However another effect of translational 
repression of proximal genes is that distal messenger RNA 
becomes exposed and destabilised, due to the loss of 
ribosome association and consequent attack by 
ribonucleases. This may provide a way of tightening r-
protein operon regulation if translational coupling is 
not entirely efficient. 
These processes are at work in regulating the 
expression of the genes in the "Lii operon". This 
"operon" contains the r-protein genes Lii and Li. (i.e. 
it is the proximal portion of the large rpoBC operon 
which codes for Lii, Li, Lb, L7/L12, 13 and  13' proteins - 
see later). Li is a repressor r-protein which binds to 
its target site at the 5' end of Lii mRNA (Dean and 
Nomura 1980, Yates et al 1980, Yates and Nomura 1981) 
and, due to translational coupling, represses synthesis 
of both proteins (Baughman and Nomura 1983). 
Translational repression does not inhibit transcription 
of this "operon", and hence the process is unrelated to 
transcriptional polarity. Mutation of the target site 
abolishes feedback regulation and results in mRNA with an 
increased half-life; 1.8 minutes for unregulated Lii 
mRNA as opposed to 0.37 minutes for mRNA regulated by Li 
binding. A double mutation which abolishes feedback 
regulation and translation initiation results in a 
transcript with a very short half-life (between 6 and 15 
seconds) (Cole and Nomura 1986). These results 
demonstrate that loss of ribosome association resulting 
from Li binding (and not some specific, perhaps 
nucleolytic, effect of Li binding) destabilises the 
message. In other words, ribosomes proceeding along the 
message stabilise this transcript. 
In an alternative approach, a strain carrying a 
mutation in the gene for r-protein S4 (rpsD), which 
results in a reduced translational repressor activity at 
its target on a operon mRNA (Jinks-Robertson and Nomura 
1982), was shown to contain a messenger RNA with 
increased stability (Singer and Nomura 1985). 
Altered mRNA stability resulting from translational 
repression also plays a significant role in controlling 
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expression from the spc operon. 	This is a large operon 
encoding ten r-protein genes. 	The r-protein S8, encoded 
by the fifth gene of the operon, is a translational 
repressor (Yates et al 1980, Dean et al 1981). It binds 
to the message near the translation initiation site of 
the third gene (encoding L5), directly inhibiting L5 
translation and, via translational coupling and increased 
mRNA degradation, indirectly controlling the expression 
of all the distal r-protein genes in the operon. 
(Cerretti et al 1988, Mattheakis and Nomura 1988). 
Surprisingly by binding at the same mRNA target site, S8 
also depresses synthesis of the first two proteins of the 
operon (Mattheakis et a] 1989). 	This is achieved by a 
process of retroregulation. 	The model proposed to 
explain this is that S8 binding, to the exclusion of 
ribosomes, exposes an endonuclease target site in the 
naked, distal mRNA. Cleavage at this site (by an as yet 
unidentified enzyme) produces a 3' end which is sensitive 
to exonucleolytic digestion. If one assumes that the 
S8-mRNA interaction is reversible and that as S8 protein 
levels increase so the probability of S8 protein being 
bound to the message is raised, then at relatively low S8 
protein concentrations it is possible that the 3' - 5' 
exonuclease could proceed past the S8 target site on the 
mRNA and degrade the message encoding the first two genes 
in the operon (L14 and L24). Only by making these 
assumptions can one reconcile this result (Mattheakis et 
al 1989) with an earlier observation, that over- 
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production of S8 in trans (from an inducible plasmid) 
inhibits synthesis of L5, and distal proteins, but .not of 
L14 and L24. (Dean et al 1981). Mattheakis et a] 
(1989) have demonstrated that shortly after induction of 
S8 synthesis from the plasmid (low S8 levels) 
retroregulation works and L14/L24 synthesis is inhibited. 
However as induction proceeds (high S8 levels) 
retroregulation is lost, presumably because bound S8 
protein is now blocking the progress of the 3' - 5' 
exonuclease along the message to the L14-L24 genes. 
The stabilities of other messenger RNAs encoding r-
protein genes, such as the monocistronic S20 mRNA, are 
also altered by translational repression. 	(Parsons et a] 
1988). 	However this may not always be a universal 
consequence of feedback control. 	For instance, r- 
protein L4 represses the expression of genes from the SlO 
operon at the level of translation (Lindahi and Zengel 
1979, Yates and Nomura 1980, Zengel et a] 1980). 
Effects seen at the messenger RNA level (after sudden 
perturbations) are primarily due to L4-mediated 
transcription attenuation upstream of the first gene in 
the operon; although a minor contribution from decreased 
mRNA stability cannot be entirely excluded (Lindahi et a] 
1983, Lindahl et a] 1989). 
31 
As I mentioned earlier, bacteriophage T4 gene 32 
protein binding to the 5' end of its own mRNA results in 
stabilisation of the transcript (Gorski et al 1985). 
In Bacillus subtilis the ermC gene (one of the 
erythromycin-resistance genes) encodes an mRNA which is 
stabilised in the presence of subinhibitory levels of 
erythromycin (Shivakumar et al 1980). Such levels of 
erythromycin induce ermC expression by a mechanism called 
"translation attenuation". The ermC coding region is 
preceded by a translatable leader sequence which when 
being translated normally (in the absence of 
erythromycin) can be folded into a secondary structure 
that renders the ermC Shine and Dalgarno sequence 
unavailable for translation initiation (Weisblum 1983). 
Erythromycin addition causes stalling of erythromycin-
bound ribosomes during translation of the leader 
sequence. This in turn "opens up" the ermC translation 
initiation site, and leads to increased ermC expression. 
This induction is accompanied by a 15 - 20fold increase 
in ermC mRNA stability which is not due simply to 
ribosome "protection" of the ermC coding mRNA. Rather 
it is the stalled ribosome in the leader mRNA which is 
responsible for conferring stability on the downstream 
transcript (Bechhofer and Dubnau 1987). The stalled 
ribosome protects the message from a progressive wave of 
5' - 3' degradation. This is either due to an 
endonuclease activity which "tracks" in this direction 
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(and 	is 	rapidly 	followed 	by 	3' 	- 	5' 	trimming 
exonucleases) or Bacillus subtilis contains its own (as 
yet unidentified) 5' - 3' exonuclease activity (Bechhofer 
and Zen 1989). The same mechanism is proposed to 
explain erythromycin induction of Staphylococcus aureus 
ermA and ermC genes (Sandler and Weisblum 1989, Mayford 
and Weisblum 1989). 
One intricate method by which mRNA stability might 
be altered is through the interaction of anti-sense RNA. 
The large majority of naturally occurring prokaryotic 
anti-sense RNAs function at the level of translation (see 
review by Inouye 1988). This can involve anti-sense RNA 
binding at, or upstream of, the translation start site of 
the targeted transcript, causing translation initiation 
to be physically impeded (Mizuno et al 1984, Dempsey 
1987, Liao et al 1987, Wu et al 1987). This could then 
influence mPNA stability secondarily, although that has 
not yet been tested. 
Alternatively the RNA-RNA duplex created by sense - 
anti-sense RNA hybridisation, could serve as a signal for 
endonucleolytic cleavage, which could trigger messenger 
decay. RNase III has been proposed to cut such a duplex 
at the 3' end of ),cIII mRNA (as previously discussed). 
(Krinke and Wulff 1987). Similarily it has been 
suggested that RNase III cleavage of a duplex created by 
base-pairing of transposon TnlO transposase mRNA and its 
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highly stable 	anti-sense 	RNA 	(Case 	et al 	1989) 
contributes to repression of transposase synthesis. 
(Simons and Kleckner 1983, Belasco and Higgins 1988). 
It has still not been wIdely demonstrated that 
preventing translation (whether by protein or anti-sense 
RNA interference) results in messenger instability. 
Actually there are several lines of evidence which would 
contradict this theory. For instance, the untranslated 
portion of ompA mRNA is no less stable than the 
translated region (von Gabain et al 1983) . Also, 
mutation of the Shine and Dalgarno sequence of the 
Bacillus subtilis ermC gene, which prevents translation 
of that message, has no effect on ermC mRNA stability 
(Bechhofer and Dubnau 1987). Even depriving a messenger 
segment of its usual complement of ribosomes does not 
necessarily render that transcript more sensitive to 
degradation (Stanssens et a] 1986, Petersen 1987, Nilsson 
et al 1987). Using several mutants of the bla gene 
Nilsson et a] (1987) observed that bla message stability 
seems to be dependent on efficient translation of a 5' 
portion of the transcript. Since specific cleavages 
have been observed in the 5' noncoding region of this 
message (Nilsson et a] 1988), it is possible that 
ribosomes either protect this transcript against cleavage 
or against the degradative effects of endonucleolytic 
processing in this region. 
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The presence of the translating ribosome on mRNA is 
not a general mechanism for wholesale protection of 
entire transcripts from ribonuclease attack. Rather 
ribosome 'protection' seems relevant only if it serves to 
mask the particular site (or sites) on the transcript 
where messenger degradation is initiated - or to block 
further degradation. 
The precision of endonucleolytic cleavage is a 
common theme in bacterial mRNA degradation. Studies on 
lacZ message decay show that, at least for this mRNA, 
these specific internal cleavage sites are abundant. 
Therefore rapid decay of this message in an apparent 5' - 
3' direction could be achieved by cleavage at these 
internal sites immediately after the passage of the last 
translating ribosome. The oligonucleotides produced 
could then be destroyed by the existing 3' - 5' 
exoribonuc leases. 
Secondary structures may offer protection against 
non-specific degradative exonucleases, but the controlled 
turnover of many messages is initiated by a specific 
internal cleavage (or cleavages). Masking of internal 
cleavage sites may be one way of controlling message 
decay. 
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1.3 RIBOSOMAL RNA PROCESSING 
There are seven rRNA operons in E. coil (rrnA, rrnB, 
r.rnC, rrnD, rrnE, rrnG, rrnH). Their positions have 
been mapped on the chromosome and they have been 
sequenced. All seven have the same basic organisation 
(summarised in Morgan 1982) and are transcribed in the 
order promoter - 16S - tRNA(s) - 23S - 5S, as a single 
30S transcript. The existence of at least one tRNA 
between the 16S and 23S genes is common to all seven 
operons. Three also contain distal tRNA genes (3' of 
the 5S gene) and ri-nD has a second 5S rRNA gene (with a 
tRNA sandwiched between the two 5S genes) (Duester and 
Holmes 1980). The mature species in these operons are 
separated by spacer sequences which are removed by 
processing. Long inverted repeats bracket both the 16S 
(Young and Steitz 1978) and 23S genes (Bram et al 1980). 
These have the potential to form long double-stranded 
stems which would "loop out" the genes. Such loops 
containing 16S and 23S sequences have been visualised by 
electron microscopy of 30S precursor RNA prepared from 
RNase 111-deficient strains (Klein et al 1985a). The 
stems are the major targets for RNase III cleavage of 30S 
RNA, which yields the direct precursors of rRNA. 
Thereafter the maturation pathways for the different rRNA 
molecules are extremely complex and involve multiple 
cleavages at the 5' and 3' ends of each species. For 
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this reason I will consider the maturation of each 
species individually, where possible. 
1.3.1 1  6 S rRNA 
An intermediate RNA molecule, pre-16S, is the first 
product of RNase III cleavage at the stem formed by 
pairing of complementary sequences flanking the 16S gene. 
The pre-16S RNA is larger than the mature species, with 
115 extra nucleotides at the 5' end and 33 extra at the 
3' end. The cut sites produce a staggered break in the 
target duplex, leading to suggestions that cleavage there 
is a two-step process, involving separate reactions for 
each strand. The processing reactions are very rapid, 
with a reaction half-time in vivo of between 12 and 30 
seconds (in rich medium at 37°C) (King and Schiessinger 
1983). The speed of these reactions suggests that 
processing may occur at the 5' end of a 30S molecule 
before transcription of the entire operon is complete. 
Detailed studies of 23S rRNA formation using 
rifampicin to block transcription initiation (King and 
Schlessinger 1983) produced more surprising results. 
Cleavage of the 23S rRNA precursor occurs at the 5' site 
before the 3' site of the same molecule has even been 
transcribed. 	This could be explained in at least two 
ways. 	Firstly, the formation of the large stem could 
involve intermolecular pairing between the 5' sequence of 
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one 23S precursor undergoing transcription and the 3' 
complementary region of another (completed) transcript. 
In this way the abs 01 .t . secondary structural requirement 
of an RNase III target site could be met, and the 5' site 
cleaved, prior to transcription of the 3' end of the same 
molecule. Alternatively, two independent structures may 
form at the 5' and 3' ends of 23S rRNA, each constituting 
a separate RNase III target site. Thus interaction 
between the 5' and 3' ends would not be necessary for 
cleavage. This would, of course, challenge the model of 
RNase III cleavage at two staggered sites on a single 
large stem - formed by the intramolecular pairing of 
complementary sequences at the 5' and 3' ends of the 23S 
rRNA precursor and would therefore challenge the 
physiological significance of this stem formation (which 
has been visualised by electron microscopy). 
In contrast the evidence from kinetic studies 
suggests that no such arguments need be raised to explain 
cleavage at the 16S rRNA precursor. 	These results 
suggest that the full 	16S precursor sequence is 
transcribed prior to RNase III processing and therefore 
the accepted model of large stem formation, and cleavage 
therein, remains unchallenged for the 16S case. 
The RNase III cleavage of 30S precursor RNA observed 
in vivo can be precisely mimicked in vitro using purified 
enzyme and naked precursor rRNA - although the efficiency 
of cleavage is highly dependent on ionic strength 
(Birenbaum et al 1978). 
The significance of RNase III cleavage has largely 
been assessed by studying rRNA formation in mutants 
deficient in the enzyme (King and Schiessinger 1983, 
Srivastava and Schiessinger 1989a) . Such cells contain 
no RNase 111-cleaved species, yet do produce mature 16S 
rRNA molecules. Hence the intermediate pre-16S rRNA - 
normally produced by RNase III processing - has been by-
passed and is clearly not essential for mature 16S rRNA 
formation. These results imply that other enzymes 
involved 	in 	16S 	rRNA 	maturation 	can 	function 
independently of RNase III cleavage. 
A mutant, the BUMMER strain, accumulates a novel RNA 
species called 16.3S RNA containing an extra 66 
nucleotides at the 5' end (Dahlberg et al 1978). 
Extracts from its parental strain can convert this 16.3S 
precursor to 16S rRNA by an endonucleolytic cleavage. 
This partially characterised activity is called RNase 
M16. RNase M16 will not cleave naked 16.3S RNA but 
requires it to be associated with ribosomal proteins in 
30S subunits or 70S ribosomes. The BUMMER strain shows 
normal kinetics for RNase III cleavage of 16S precursors. 
However, final maturation of 16S rRNA in this strain is 
almost three times slower than in wild-type strains (King 
and Schiessinger 1983). 
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These results suggest that the BUMMER strain is 
deficient in the activity responsible for 16S rRNA 5' 
maturation; that the reaction depends to some extent on 
ribosome assembly; and that it is an endonucleolytic 
cleavage of the intermediate molecule already made by 
RNase III processing of 30S precursor. 
Srivastava and Schiessinger (1989a) also present 
evidence which indicates that 16S rRNA 5' maturation may 
be achieved by a single endonucleolytic cleavage and 
suggest a similar mechanism for 3' end formation 
(Srivastava and Schiessinger 1989b). 	However 16S rRNA 
3' maturation is less well characterised. 	A partially 
purified enzyme activity has been identified which 
converts a precursor RNA-protein complex into a 16S rRNA-
protein complex (Hayes and Vasseur 1976). This is 
achieved by trimming the 3' end of the precursor and may 
be endonucleolytic - since no intermediates containing 
multiple 3' ends (indicative of exonuclease processing) 
have been detected. 
An alternative, yet complementary, approach to 
investigating the processing of 16S rRNA has been the 
attempt to define the sequences surrounding, or even 
inside the gene which are required for maturation. 
Proper 5' end formation clearly does not require the 
presence of the large double-stranded stem, which 
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brackets the gene, since mutants devoid of this secondary 
structure still produce 16S rRNA with the correct 5' 
terminus. (Krych et al 1987, Srivastava and 
Schlessinger 1989b). Similarly 16.3S RNA, which has a 
mature 3' end and only 66 extra nucleotides at the 5' 
end, can be converted to mature 16S rRNA by cell 
extracts. (Dahlberg et al 1978). Equally, correct 16S 
rRNA 3' ends are made without the large stem being 
present (Srivastava and Schlessinger 1989b). Deletions 
within part of the 16S gene - even of only a single base 
- can lead to a failure of maturation (Gourse et al 1982, 
Stark et a] 1982, Stark et a] 1984). However it should 
be stressed that in a series of mutants where changes 
were localised to the 3' end of the 16S gene, no effect 
on processing or ribosome assembly was seen. (Jemiolo 
et a] 1985). 
Partial, or entire, deletion of the downstream, 
spacer tRNA impairs RNase III processing at the 16S rRNA 
target (Szymkowiak et a] 1988). 	Why this should be so 
is not obvious. 	Unfortunately this work sheds no light 
on the importance of the spacer tRNA as regards 
rn.aturation, of 16S rRNA, because the mutants used also 
had extensive deletions wj..th.i...nthe 16S gene. 
The importance of the spacer tRNA sequences is more 
effectively tackled by Srivastava and Schiessinger 
(1989b). They have constructed plasmids with deletions 
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in the distal spacer region : between 16S and the spacer 
tRNA. 	As predicted these deletions have no effect on 5' 
end formation. 	Correct 3' end formation appears to 
require an intact spacer tRNA positioned more than 24 
nucleotides downstream of the 16S gene. One hypothesis 
regarding the role of tRNA in 3' end formation is that it 
acts as a guide for RNase F, directing it towards the 16S 
rRNA 3' end. However since 16S rRNA matures normally in 
a temperature-sensitive RNase P strain at the non-
permissive temperature (Apirion and Gegenheimer 1981) the 
enzyme's role (if any) is obviously not an essential one. 
This has been demonstrated more directly by Srivastava 
and Schiessinger (1989b). They were able to show that 
after 3' maturation the RNA released had not been 
processed by RNase P. RNase III or any other enzyme. No 
pri,.or cleavage is needed at the 3' end s before 16S 
maturation can begin. 
Why then could this correctly placed spacer tRNA be 
required for 3' maturation? 
There are suggestions that the conformation of 16S 
RNA in the precursor transcript is different from that in 
the mature molecules of 30S ribosomal particles (Klein et 
al 1985b). Moreover reconstitution of 30S ribosomal 
subunits in vitro occurs with a much lower activation 
energy if the precursor form of 16S RNA is used instead 
of the mature form. (Mangiarotti et al 1975, Traub and 
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Nomura 1969). 	The theory, then, is that the tRNA 
sequences may be necessary to achieve, or retain, the 
correct conformation of pre-rRNA required for both 
processing and ribosome assembly. This could explain 
why partial, or entire, deletion of this tRNA restricts 
RNase 	III processing of the 16S rRNA precursor 
(Szymkowiak et al 1988). 	Loss of part, or all, of the 
€RNA may alter the precursor. conformation to such an 
extent as to impair RNase III cleavage. 
1.3.2 23S rRNA 
Precise definition of the reactions involved in 
maturation of 23S rRNA is difficult because, besides the 
predominant 5' and 3' termini, other termini can also 
exist in wild-type cells (Sirdeshmukh and Schiessinger 
1985). However, it is known that, like 16S rRNA, RNase 
III processing liberates an intermediate species (pre-23S 
RNA) from the 30S precursor transcript by cleavage at 
target sites which bracket the gene. In both cases this 
initial reaction is then followed by a series of 
maturation cleavages. 
One important difference between 16S and 23S rRNAs 
is that whilst maturation of the former can proceed 
without prior RNase III cleavage, such processing is 
Abs.PJ.Ate. 	required to allow the production of mature 23S 
rRNA. 	In RNase III deficient strains, failure to 
43 
process 30S precursor transcript results in the complete 
inability to produce mature 23s rRNA (King et al 1984). 
Instead these strains contain various species of 23S rRNA 
which have between 20 and 97 extra nucleotides at the 5' 
end and extensive additional 3' sequence. Intriguingly 
some (or all) of these unprocessed pre-23S RNA molecules 
must form ribosomes which are capable of protein 
synthesis, since the RNase Ill-deficient strains are 
viable. Thus, although RNase III cleavage is essential 
for 23S rRNA maturation, it would appear that maturation 
itself is not absolutely essential to make 23S RNA 
functional. This is in stark contrast to 16S rRNA, 
where maturation is required for 30S ribosome formation. 
The unprocessed 23S RNA (derived from RNase III 
deficient strains) can be cut in vitro by purified RNase 
III (Sirdeshmukh and Schlessinger 1985). Major cleavage 
occurs at two distinct sites at the 5' end, and a single 
position at the 3' end, yielding two types of 
intermediate pre-23S rRNA molecule (with three or seven 
extra nucleotides at the 5' end, and eight extra at the 
3' end). 	There also appears to be a minor RNase III 
cleavage site at the 5' end. 	Processing here generates 
a molecule which is four nucleotides shor..terat the 5' 
end than the 'accepted' mature molecule. The functional 
significance of this is not known (Sirdeshmukh et al 
1985) 
M,  
Removal of the extra nucleotides from pre-23S RNA in 
vitro to generate mature termini, requires a wild-type 
cell extract which is capable of in vitro protein 
synthesis (Sirdeshmukh and Schiessinger 1985). These 
authors suggest that maturation of the 5' end occurs 
endonucleolytically, whilst correct 3' end formation 
depends on an exonuclease activity. Neither activity 
has been identified. 
1.3.3 5S rRNA 
The pattern of E coil 5S rRNA processing is similar 
to that of its 16S and 23S RNA molecules. 	An initial 
endonucleolytic 	cleavage 	produces 	an 	intermediate 
species, which is further processed and trimmed to make 
the mature molecule. 	In this case the primary 
endonuclease is RNase E. 	Mutants deficient in this 
enzyme (rne) accumulate a 9S molecule which contains 5S 
rRNA sequences running from the RNase III target site at 
the 3' end of 23S rRNA to the 3' terminus of the rRNA 
operon (Apirion and Lassar 1978, Ghora and Apirion 1979, 
Misra and Apirion 1979). This 9S RNA molecule can be 
processed in vitro, using cell extracts from an rne 
strain, to produce a pre-5S rRNA molecule (Ghora and 
Apirion 1978) which is six nucleotides longer than the 
mature 5S rRNA. Pre-5S rRNA contains three extra 
nucleotides each at the 5' and 3' ends (Roy et al 1983). 
How these are removed during maturation is not known. 
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Species carrying one, two or all three additional 
nucleotides at the 5' end accumulate in cells wherein 
protein synthesis has been shut down (Feunteun et al 
1972) . 	They have also been detected shortly after 
pulse-labelling of exponentially growing cells. 	Their 
disappearance then coincides with the emergence of mature 
5S rRNA (Jordan et al 1970). 	This work suggests that 
these molecules are true precursors of 5S rRNA. 	These 
precursors have been found in polysomes, indicating not 
only that they can probably function in protein 
synthesis, but also that this is where final maturation 
occurs (Feunteun et a] 1972). There appear to be no 
insights into 5S rRNA 3' maturation. 
5S rRNA processing in Bacillus subtilis is less 
complicated. In this case the endonuclease RNase M5 
generates both mature 5' and 3' termini by a single 
cleavage (Meyhack et a] 1977). RNase M5 is comprised of 
two protein components: 	one, the a subunit, is required 
for catalysis; 	the other is a ribosomal protein 
apparently needed to attain the correct orientation for 
cleavage. (Stahl et a] 1984, Pace et al 1984). 
Interestingly RNase MS seems to recognise sequences of 
the mature 5S RNA within the precursor, since addition of 
synthetic sequence to the 5' or 3' end of the mature SS 
RNA gene does not affect the proper processing of such a 
molecule (Pace 1984). No similar activity has been 
identified in E. coli. 
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Despite the ability of some cleavages to occur in 
vitro on naked pre-RNA, a strong common theme of 
ribosomal RNA maturation seems to be the requirement of 
ribosomal protein interaction. Some of the final 
processing reactions even seem to require the pre-
:'ribosome to be engaged in protein synthesis. 
Once made, mature ribosomal RNAs suffer only limited 
turnover. 	The intact ribosome is highly resistant to 
cytoplasmic 	nucleases, 	but 	is 	sensitive 	to 	the 
periplasmic RNase I (Raziuddin et al 1979) Release of 
RNase I from the periplasm, under adverse conditions, may 
trigger the degradation of rRNA in the cell. 
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1.4 TRANSFER RNA 
Fifty three tRNA genes have been located in the E. 
coil chromosome. They are distributed throughout the 
genome in operons of diverse organisation (Fournier and 
Ozeki 1985). 19% are in monocistroniC tRNA operons, 42% 
in multicistronic tRMA operons, 26% are in rRNA operons, 
and 13% are in complex operons with protein coding genes 
(Altman et al 1981, Hudson et al 1981, Ishii et al 1984, 
Rossi et al 1981). 
Every tRNA gene transcript - even those from 
monocistronic operons - requires 5' and 3' processing to 
produce its mature functional tRNA molecule. Maturation 
of the 5' end of all E. coli tRNA species is carried out 
by the endonuclease RNase P (Kole and Altman 1981, 
Deutscher 1984). A particularly interesting feature of 
the ribonucleoprotein RNase P is that the RNA component 
(MIRNA) 	is the catalytic subunit of the enzyme. 
(Guerrier-Takada et al 1983). 	Since all tRNA molecules 
are eventually cleaved at the 5' end by RNase P it is 
theoretically possible that the same enzyme separates the 
individual tRNA precursors out of the multicistronic 
.tra,nsçript. This does happen in bacteriophage T4, where 
a dimeric tRNA precursor (containing two RNase P target 
sites) can be separated by RNase P cleavage. However it 
should benoted that the rapidity of cutting is not equal 
for both sites (Schmidt and McClain 1978). This point 
is consistent with the idea that the initial separation 
of rnulticistronjc tRNA precursors is carried out instead 
by one or more alternative endonucleases. Where the 
multicistronic transcript is a poor substrate for RNase P 
cleavage, cutting by enzymes such as RNase P2, RNase F or 
RNase 0 has been postulated. 	(Note that RNase P2, RNase 
F and RNase 0 may be one and the same enzyme). 	(King 
and Schiessinger 1987). 	There is in fact evidence that 
some multicistronic tRNA operons are cleaved by RNase 0 
prior to RNase P maturation (Sakano and Shimura 1975). 
In the case of one bacteriophage T4 tRNA, (tRNAG 1 n) 
RNase III is required to cut at the 5' end prior to RNase 
P maturation (Fukuda and Abelson 1980, Schmidt 1984, King 
et ad 1986) RNase PC also makes several cuts in the 
primary transcript of the phage T4 tRNA operon to 
separate the tRNA precursors, prior to final processing 
(Goldfarb and Daniel 1980). 
Recently it has been shown that RNase III cleavage 
at the 3' end of a tRNA (metY : the first gene of the 
complex polycistronic operon metY - nusA infB) releases 
it from the full-length operon transcript and 
simultaneously initiates degradation of the downstream 
mRNA (Regnier and Grunberg-Manago 1989). 5' maturation 
of this tRNA, presumably mediated by RNase P proceeds 
with or without prior 3' RNase III cleavage. 3' 
maturation is probably carried out by exonucleases at a 
very rapid rate (as below) 
Also, interestingly, RNase P (Nomura and Ishihama 
1988) and RNase E (Ray and Apirion 1981) have been shown 
to make endonucleolytic cleavages near the 3' end of 
certain tRNA molecules as a preliminary step in 3' end 
maturation. 	Mature 3' ends are generated by exonuclease 
activity. 	Several ribonucleases have been identified 
which have the capability to remove nucleotides from the 
3' end of tRNA molecules, namely: 	RNase D, RNase II, 
RNase BN and RNase T. 	However RNase D mutants grow 
normally and are not impaired in tRNA biosynthesis 
(Blouin et al 1983). Likewise a mutant devoid of the 
exonucleases RNase D, RNase BN and RNase II also appears 
to have unaffected growth and tRNA production (Zaniewski 
et al 1984) . It seems that these exonucleases are 
functionally redundant and that new nucleases for 3' 
processing may remain to be discovered. With regard to 
this latter point, the ability of a mutant devoid of all 
four exonucleases to correctly process the 3' terminus in 
vitro has been shown to be due to a phosphorolytic 
exonuclease activity (Cudny and Deutscher 1988). 
The apparent 	functional 	interchangeability 	of 
exonucleases has made the precise mechanism of 3' end 
formation difficult to elucidate, though certain clues 
have been uncovered. Cudny and Deutscher (1980) 
compared the 3' processing activities of purified RNase 
II and RNase D preparations. RNase D, which is a non- 
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processive exonuclease, managed to process a mixture of 
tRNA precursors properly generating correct amino acid 
acceptor activity in the mature molecules. Processing 
slows down greatly at the CCA 3' terminal sequence, 
thereby allowing aminoacylation and highlighting the 
careful nature of RNase D trimming. 
RNase II, which is a processive exonuclease, removes 
precursor nucleotides but also one to two extra 
nucleotides and so loses amino acid acceptor activity. 
For one particular molecule (tRNATYr precursor) RNase II 
degradation is extensive. This evidence suggests that 
RNase D is an important (albeit nonessential) tRNA 3' 
maturation exonuclease whilst P.Nase II is a nonspecific 
degradative enzyme. 
Studies on mutants lacking both RNase D and RNase II 
led to the discovery of RNase BN (Asha et al 1983) 
another exonuclease involved in tRNA 3' trimming. RNase 
BN seems to be required for the processing of some phage 
encoded tRNA transcripts but not those of E. coli. The 
important difference between these molecules is that 
whilst all E. coil precursor transcripts contain the 
entire mature species, some phage transcripts require the 
post-transcriptional addition of a 3' CCA. 	(Fukuda and 
Abelson 1980). 	Consequently these 3' processing 
reactions are different in that the additional precursor 
nucleotides must be removed from the phage transcript 
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prior to the CCA addition. 	The existence of an RNase BN 
mutant strain which is unable to process these particular 
phage transcripts helped pinpoint the enzymes role in 
this particular reaction (Seidman et al 1975). However 
since no E. coli tRNA precursor requires this type of 
processing, the exact function of RNase BN in the 
uninfected cell remains unclear. 
Unclear also is the importance of the reaction 
mediated by RNase T. This non-processive exonuclease 
removes the 3' terminal AMP from mature tRNA molecules 
(Deutscher et al 1984). 	It can be added back by tRNA 
nucleotidyl transferase (Deutscher et al 1977a). 	The 
cyclic nature of these enzyme reactions has led to the 
process being called tRNA end-turnover. As I have said, 
the importance of this process is unknown, although tRNA 
nucleotidyl transferase (cca) mutants do show 
accumulation of defective tRNA molecules (Deutscher and 
Hilderman 1974) and a consequent decrease in growth rate 
(Deutscher et al 1977b). RNase T deficient derivatives 
of such mutants (i.e. cca, RNase T doublemutants) show 
less accumulation of defective tRNAs and exhibit a faster 
growth rate than their RNase T parents. The amount of 
defective tRNAs in cells therefore appears to be 
determined by the balance of these two enzymes. However 
since single RNase T mutant strains (lacking as much as 
70% of wild-type RNase T activity) display normal growth, 
the physiological significance of end-turnover remains a 
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mystery (Deutscher et al 1985). 	Perhaps the major 
function of RNase T lies elsewhere. 
Once the processing and trimming of precursor tRNAs 
is complete, the mature molecule is remarkably resistant 
to further nuclease attack. This is due to the highly 
compact, stable structure adopted by mature tRNAs. 
Mutations which disrupt this structure often render the 
molecule sensitive to degradation (Smith 1974). 
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1 .5 E. CULl RNA POLYMERASE 
1 .5. 1 INTRODUCTION 
E. coli RNA polymerase is a large and complex 
molecule comprised of four subunits : a, 13, 0' and, in 
the major holoenzyme, c70 (Burgess 1969). These are 
encoded by the genes rpoA, B, C and .D respectively 
(nomenclature : Hayward and Scaife 1976). The DNA 
sequence of these genes allows one to predict proteins of 
the following molecular weights : a (36Kd) (Post and 
Nomura 1979, Post et al 1980, Meek and Hayward 1984, 
Bedwell et al 1985), 13 (150Kd) (Ovchinnikov et al 1981) 
(3' (155Kd) (Ovchinnikov et al 1982) and d 70 (70Kd) 
(Burton et al 1981). The gene rpoZ, for an associated 
factor : the omega (w ) factor, has also been cloned and 
sequenced (Gentry and Burgess 1986). From this DNA 
sequence one can predict a protein of molecular weight 
lOKd. 	Normal assembly and function of RNA polymerase is 
not dependent on the association of omega factor. 	It 
will be discussed, separately, later. 
The rpoA, B, C and D genes are present in the cell 
in three different operons : the a operon, the rpoBC 
operon and the MMS operon (which includes rpoD). 
Assembly of the polymerase subunits to form an active 
enzyme proceeds as follows: 
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13 	(3'C17  
a+a ---> a2 --- > a2(3 ---> a23(3' ---> a21313'cY70 
This pathway was elucidated from the results of work 
with assembly mutants (Ito et al 1975, Ishihama et al 
1976, Taketo and Ishihama 1976). 
The core enzyme (a2(313') displays a non-specific DNA 
binding ability which can be converted, upon addition of 
d 70 , to a highly specific, stable interaction with 
transcriptional promoters. 	The core enzyme plus sigma 
is the holoenzyme. 	Genuine transcription initiation can 
now be achieved. 	The sigma factor is released from the 
polymerase molecule shortly after mRNA chain elongation 
starts. Other factors may then interact with polymerase 
at, or before, the stage of transcription termination. 
These processes will be touched on during my discussion 
of the RNA polymerase subunits and their genes. I will 
also focus on the regulation of gene expression in the 
rpoBC operon which - although well studied - still poses 
some very interesting questions relevant to the control 
of gene expression in general. 
1.5.2 a SUBUNIT 
The a subunit of RNA polymerase is encoded by the 
rpoA gene, which is cotranscribed with the ribosomal 
protein genes S13, Sil, S4 and L17 in an operon at 73 
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minutes on the E. coil chromosome (Jaskunas et al 1975a, 
1975b, 1975c, 1977, Jaskunas and Nomura 1977, 	Bachmann 
1983). 	Transcription extends from the upstream spc 
operon into the a operon, essentially occluding the a 
promoter (Ceretti et al 1983). This is akin to the 
situation in the rpoBC operon where transcription from 
PL11 may partially occlude PL1O (see later). 
a dimers are produced in about 10% molar excess over 
13 and  13' (Iwakura et al 1974, Hayward and Fyfe 1978a). 
The regulation of the rpoA gene is intriguing. It 
resides between the genes for two ribosomal proteins (S4 
and L17, see Fig. 1.2), yet it appears to be regulated 
independently of them and of the other r-proteins in the 
a operon. Whilst the synthesis of the r-proteins - S13, 
S11, S4 and L17 - is subject to stringent control (Dennis 
and Nomura 1974), a subunit synthesis is not (Reeh et al 
1976, Blumenthal et al 1976). 	Also, a subunit 
production is 	enhanced during a challenge with 
rifampicin, whereas S4 and L17 syntheses are not 
similarly induced (Nakamura and Yura 1976, Hayward and 
Fyfe 1978b, Pedersen et al 1978). 
Si nuclease analysis of a operon mRNA has shown that 
there is no unique transcription initiation or 
termination within the a operon, nor any cleavage events 
which could dissect the message and so easily explain the 
independent regulation 	(Thomas et al 1987). 	It thus 
Structural organisation of the a operon. 	Pa is the 
partially occluded promoter of the a operon. 	Open boxes 
represent the structural genes. 
•Fig ... 
Structural organisation of the MMS operon. 	rpsU 
encodes r-protein S21, dnaG encodes primase and rpoD 
encodes sigma 70. 	Fl, P2, P3, Pa, Pb and Phs are 
promoters; 	ti and t2 are terminators. 	Open boxes 
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appears that the differential expression occurs at the 
translational level. 
All four 	r-proteins 	of 	the a 	operon are 
translationally regulated by the repressor r-protein S4 
(Jinks-Robertson and Nomura 1982) which binds at a sincrle 
target site upstream of the S13 operon (Deckman and 
Draper 1985, Thomas et al 1987). Mutational and 
nuclease analyses have demonstrated that this mRNA site 
forms a complex "pseudoknot" structure (Deckman et al 
1987, Deckman and Draper 1987, Tang and Draper 1989) 
which may form to bring sites into close proximity in the 
RNA tertiary structure (Draper 1989). S4 binding at 
this site represses the synthesis of r-proteins from the 
a operon without affecting a subunit synthesis (Thomas et 
al 1987). 
The function of a is unclear. 	Its major role may 
be to hold the core enzyme together (Chenchick et al 
1981). Temperature-sensitive mutations in rpoA can 
alter the transcriptional fidelity of RNA polymerase in 
vitro, although these mutants show no indication of 
erroneous transcription in vivo (Ishihama et al 1980). 
The reconstitution of active RNA polymerase from its 
isolated subunits has an absolute requirement for a (Heil 
and Zillig 1970), a213 being an intermediate in the RNA 
polymerase assembly pathway. It is therefore not 
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surprising that a temperature-sensitive a subunit mutant 
blocks assembly at an early stage (Kawakami and Ishihama 
1980). 
1.5.3 	[]T 
The 13 subunit is encoded by the rpoB gene. 	This is 
part of the large and complex rpoBC operon which I will 
discuss later. This subunit appears to be involved in a 
range of functions in all areas of transcription. 
Mutations conferring resistance to the antibiotic 
rifampicin - a drug known to block transcription 
initiation - are localised to the 13 subunit of RNA 
polymerase (Heil and Zillig 1970). Some rifr 13 subunits 
have an altered mobility with respect to rife 13 subunits 
(Rabussay and Zillig 1969). 
The 	connection 	between 	f3 	and 	transcription 
initiation is strengthened by the work of Glass et al 
(1986a, 1986b). They isolated a deletion mutant which, 
although displaying no obvious phenotype in vivo, showed 
altered promoter selectivity in vitro (Glass et al 
1986a). This could be an indirect effect since the 
region deleted in the mutant may be one which is involved 
in sigma binding (Glass et al 1986b). Other studies on 
rpoB mutants also suggest a role for 13 subunit in 
transcription initiation (Tessman and Petersen 1976, 
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Nomura et al 1984, reviewed in Lathe 1978, Yura and 
Ishihama 1979). 
The 	13 	subunit 	also 	binds 	the 	antibiotic 
streptolydigin (Iwakura et al 1973) - a drug which 
inhibits both initiation and elongation. 	This indicates 
a possible role for 13 in elongation too. 	The amino- 
terminal region of the 13 subunit has been shown to be 
involved in transcriptional elongation (Nikiforov et al 
1983, 1985) and affinity labelling of RNA polymerase with 
uridine triphosphate analogues demonstrated the location 
of the substrate binding site on the 13 subunit (Frischauf 
and Scheit 1973, Armstrong et al 1976). 
Interestingly, 	a 	transcriptional 	proofreading 
mechanism has been proposed whereby RNA polymerase could 
monitor the fidelity of transcription (Kahn and Hearst 
1989, Libby et al 1989). The reduced accuracy displayed 
by an rpoB mutant suggests that the 13 subunit is involved 
in this proofreading mechanism (Libby et al 1989). 
A whole 'bank' of mutations conferring rifampicin 
resistance is located in the middle of the rpoB gene. 
Different alleles affect termination and/or 
antitermination of transcription (Jin and Gross 1988, Jin 
et al 1988a, 1988b). In addition, several suppressed 
amber mutants located in the 13 gene allow the growth of A 
phage defective in N-mediated antitermination, also 
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suggesting the participation of 13 subunit here (Nene and 
Glass 1984) 
Recently, two mutations which were selected to 
suppress the termination defects of a rho mutant 
(Guarente 1979) were mapped to the distal half of rpoB 
(Jin and Gross, 1989). 
Thus there is strong genetic evidence for the 
involvement of 13 in termination. 
1.5.43 . SUBUN.IT  
The gene rpoC, part of the rpoBC operon, encodes the 
13 ' subunit of RNA polymerase. It is the only subunit of 
RNA polymerase which can bind to DNA by itself (Zillig et 
al 1970, 1971, Fukuda and Ishihama 1974). However this 
binding seems to be non-specific, since 13' is highly 
basic and binds to other polyanions such as heparin 
(Zillig et al 1970). This property of 13' presumably 
contributes to the non-specific DNA binding ability of 
RNA polymerase core enzyme. A temperature-sensitive 13 ' 
mutation affects the DNA binding properties of RNA 
polymerase (Panny et al 1974). 
Mutational studies have also implicated 13' subunit 
in the process of promoter selection (Gross et al 1976, 
Nomura et al 1984) (as with (3) although, as noted below, 
this is primarily the responsibility of a subunit. 
Finally, it has been suggested that 0' participates 
in termination since one of the polymerase mutants 
responsible for suppression of the termination defects of 
a rho mutant (Guarente 1979) maps in rpoC (Jin and Gross 
1989). 
1.5.5 ci SUBUNIT 
In E. coli the primary sigma factor, responsible for 
the majority of cellular transcription initiation, is 
70, encoded by the gene rpo.D. This gene is located in 
an unusual operon with genes whose products are involved 
in translation initiation (rpsu) and priming of DNA 
replication (dnaG) (Burton et al 1983, Lupski et al 
1983). Since these genes are involved in initiating the 
syntheses of the cells major macromolecules, the operon 
has been called the macromolecular synthesis (MMS) operon 
(Lupski and Godson 1984). 
Transcription in the MMS operon can initiate at six 
known promoters (see Fig. 1.3). These have different 
strengths, as judged by their relative abilities to drive 
expression of the CAT gene in plasmid constructs (Lupski 
et al 1984). 	Promoter occlusion by Pi appears to 
operate at P2 and P3 (Lupski et al 1984). 	Transcription 
61 
from the heat-shock promoter (Phg), present in the coding 
region of dnaG, is thermoinducible and dependent on the 
rpoH gene product, C32 (Taylor et al 1984, Grossman et al 
1984). The terminator Ti is more than 90% efficient in 
stopping transcripts initiated at Pi, P2 or P3 from 
passing into the dnaG gene (Burton et al 1983, Lupski et 
al 1983, 1984). As mentioned earlier, an RNA processing 
event in the dnaG - rpoD intergenic region may expose the 
3' end of dnaG message to exonuclease attack. 
Degradation could then be blocked at the Ti terminator 
structure. This would help explain the relatively low 
levels of dnaG expression (Burton et al 1983). 
Antitermination at Ti, either by an endogenous E. 
coil antiterminator protein (Lupski et al 1983, Peacock 
et al 1985) or by ), N gene product (Nakamura and Yura 
1975) could lead to the overexpression of the downstream 
genes dnaG (see Wold and McMacken 1982) and rpofl. 
Selective, increased expression of the rpoD gene product 
(ci 70 ) has been detected during ), infection (Nakamura and 
Yura 1975). Further differential expression may be 
achieved at the translational level, by differences in 
translation efficiency and codon usage between the three 
genes (Lupski and Godson 1984). 
A "dissection" of sigma protein into functional 
regions and sub-regions is presented in a review by 
Hellman and Chamberlin (1988). 	This allocates sigma's 
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distinct functional activities, such as core binding, 
promoter recognition, and DNA melting to specific regions 
within the protein. These are often conserved between 
species and amongst the alternative sigma factors. 
The sub-region "2-4" appears to be involved in 
recognising the "-10 region" of promoters (consensus 
sequence TATAAT for c1 70 ) by making direct contact with 
the DNA (Siegele et al 1989, Zuber et al 1989) whilst 
residues in sub-region "4-2" of the major sigma appear to 
be in direct contact with nucleotides in the "-35 region" 
of bacterial promoters (consensus sequence TTGACA) 
(Gardella et al 1989, Siegele et al 1989). 
Besides ci 70 , E coli has four other cr factors (so far 
identified) each directing core enzyme to promoters with 
their own unique recognition sequences:- i) C32 (encoded 
by rpoH) which transcribes heat-shock genes from their 
special promoters (Grossman et al 1984) ii) C154  (rpoN), a 
factor required for the transcription of nitrogen-
regulated (and other types of positively-regulated) genes 
(Kustu et al 1986). iii) CrF which appears to be 
responsible for transcription of the flagellar, 
chemotaxis and motility genes in E. coli (Arnosti and 
Chamberlin 1989). iv) CE which activates transcription 
from rpoH P3 (Wang and Kaguni 1989, Erickson and Gross 
1989), the only one of the a 32 gene promoters which is 
functional at 50°C (Erickson et al 1987). clE also 
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activates the promoter of the htrA gene, the product of 
which is required for viability at temperatures above 
42°C (Lipinska et al 1988, 1989). Thus aE seems to be 
involved in high-temperature gene expression. 
Streptornyces coelicolor and Bacillus subtilis have 
batteries of sigma-factors, some of which are involved in 
the control of differentiation and developmental 
regulation of gene expression in these organisms (Buttner 
1989, Losick et al 1986). 
1.5.6 tJ SUBUNIT 
The omega subunit is a factor which is associated 
with RNA polymerase (Burgess 1969) but which is not 
essential for normal RNA polymerase function. It is 
encoded by the gene rpoZ (Gentry and Burgess 1986). 
Interestingly this is located in the same operon as spoT 
(Gentry and Burgess 1989), a gene whose product is 
involved in ppGpp metabolism (Cashel and Rudd 1987). 	In 
vitro studies suggest that 	factor is involved in the 
ppGpp-mediated alteration 	of promoter 	selectivity, 
associated with the "stringent response" during 




Transcriptional regulation of the rpoBC operon is 
complex. Figure 1.4 details the major (FLu) and 
secondary (PL10) (Linn and Scaife 1978, Yamamoto and 
Nomura 1978, Post et al 1979) and minor (PL7, PO, F2) 
promoters of the operon. Detailed Sl nuclease analysis 
has shown that PLXI is the predominant promoter in vivo, 
from which all six genes are transcribed, and that there 
is also significant transcription initiation at PL1O 
(Downing and Dennis 1987). It may be that Ptii is the 
predominant promoter in vivo due to promoter occlusion of 
PL10 (Bruckner and Matzura 1981) although the exact 
mechanism of this is unknown. 
There is no indication of initiation at any of the 
proposed weak promoters in the intact rpoBC operon. 
These minor promoters have been detected by indirect 
transcriptional analyses in vivo of several lambda and 
plasmid partial-operon clones (Ma et al 1981, Barry et al 
1979, An and Friesen 1980, Railing and Linn 1984). 
Their strengths have been estimated at 1-2% of those of 
the major promoters, and hence their possible 
contribution 	to 	normal 	operon 	expression 	is 
insignificant. 	Whether they are evolutionary relics 
"uncovered" by in vitro manipulation (which normally play 
Structural organisation of the rpoBC operon. 	rpM, 
rplA, rplJ and rpJL encode r-proteins Lii, Ll, LlO and 
L7/L12 respectively. 	rpoB and rpoC encode the (3 and j3' 
subunits of RNA polymerase respectively. 	PL11 and PL10 
are strong promoters; 	PL7, Pa and Pa , are much weaker 
promoters. 	tL7 and to are respectively, partial and 
strong terminators. 	ms is the RNase III target site. 
Open boxes represent the structural genes. 
Fig 1.4 
PulrplK 	rptA 	Piio rplJ. 	rplL 	tL7 F ms 	
rpoB 	rpoC 
II I, 	 I 
65 
no role in vivo), or whether they are functionally 
significant during, for example, extreme growth 
conditions, is unknown. 
1.6.2 TERMINATORS 
There are two terminators in the rpoBC operon : tL7 
and t' (see Fig. 1.4). 
tL.7 
tL7 is a partial terminator (or attenuator) of 
transcription. Approximately 80% of all transcripts 
which emanate from PL11 and PL1O are terminated at tL7. 
The remaining 20% of mRNA molecules continue into the 
rpoBC genes. Prior to the physical identification of an 
attenuated transcript by Si nuclease and direct RNA 
sequence analyses (Barry et al 1980), and remarkably by 
recent electron microscopy studies (French and Miller 
1989), the existence of an attenuator had been reasoned 
on the basis of several observations. 
Lindahl et al (1977) suggested that since rp1KAJL 
and rpoBC are cotranscribed and since there is a roughly 
fivefold excess of ribosomes over RNA polymerase 
molecules in the cell, then a regulatory mechanism such 
as transcriptional attenuation might exist to attain such 
differential expression. Transcription studies 
S. 
confirmed that this ratio exists at the mRNA level and 
strengthened the argument for the existence of an 
attenuator (Dennis 1977). Sequence analysis of the 
rpoBC operon (Post et al 1979) - since revised and 
extended (Morgan et al 1984, Delcuve et al 1980, 
Ovchinnikov et al 1981, 1982) - also indicated that there 
was a simple terminator in the rplL - rpoB intercistronic 
region. tL7 is assumed to be a factor-independent 
terminator, although one report does suggest that rho 
increases, and that both NusA and the sfrB gene product 
decrease, termination efficiency in the rplL - rpoB 
intergenic region (Railing and Linn 1987). 
The efficiency of this terminator is fixed over a 
range of growth rates (Ralling et al 1985). 	However, it 
can be altered. 	One of the earliest indications of this 
was the response of partial diploids (rifr/rifs 
containing a mixture of drug-resistant and drug-sensitive 
RNA polymerase) to a challenge with rifampicin. Against 
the background of a decrease in total protein synthesis 
caused by the drug, the RNA polymerase subunits 13 and  13' 
showed transiently increased rates of synthesis (Hayward 
et al 1973). Such induction was then shown to occur for 
all four of the RNA polymerase subunits in merodiploids 
(Hayward and Fyfe 1978b) and also in sensitive haploid 
strains treated with subinhibitory levels of rifampicin 
(Nakamura and Yura 1976). 
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In contrast, streptolydigin - which also binds to 
the 13 subunit - does not produce this effect (Tittawella 
and Hayward 1974, Nakamura and Yura 1976). Thus it 
appears that the effect is a consequence of rifampicin 
binding, rather than just generalised drug inactivation 
of polymerase. 
Direct analysis of mRNA after rifampicin induction 
revealed a marked increase in the levels of rpoBC message 
relative to those of rpIKAJL (Blumenthal and Dennis 1978, 
Bass et al 1979). There is no evidence that rifampicin 
stimulates •any of the promoters in the rpoBC operon (Howe 
et al 1982, Newman et al 1982, Fukuda and Nagasawa-
Fujimori 1983, Morgan and Hayward 1985, Morgan and 
Hayward 1987), whereas several papers have shown, both 
indirectly and directly, that rifampicin promotes 
transcriptional readthrough at the attenuator tL7 (Howe 
et al 1982, Newman et al 1982, Fukuda and Nagasawa-
Fujimori 1983, Morgan and Hayward 1987). However, this 
does not reflect some specific regulatory feature of the 
tL7 attenuator in the rpoBC operon. Rifampicin also 
causes readthrough of all rho-independent and rho-
dependent terminators tested (Howe et al 1982, Newman et 
al 1982, Cromie and Hayward 1984). The likeliest 
explanation seems to be that a direct action of the drug 
on RNA polymerase (via the 13 subunit) alters the 
efficiency of transcription termination in general. 
This is consistent with the findings that rifampicin- 
resistant mutants can affect termination positively or 
negatively (Yanof sky and Horn 1981, Fisher and Yanof sky 
1983, Jin and Gross 1988, Jin et al 1988) at simple or 
complex terminators (Jin et al 1988). 
One possibility suggested by Tittawella (1976) is 
that rifampicin induced acceleration of 3' synthesis 
first requires the production of a positive control 
protein (it) made during the first four minutes of drug 
treatment. 	This would then presumably act at tL7 
mediating readthrough in some fashion. 	No such positive 
control protein has yet been identified, biochemically or 
genetically. 
Studies with RNA polymerase subunit mutants also 
suggested that the efficiency of tL7 	could be 
specifically modulated. 	Using a poorly suppressed amber 
mutation of rpoB or an rpoB t.s. mutation at the non-
permissive temperature, the synthesis of 313' subunits was 
shown to be stimulated (Glass et al 1975, Dmitriev et al 
1976). Temperature-sensitive mutants of rpoC, which are 
assembly-defective, also over-produce these subunits at 
their non-permissive temperature (Kirschbaum et al 1975, 
Taketo et al 1976, Taketo and Ishihama 1976, Khesin et al 
1976, Taketo and Ishihama 1977). Stimulation of 13 13 ' 
synthesis in both cases could be due to transcriptional 
readthrough at the attenuator (Dennis 1977b, Kirschbaum 
1978, Little and Dennis 1979, Little and Dennis 1980, 
Little et al 1981). 	This does not necessarily imply a 
specific modulation of tL7 efficiency in response to the 
lowered levels of active RNA polymerase. Instead it is 
possible that at the higher-temperature the mutant enzyme 
is •g.Jjy defective in transcription termination. 
This is comparable with the "rifampicin-bound" situation 
discussed above. Certain t.s. rpoB mutants show a 
decrease in the rate of 00' synthesis when shifted to the 
non-permissive temperature (Kirschbaum et al 1975, Taketo 
and Ishihama 1976, Taketo et al 1976). Thus (as 
discussed above) depending on the mutation in rpoB, the 
ability of RNA polymerase to function at termination may 
be increased or decreased. As a consequence the 
readthrough of the rpoBC attenuator (tL7) would be 
altered, as would 1313' expression, not as a specific, 
direct response to the changed levels of activ,e RNA 
polymerase, but non-specifically and indirectly. 
However, as a counter argument, one interesting 
study with an rpoD t.s. mutant strain maintains the 
possibility that the rpoBC attenuator is a site for 
specific autogenous regulation of transcription. 	At the 
non-permissive temperature this t.s. 	sigma mutant 
produces RNA polymerase which 	is inefficient at 
transcription initiation. 	Under these conditions 
increased production of 1313' is observed (Blumenthal and 
Dennis 1980). 	Since, during transcription, the sigma 
subunit normally disengages shortly after RNA chain 
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elongation starts, it is unlikely to be involved in 
readthrough of terminators. Therefore the model of non-
specific readthrough of tL7 to explain increased 13 13 ' 
production in the rpoD t.s. mutant, is not easily 
applicable here. It is possible that this work 
demonstrates a specific regulatory mechanism which 
"compensates" for the decrease in levels of initiation-
competent RNA polymerase by increasing the transcription 
of rpoBC through tL7 attenuator readthrough. 
It is interesting, on the other hand, to note that 
sequences around prokaryotic promoters can affect the 
efficiency of termination at downstream sites 
(Telesnitsky and Chamberlin 1989, Gouger et al 1989). 
Telesnitsky and Chamberlin (1989) suggest that this might 
be due to sequence-mediated alterations in the 
conformation of the transcribing RNA polymerase, which 
could alter its ability to terminate at simple (factor-
independent) terminators. One could imagine that rpoD 
t.s. mutants might also contribute to altering the 
conformation of the transcribing RNA polymerase, 
rendering it inefficient at termination at tL7, and 
thereby explaining the increase in 1313' production. 
The transcripts which read through tL7 (to encode 
rpoBC) are finally terminated at to- (Squires et al 
1981). 
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1.6.3 rp AC _..MS.S_E.NGER_.RNA PROCESSING 
Two intercistronic regions of rpoBC messenger RNA 
are subject to endonucleolytic processing : the rplA - 
rplJ intergenic space (Bruckner and Matzura 1981, Morgan 
and Hayward 1985, Downing and Dennis 1987) and the rplL - 
rpoB intergenic region (Barry et al 1980, Fukuda and 
Nagasawa-Fujimori 1983, Downing and Dennis 1987, Morgan 
and Hayward 1987, Railing and Linn 1987). 
rp.lA . .rp.l...J 
This intergenic space contains the PL10 promoter, 
but lacks any recognisable rho-independent termination 
signals. Si nuclease mapping shows the 5' end of the 
putative PLIO - initiated in vivo transcripts to be 
extremely heterogeneous (Morgan and Hayward 1985, Downing 
and Dennis 1987). This may reflect some sort of 
progressive processing at the 5' end of the PL10 
initiated transcript. Discrete processing sites, both 
5' (Downing and Dennis 1987) and 3' (Bruckner and Matzura 
1981, Morgan and Hayward 1985, Downing and Dennis 1987) 
of the putative PL10 initiation site, have been detected. 
Two major endonucleolytic sites at positions 1500 and 
1595 (scale of Post et al 1979) are detected in three 
separate studies (Bruckner and Matzura 1981, Morgan and 
Hayward 1985, Downing and Dennis 1987). The identity of 
the ribonuclease (or ribonucleases) which makes these 
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specific cleavages is not known, although it is clear 
that RNase III is not involved (Downing and Dennis 1987). 
Equally unclear is the functional significance of these 
cleavages. 
RNase III dp...es process rpoBC mRNA in this region. 
This was first observed during Sl nuclease mapping 
studies of the rpoBC operon (Barry et al 1980). 
Plasmids were used to increase the level of mRNA specific 
for this region, by increasing the copy number or further 
by fusion to the inducible arabinose promoter. Total 
RNA was extracted from cells, hybridised to appropriate 
DNA probes, treated with Si nuclease and the resultant 
nuclease-resistant DNA-RNA hybrids were analysed on 
acrylamide gels. A hybrid corresponding to the tL7 - 
attenuated transcript was observed, but no full-length, 
readthrough message could be detected. Instead an array 
of discrete, smaller bands was seen, which were 
interpreted as being processing products of the 
readthrough transcript. The cleavage sites occur in the 
vicinity of a potential large stem-loop structure, which 
resembles known RNase III sites. Si nuclease analysis 
of RNA prepared from an RNase Ill-deficient strain showed 
no indication of processing at this position. The exact 
location of cleavage has proved difficult to define. 
The combined data of these detailed studies suggest that 
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the RNase III target site is cut on both "arms" of the 
large stem. 	On the 5' arm, cleavages has been mapped at 
positions 2770 (±3) (Railing and Linn 1987), 2776 (±1) 
(Downing and Dennis 1987) and 2785(±3) (Fukuda and 
Nagasawa-Fujimori 1983, Downing and Dennis 1987, Railing 
and Linn 1987); and on the 3' arm, at 2864 (Fukuda and 
Nagasawa-Fujimori 1983) and 2860 (Barry et al 1980) 
(scale of Post et al 1979). 	The indication from these 
papers is that processing at the 5' arm is perhaps more 
efficient than cleavage at the 3' arm. 	On the whole, 
processing at this site is normally inefficient 
approximately 50% of transcripts are cleaved by RNase III 
in vivo (Morgan and Hayward 1987) at a variety of growth 
conditions and growth rates (Downing and Dennis 1987). 
In vivo, mRNA derived from plasmids containing the rplL - 
rpoB intergenic region seems to be processed at the RNase 
III site with much higher efficiency (Barry et al 1980). 
This may be a general feature of plasmid-borne RNase III 
target sites (Panayotatos and Truong 1985). 	Transcripts 
made in vitro do not seem to be well processed at this 
site (Fukuda and Nagasawa-Fujimori 1983). 
The functional significance of RNase III cleavage of 
rpoBC mRNA is debatable. No differences were detected in 
the rate of rpoBC transcription or the synthesis rates of 
13 and  13' proteins in an rnc105 mutant (N2077) and its 
isogenic wild type partner (N2076) under steady-state 
growth, in one study (Dennis 1984). However Portier et 
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al (1987) present preliminary evidence that 13 and 3' 
proteins are overexpressed in an rnclO5 mutant (BL321) 
relative to its isogenic wild type partner (BL322). 
A study employing plasmid-borne deletions of the 
RNase III target site suggests that sequences in this 
region are involved in determining the translational 
efficiency of rpoB mRNA, but that processing per se is 
not involved in this (Dennis 1984). However another 
possible conclusion one could draw from this work is that 
the observed reduction in rpoB translational efficiency 
from these plasmids is predominantly due to effects on 
autogenous translational repression. By comparison the 
observed, deletion-mediated alterations in intrinsic 
translational efficiency are fairly minor. Clearly this 
topic requires further investigation. 
1.6.4 	TRANSLATIONAL REGULATION 
All six genes of the rpoBC operon are subject to 
translational regulation. The four ribosomal genes 
exhibit an autogenous control which seems to be common 
for ribosomal proteins generally. - As discussed earlier, 
the r-protein genes Lii and Li are regulated by the 
binding of repressor r-protein Li to its target site at 
the 5' end of L11mRNA (Dean and Nomura 1980, Yates et al 
1980, Yates and Nomura 1981). As I also mentioned, 
translational coupling ensures that this event represses 
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the synthesis of both proteins simultaneously (Baughman 
and Nomura 1983). This translational repression is 
accompanied by an increased instability of this message 
(Cole and Nomura 1986). 
In common with all the known ribosomal translational 
repressor proteins, Li recognises a specific site at its 
target mRNA and also binds directly to rRNA (reviewed in 
Noller 1984). 
The sites in Li protein and Lii mRNA involved in the 
repressor-mRNA interaction are conserved in other 
bacterial species. Li protein from Serratia marcescens 
and Proteus vulgaris both regulate the E coli Lii operon 
(Sor and Nomura 1987). The Lii mRNA target site 
sequence conservation between these three species is 
highlighted in Fig. 1.5 (taken from Draper 1989). 
Furthermore, E. coli Li protein can bind to a segment of 
Dictyostelium discoideum 26SrRNA which is homologous to 
the E. coli rRNA binding site (Gourse et al 1981), thus 
indicating that there is also significant conservation of 
this site. The identical nucleotides are also marked in 
Fig. 1.5. 
The conserved bases focus attention on a consensus 
Li binding site present in both L11mRNA and 23SrRNA 
(Branlant et al 1981, Gourse et al 1981, Draper 1989). 
This site displays both primary and secondary structure 
Binding site for Li protein on E. coii L11mRNA. 
Base numberings are from the 5' terminus of the mRNA 
transcript. 'Tick' marks are located every 10 bases. 
Bases in bold face are conserved in Li binding sites from 
Serratia marcescens, Proteus vuiçraris and E. 	coil 
messages. 	Boxed sequence is conserved in primary and 
secondary structure between E. coil Lii mRNA and 23SrRNA. 
Underlined bases indicate the initiator AUG and Shine-
Dalgarno sequence. 
F,g.1 .. B 
Binding 	site 	for 	Li protein 	on 	E. coil 23SrRNA. 
Base numberings are 	from the 	5' 	end 	of 	E. coil 23SrRNA 
'Tick' 	marks are 	located every 	10 bases. Bases in bold 
face are 	conserved in Li binding sites from Dictyosteilum 
dlscoldeum 26SrRNA and E. coil 23SrRNA. 	Boxed sequence 
is 	conserved 	in 	primary and 	secondary 	structure between 
E. 	coil 23SrRNA and Lii mRNA. 
... 6..A
Binding site for L8 complex on E. coil LlO mRNA. 
Base numberings are from the 5' terminus of the mRNA 
transcript. 	'Tick' marks are located every 10 bases. 
Boxes outline 	nucleotides 	similar 	in primary and 
secondary structure between L10 mRNA and 23SrRNA. 
Binding site for L8 complex on E. coil 23SrRNA. 
Base numberings are from the 5' end of E. coil 23SrRNA. 
'Tick' marks are located every 10 bases. Boxes outline 
nucleotides similar in primary and secondary structure 
between 23SrRNA and L10 mRNA. 
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conservation. 	Mutations which relieve translational 
regulation occur in this conserved region (Thomas and 
Nomura 1987) and destruction of the potential secondary 
structure by site-directed mutagenesis (Baughman and 
Nomura 1984) abolished translational regulation. 
Similarly site-directed mutations within the 23SrRNA 
"consensus" site also effect Li binding (Said et al 
1988). 
The 	ability 	to 	interfere 	specifically 	with 
translational control allowed its significance to be 
elucidated. A chromosomal mutation which abolishes 
translational regulation of L11mRNA also abolishes 
growth-rate-dependent regulation and stringent control of 
Lii and Li proteins (Cole and Nomura 1986b). As 
expected, the regulation of other r-proteins, not under 
Li control, is unaffected by this mutation. This work 
demonstrated the physiological importance of 
translational regulation of r-protein synthesis. Growth-
rate-dependent regulation of r-protein synthesis in other 
operons was already known not to involve altered promoter 
activity (Miura et al 1981); therefore such a 
translational control mechanism may be widespread amongst 
r-protein genes. 
Stringent control of ribosomal protein synthesis was 
previously thought to be achieved at the transcriptional 
level, for all r-protein operons. Aminoacyl tRNA 
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limitation causes a rapid reduction in rRNA and r-protein 
synthesis (called the "stringent response": for a review 
see Cashel and Rudd 1987). It seems clear that rRNA 
synthesis is directly affected by stringent control, but 
less clear how r-protein synthesis is regulated under 
these conditions. The promoter for the SlO r-protein 
operon appears to be responsible for the stringent 
control of r-protein production from this operon 
(Freedman et al 1985). However neither PL11 nor PL10 
(of the rpoBC operon) is subject to stringent control in 
vivo (Wright et al 1988, Morgan and Hayward 1985). This 
is in agreement with the conclusion of Cole and Nomura 
(1986b) that stringent control of the 'Lii operon' is 
mediated at the translational level. 	Such indirect 
control could be achieved as follows. 	Stringent control 
would directly lower the levels of rRNA, which would lead 
to free Li protein accumulation. 	This could then 
repress translation of rplKA. 	This may be a common 
model for the stringent control of the synthesis of r-
proteins, but it is clearly not a universal one (see 
above). Acceptance of it as a general model requires 
one to explain away apparently contradictory data. 
For instance, the observation that PL1O is sensitive 
to ppGpp in vitro (Kajitani and Ishihama 1984) suggests 
that it should be stringently regulated in vivo. This 
must be countered with the direct evidence against it 
(Morgan and Hayward 1985, Wright et al 1988) and with the 
vL 
argument that these in vitro experiments detect a 
phenomenon which is distinct from the physiological 
stringent control (Baracchini et al 1988). Also, the 
evidence that transcription of the rpIKAJL genes is 
reduced during partial amino acid starvation (Maher and 
Dennis 1977) must be explained in terms of increased 
messenger instability. Translational repression of Lii 
and Li sharply decreases the half-life of their mRNA 
(Cole and Nomura 1986a). Therefore stringent control of 
r-protein synthesis from this operon - mediated by 
translational repression - could also decrease the 
stability of rp1KAJL transcripts. 
This model is also attractive because it explains 
why the cotranscribed rpoBC genes do not exhibit 
stringent control (Maher and Dennis 1977), without the 
need to invoke some specific modulation of tL7 efficiency 
during amino acyl tRNA limitation. 
The other two r-proteins of the rpoBC operon (LiO 
and L7/L12) are similarly regulated at the translational 
level. A protein complex of L10-L7/Li2 (termed L8) binds 
to the leader sequence of L1OmRNA, blocking translation 
of both LiO and L7/L12 (Yates et al 1981). The L8 
complex also has a specific binding site on 23SrRNA 
(Beauclerk et al 1984). 	These two binding sites are 
compared in Fig. 1.6 (from Draper 1989). 	Nuclease 
protection studies indicate that the L8 complex binds at 
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a site more than 100 nucleotides upstream of the rplJ 
ribosome binding site (Johnsen et al 1982). Analysis of 
genetically selected mutations in the rplJ leader (Fiil 
et al 1980, Friesen et al 1983) combined with the results 
of site-directed mutagenesis of this region (Christensen 
et al 1984) support the idea that long range RNA 
secondary structure interactions are responsible for the 
translational regulation of the 'LlO operon', presumably 
by bringing the LB and ribosome binding sites into close 
proximity. By analogy with the 'Lii operon', it is 
presumed that growth-rate-dependent regulation and 
stringent control of L10 and L7/L12 syntheses are 
mediated at the translational level. 
The 13 and  13' subunits of RNA polymerase are also 
translationally regulated. An early indication of this 
was that over-expression of rpoBC mRNA, either from an 
inducible Arifdl8 lysogen or from a multicopy plasmid, 
did not result in equivalent increases in f313' syntheses 
(Kirschbaum and Scaife 1974, Dennis and Fiil 1979). 
In vitro studies in which purified RNA polymerase 
holoenzyme, or its assembly intermediates, were added to 
in vitro transcription-translation systems indicated that 
cx213 and holoenzyme could both act as translational 
repressors of 1313' synthesis (Fukuda et al 1978, Kajitani 
et al 1980). This translational repression can be 
lifted in vitro by rifampicin - presumably by direct 
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interference, since the drug binds to the 13 subunit of 
RNA polymerase (Lang-Yang and Zubay 1981, Fukuda and 
Nagasawa-Fujimori 1983). 
In vivo experiments have shown that cells compensate 
for a limitation of 13 and 13' syntheses, produced by poor 
suppression of amber mutations in rpoB, primarily by 
increasing the translational efficiency of rpoB mRNA. 
This compensatory mechanism allows those strains to 
produce enough RNA polymerase to support a near-normal 
rate of growth, despite the poorly suppressed mutation 
(Dennis et al 1985). The existence of such a mechanism 
suggests that the production of 1313' subunits are 
autogenously regulated at the translational level. This 
was directly demonstrated by overexpression of 1313' 
proteins from a lysogen carrying the rpoBC genes fused to 
the strong, controllable promoter PL in phage X. 
Induction of the lysogen increases rpoBC mRNA levels by 
at least tenfold, whilst f313' oversyntheses is about 2 - 
3fold. Overproduced 1313' also regulate the synthesis of 
P from the chromosome in strains carrying electrophoretic 
mobility mutations in rpoB. This regulation was shown 
to be post-transcriptional (Meek and Hayward 1986). 
Similarly, over expression of polymerase from inducible 
plasmids is also ultimately compensated for by repression 
of 1313' syntheses from the chromosome (Bedwell and Nomura 
1986). 
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There is also a suggestion that 13 and  13' syntheses 
can be regulated independently. Excess 13 subunit (alone 
or, more probably, as part of a complex) autogenously 
regulated 13 synthesis, but did not affect the rate of 13' 
synthesis (Meek and Hayward 1986). It is possible that 
alternative regulatory molecules (probably of a very 
similar nature) control 13 and 13' syntheses. 
A recent study (Passador and Linn 1989) has clearly 
demonstrated the existence of autogenous regulation of 13 
subunit synthesis at the translational level. A series 
of transcriptional and translational fusions of rpoB to 
the lacZ reporter gene have been constructed in lambda 
vectors. 	In parallel, plasmids carrying rpoBC under the 
control of a regulatable promoter were also made. 	A 
comparison of the results from lysogens carrying either 
the transcriptional or translational fusion plus the 
multicopy plasmid showed that whilst 1313' overproduction 
did not specifically affect the .i pi1pi of the rpoB 
- lacZ fusions, it did have a significant affect on the 
translation of the fusions. This is a neat and 
relatively straightforward way of analysing the 
translational feedback regulation of rpoB. 
One of the most intriguing problems has been to 
locate the precise target site on rpoB mRNA at which the 
regulatory molecule acts. Deletion studies of the rplL 
- rpoB intergenic region (Dennis 1984) suggested that 
sequences in the vicinity of the RNase III processing 
site may be important for translational efficiency grkd 
regulation. However, autogenous regulation appears to 
occur when almost all of the intergenic region is removed 
- right up to 26 base pairs short of the rpoB initiation 
site (Meek and Hayward 1986). Joint consideration of 
these papers points to the possibility of a complex, long 
range RNA secondary structure involving the interaction 
of sequences at the RNase III target site and the site 
for autogenous regulation. However a surprising result 
from the work of Passador and Linn (1989) indicates that 
at least part of the translational regulation site may 
lie well inside the coding region of rpoB (between 126 
and 403 base pairs inside rpoB). This is intriguing, 
and may be similar to the translational regulation of the 
qnd gene of E. coli which is mediated by the interaction 
of an internal sequence (located at codons 69 - 74 of the 
qnd structural gene) with the ribosome binding site of 
the gene, to which it is complementary (Carter-Muenchau 
and Wolf 1989). This type of interaction has also been 
postulated for the trmD operon of E. coli (Wikstrom and 
Bjork 1989). 
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1 . 7 THIS THESIS 
In this introduction an attempt has been made to 
survey two broad areas of bacterial molecular biology 
ribonucleases and RNA polymerase in E. coli. 	My thesis 
work has focussed on a point where these topics converge 
the role of RNase III processing in controlling 
expression of the RNA polymerase subunit genes rpoBC. 
This subject has attracted a fair degree of attention but 
is, as yet, not properly resolved. The following 
chapters describe work which is, initially, a comparison 
of rpoBC gene expression in rnc and rncl05 strains under 
steady-state and perturbed growth conditions. 
Subsequently a more detailed analysis of the role of 
processing at the RNase III target site in the rplL - 




2.1.1 STANDARD SOLUTIONS 
1 x TE : 	10mM Tris-HC1, 1mM EDTA; 	adjusted to 
pH8.0 with concentrated HC1. 
10 x TBE : 	0.89M Tris base, 0.89M boric acid, 20mM 
EDTA pH8.0. 
10 x TAE : 	0.4M Tris base, 0.2M sodium acetate, 10mM 
EDTA; 	adjusted to pH8.3 with glacial 
acetic acid. 
20 x SSC : 	3M NaCl, 0.3M sodium citrate; adjusted to 
pH7.0 with concentrated NaOH. 
20 x SSPE : 	3.6M NaCl, 	0.2M NaH2PO4, 	20mM EDTA; 
adjusted to pH7.4 with concentrated NaOH. 
50 x Denhardt's Solution : 1% (w:v) Ficoil, 1% (w:v) 
polyvinylpyrrolidine, 1% (w:v) BSA (Pentax 
Fraction V); filter-sterilised through a 
0.45m Acrodisc filter and stored in 
aliquots at -20°C. 
RNase A : 	5mgml 1 . 	Heated to 100°C for 15 minutes, 
allowed to cool slowly to room temperature 
and stored in aliquots at -20° C. 
10 X Tris-glycine running buffer : 3% (w:v) Tris base, 
14.4% (w:v) glycine; adjusted to pH8.6 
with concentrated NH40H. 
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Phenol : 	Redistilled under nitrogen into TE. 	For 
extractions of DNA solutions phenol was 
equilibrated with lM Tris-HC1 (pH8.0) and 
then TE buffer. 8-Hydroxyquinoline was 
added to 0.1% (w:v) and aliquots stored at 
-20°C. For extractions of RNA solutions 
phenol equilibrated with dH20 was used. 
Chloroform : 	Chloroform and iso-amyl alcohol mixed 24:1 
(v:v); 	stored in closed bottles at room 
temperature. 
2. 1 .2 	GROWTH MEDIA 
All quantities listed are for 1 litre final volume, 
unless otherwise stated. 	Solutions are autoclaved (see 
section 2.2.2) and stored at room temperature. 
Antibiotic and amino acid stock solutions were added to 
media immediately before use. 
L-broth (LB) : 	lOg Difco Bacto tryptone, 5g Bacto 
yeast extract, lOg NaCl; adjusted to 
pH7.2 with NaOH. 
LB-agar : 	 LB plus 15g Difco agar. 
BBL-agar : 	 lOg Baltimore Biological Laboratories 
trypticase, 5g NaCl, lOg Difco agar. 
BBL-top agar: 	as for BBL-agar, but with only 6.5g 
Difco agar. 
Spizizen minimal medium : 2g (NH4)2SO4, 14g K2HPO4, 6g 
KH2PO4, 	ig 	Na3citrate.2H20, 	0.2g 
M9SO4.7H20 	with 	the 	following 
supplements 	as 	required 	: 	0.2% 	(w:v) 
sugars, 	2mg 	vitamin 	Bi, 	20mg 	amino 
acids, 	5mg nicotinic acid. 
Spizizen minimal agar: 	Spizizen 	minimal 	medium plus 	15g 
Difco agar. 
Bacterial buffer: 3g KH2PO4, 	7g 	Na2HPO4, 	4g NaCl, 	0.2g 
MgSO4 .7H20. 
Phage buffer: 3g KH2PO4, 	7g 	Na2HPO4, 	5g NaCl, 	lOml 
0.1M MgSO4, 	lOml 	0.01M 	CaCl2, 	imi 	1% 
(w:v) 	gelatin. 
Antibiotics 	: When 	required, 	the 	media 	were 
supplemented 	with 	the 	following 
antibiotics 	at 	the 	stated 	final 
• concentrations. 
Ampicillin 100tgml - ' 
Chloramphenicol 50pgml - ' 
Streptomycin 200.tgml-1 
2.1.3 	BACTERIAL STRAINS 
All strains were derivatives of E. coli K12. 
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Table 2.1 
Strain Genotype Reference or Source 
JM101 .(lac-pro) , 	thi, 	supE/ Messing et al 	(1981) 
F' traD36, proAB, 	laclq 
lacZ, 	LM15. 
TGI A (lac-pro), supE, 	thi, Gibson 	(1984) 
hsdD51F' 	traD36, 
proAB, 	laclq, 	lacZ 
A M15. 
NM570 (lac-pro), 	thi, 	supE, N. Murray 
hsdM, hsdS, recA131F' (Edinburgh) 
proAB, 	laclq, 	lacZA 
M15. 
AK14 (lac-pro), araBi, A. Kumar 
recA: Cmr/F' proAB, (This 	lab.) 
laclq, 	lacZ 	A M15. 
N2076 thi-1, arqHl, nadB4, Apirion and Watson 
lacYl, gal-6, malAl (1975) 
xyl-7, ara-13, mt1-2, 
rpsL(Strr). 
N2077 rnclO5 (otherwise Apirion and Watson 
isogenic with N2076) (1975) 
BL322 thi-1, arqHl, supE44 Studier 	(1975) 
BL321 rncl05 (otherwise Studier 	(1975) 
isogenic with BL322) 
HB101 	F, proA2, lacYl, ara14, Boyer and Roulland- 
qalK2, xyl-5, mU-1, 	Dussoix (1969) 
rpsL(Strr), recA13, 
hsd20(rBmB). 
2. 1 .4 BACTERIOPHAGE 
Table 2.2 
Phage 	Genotype 	 Reference or Source 
)., DWM321 
	
	si, )-1°, si, ).. (2-3) D. Meek (This lab.) 




Plasmid Description 	 Reference or Source 
pNA60 	pSF2124 with 2.87 kb 
	
A. Nicolaidis 
('rpoB') EcoRI fragment 
of ). rifdl8 DNA inserted 
at EcoRI site. Apr 
pSKS106 P1ac vector for 	Shapira et al 
expression of proteins 	(1983) 
fused to 3-galactosidase 
via multiple cloning 
sites in the 5' end 
of lacZ gene. Apr 
pRAM1 	pSKS106 with 277 bp 	This work 
Hindlil -XmaI fragment 
from M13mp19-5, cloned 
between the same sites 
in the multiple cloning 
region. Produces a 
rpoB' - 'lacZ-encoded 
fusion protein. Apr 
all 
pRAM2 	Analogue of pRAMI carrying 	This work 
169 bp HindIII-XmaI fragment 
from M13mp19-9. Contains 
entire deletion of RNase III 
target site of rplL-rpoB region. 
Apr 
pRAM3 	Analogue of pRAMI, carrying This work 
174bp HindIII-XmaI fragment 
from M13mp19-6. Contains 
partial deletion of RNase III 
target site. Apr 
pRAM4 	Analogue of pRAMI, carrying This work 
247bp HindIII-XmaI fragment 
from M13mp19-11. Contains 
partial deletion of RNase III 
target site. 	Apr 
pMRMI 	Analogue of pRAMI, carrying 
271bp HindIII-XmaI fragment 
from M13mp19-10. Deletes 
two copies of UUU triplet 





2.2 	GENERAL METHODS 
2.2.1 GENERAL GUIDELINES 
All procedures were carried out at room temperature, 
unless otherwise stated. 
For RNA work, all materials were handled with gloved 
hands and all glassware was soaked in 0.1% (v:v) DEP 
solution at 37°C for 16 hours and baked at 250°C for 16 
hours prior to use. 
All small-scale procedures were performed in 1.5m1 
polypropylene microfuge tubes (unless otherwise stated). 
These were sterilised by autoclaving at 120° C, 15psi for 
15 minutes. Large-scale procedures were performed in 
15m1 or 30m1 Corex tubes (sterilised by baking at 250° C 
for 16 hours) or in 50ml Falcon Tubes (sterile as 
purchased). Liquids were dispensed using Gilson 
Pipetman P-20, P-200 and P-1000 automatic pipettors and 
tips (sterilised as for microfuge tubes) or glass 
pipettes (sterilised as for Corex tubes). 
2.2.2 PREPARATION AND STERILISATION OF SOLUTIONS 
All solutions were prepared using dH20 and (for 
stock solutions) were filtered through Whatman No. 1. 
filter paper. Most solutions were sterilised either by 
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autoclaving at 120°C, 15psi for 15 minutes or by 
filtration through Acrodisc filter-sterilisation units 
(0.45i.im pore size, Gelman Sciences). Solutions were 
stored at room temperature, unless otherwise stated. 
2.2.3 DEIONISATION OF SOLUTIONS 
Where required (as stated in particular methods) 
solutions were deionised by treatment with 0.1 volume of 
mixed-bed ion-exchange resin (20-50 mesh, Bio-Rad 
Laboratories) for 60 minutes at room temperature. The 
resin was removed by filtration through Whatman No. 1 
filter paper. 
2.2.4 DIALYSIS 
Dialysis tubing (Visking 8/32") was prepared by 
boiling in a large volume of 2% (w:v) sodium bicarbonate 
1mM EDTA for 10 minutes, rinsing thoroughly in dH20 and 
boiling for a further 10 minutes in dH20. It was stored 
at 4°C in 50% (v:v) ethanol and was washed thoroughly 
with dH20 before use. Tubing was always handled with 
gloved hands. 
2.2.5 DEPROEINISATION OF NUCLEIC ACID SOLUTIONS 
Aqueous nucleic acid solutions were deproteinised by 
extraction with phenol and chloroform. 	An equal volume 
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of phenol/chloroform (1:1, 	(v:v)) was added to the 
nucleic acid solution and the phases mixed by vortexing. 
The phases were then separated by centrifugation in a 
microfuge (11,600g) or Sorvall SS34 rotor at 10,000 rpm 
(12,000g) for 3-5 minutes and the upper (aqueous) phase 
transferred to a fresh tube. 	Extraction was repeated as 
required. 	The procedure was then repeated with 
chloroform to remove any residual phenol. 	Nucleic acids 
were subsequently ethanol precipitated (see section 
2.2.6) which removed any residual chloroform. 
2.2.6 ETHANOL PRECIPITATION OF NUCLEIC ACIDS 
To precipitate nucleic acids from an aqueous 
solution, 0.1 volumes of 3M sodium acetate (pH5.2) or 
0.025 volumes of 4M NaCl and 2-3 volumes of ethanol were 
added and the mixture incubated at -70° C for 15 minutes 
or at -20° C for 1 hour. The precipitated nucleic acids 
were recovered by centrifugation in a microfuge (11,600g) 
or Sorvall SS34 rotor at 10,000 rpm (12,000g) for > 15 
minutes at 4°C. The pellet was washed by resuspension 
in 70% (v:v) ethanol and recovered by centrifugation, as 
before. 	Following the wash step, the supernatant was 
drained off and the pellet dried under vacuum. 	The 
nucleic acid could then be resuspended in the desired 
volume of the appropriate buffer. 
2.2.7 
The A260 and A280 of the nucleic acid solution were 
determined by UV spectrophotometry. 	Purity was 
estimated by the ratio of A260 to A280. 	Concentration 
was estimated by assuming that an A260 of 1.0 corresponds 
to 50igml' for double stranded DNA and to 40pgml' for 
SS DNA or RNA. Alternatively the concentration of a 
double stranded DNA solution was estimated by comparison 
of the test DNA with that of standard (known) DNA 
solutions in an agarose gel after staining with EtBr (see 
section 2.9.1). 
2.2.9 AUTORADIOGRAPHY 
[32P] labelled nucleic acids, whether in gels or on 
filters, were detected by exposure to Xray film (DuPont 
Cronex or Amersham Hyperfilm MP) in light-proof lead-
shielded cassettes. Depending on the amount of 
radioactivity present, one of the following methods of 
exposure was used (in order of increasing sensitivity): 
i) at room temperature; ii) at -70°C with a calcium-
tungstate intensifying screen; iii) with a pref lashed 
film at -70° C with an intensifying screen. 
[ 35S] labelled nucleic acids, in a fixed and dried 




3H] labelled nucleic acids, in a gel impregnated 
with Enlightning (DuPont) and then dried, were detected 
by exposure to pref lashed Xray film (Hyperfilm MP) at 
_700 C. 
W. 
2.3 	PHAGE TECHNIQUES 
2.3.1 PREPARAT ION.F 	AND 	 T.Q 
For 	X titrations a fresh 5ml overnight culture, 
grown from a single bacterial colony in LB at 370 C, was 
diluted twenty-fold into 20m1 of prewarmed LB and grown 
at 37°C to a concentration of 2-5 x 10 8 cells ml -1 . 
Cells were then harvested by centrifugation in a MSE 
Minor 'S' bench-top centrifuge at 4100 rpm (2480g) for 5 
minutes and resuspended in lOmi of 10mM MgSO4. These 
cells were then stored at 4°C. 
A phage were tenfold serially diluted in phage 
buffer. 0.1ml of these phage dilutions plus 0.2m1 of 
cells were mixed and incubated at 37°C for 20 minutes to 
allow adsorption of the bacteriophage particles to the 
bacteria. 	3m1 of molten BBL top agar were added and the 
mixture poured onto a fresh BBL agar plate. 	The top 
agar was allowed to set at room temperature before the 
plate was inverted and incubated at 37°C overnight. 
Plaques were then scored. 
2.3.2 	.PLT.ATES 
Using a sterile toothpick, a single fresh plaque was 
picked into lml of phage buffer. 	Two drops of 
chloroform were added and mixed, before incubation at 
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37°C for 30 minutes. 	0.1ml of phage suspension was 
added to 0.2ml of cells (prepared as described in section 
2.3.1) and incubated at 37°C for 20 minutes. 3m1 of 
heated BBL top agar was added, mixed and poured onto a 
fresh, moist LB agar plate. The plate was incubated at 
37°C until confluent lysis was achieved (6 - 8 hours). 
The agar was then covered with 4m1 of LB and the plate 
incubated at 4°C overnight. The next day, the broth was 
harvested, mixed with 2 - 3 drops of chloroform and 
clarified by centrifugation in a SS34 rotor at 8000 rpm 
(8000g) at 4°C for 10 minutes. The supernatant was 
carefully drawn off and titrated. 
2.3.3 •. 	Qflj4SATES 
A fresh overnight culture was diluted 40fold in 
200m1 prewarmed LB, supplemented with 10mM MgSO4, and 
grown at 37°C to an A650 of 0.45 - 0.6. Phage (prepared 
as described in section 2.3.2) were then added to give an 
MOl of 1. 	The A650 of the culture was monitored until 
it reached a minimum (due to cell lysis). 	At this 
point, 0.5m1 of chloroform was added and the lysate 
shaken for a further 10 minutes, before being clarified 
by centrifugation in 250m1 plastic bottles in a GS-A 
rotor at 7000 rpm (8000g) at 4°C for 10 minutes. The 
supernatant was stored at 4°C with 20tl of chloroform per 
ml., and was titrated at this stage. 
The phage were concentrated by sedimentation in a 
MSE ultracentrifuge at 21,000 rpm (40.000g) at 4°C for 3 
hours and the pelleted phage resuspended in 0.05 volumes 
of phage buffer by shaking gently at 4°C. After further 
clarification by centrifugation in a SS34 rotor at 9000 
rpm (10,000g) at 4°C for 15 minutes, the supernatant was 
treated with RNase A and DNase I (both at a final 
concentration of 10gmll) at 20°C for 2 hours. 
2.3.4 	A PHAGE  
In order to purify the phage, the nuclease-treated. 
supernatant (see section 2.3.3) was separated on a CsC1 
step gradient. Three steps of CsC1 in phage buffer were 
used, with densities of 1.3, 1.5 and 1.7gml' (31%, 45% 
and 56% (w:w), respectively). The 1.7gml - ' CsC1 
solution was loaded into a 14ml MSE polycarbonate tube 
first. 	The less dense solutions were then carefully 
overlaid using a syringe. 	The supernatant was loaded 
onto the surface of the gradient. 	The tubes were then 
placed in a MSE 6 x 14 Ti swing-out rotor and spun in a 
MSE ultracentrifuge at 33,000 rpm (140,000g) for 2 hours. 
After centrifugation, the visible phage band was 
collected through the side of the tube using a syringe 
fitted with a 19G needle. CsCl was removed from the 
collected phage band by dialysis against phage buffer at 
4°C for one hour. 
2.3.5 	J _DNA PREPARATION 
A DNA was prepared from the dialysed phage (see 
section 2.3.4) by phenol extraction (three times). The 
final aqueous layer was then dialysed against several 
changes of TE buffer at 4°C over a 24 hour period. The 
phage DNA was precipitated with ethanol and the dried 
pellet resuspended in a desired volume of TE. DNA 
concentration and purity were estimated by UV 
spectrophotometry at 260nm and 280nm. 
2.3.6 M13 PHAGE TITRATIONS 
M13 phage were tenfold serially diluted in phage 
buffer. 101 of these phage dilutions plus 0.2m1 of a 
fresh overnight culture were added to 3ml of molten BBL 
top agar, containing 20i.tl of IPTG (24mgml -1 ) and 30i.d. of 
Xgal (24mgml-1 in dimethylformamide). 	This mixture was 
then poured onto a fresh BBL agar plate. 	The top agar 
was allowed to set before the plate was inverted and 
incubated at 37°C overnight. This procedure was 
repeated if further plaque purification was required. 
2. 3.7 LARGE SCALE M13 PHAGE ISOLATION 
5ml of LB, inoculated with a single fresh M13 plaque 
(prepared as described in section 2.3.6), and a separate 
30m1 host cell culture, were grown overnight at 37°C. 
'I 
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The following day the cell culture was diluted 25-fold in 
400ml LB and grown at 37°C to an A650 of 0.2. 200&l of 
the overnight phage culture were then added (MCI of 0.1 - 
0.5) and the cells grown at 37°C for a further 5 hours. 
The cells were then collected by centrifugation in 500ml 
plastic bottles in a GS-3 rotor at 8000 rpm (10,000g) at 
4°C for 10 minutes and the supernatant removed to a fresh 
plastic bottle. 8g of PEG 6000 and 11.7g of NaCl were 
added to the supernatant and thoroughly dissolved before 
the bottle was left on ice overnight. 
The next day the sample was centrifuged in a GS-3 
rotor at 8000 rpm (10,000g) and 4°C for 20 minutes, to 
harvest the phage. 	The resultant pellet was resuspended 
in 5ml of phage buffer. 	Any remaining cell debris was 
removed by centrifugation in a SS34 rotor at 8000 rpm 
(8000g) at 4°C for 10 minutes. 	This final supernatant 
was separated on a CsCl step gradient. 	Four steps of 
CsC1 in phage buffer were used with densities of 1.25, 
1.30, 1.35 and 1.40gml' 	(27.0%, 31.2%, 35.2%, 38.8% 
(w:w) respectively). 	The 1.40gml' CsCl solution was 
loaded first into a 14ml MSE polycarbonate tube and the 
others were carefully overlaid using a syringe. 	The 
phage-containing supernatant was gently loaded onto the 
surface of the gradient. 	Ultracentrifugation was then 
carried out exactly as described in section 2.3.4. 	The 
visible M13 phage band was then collected through the 
side of the tube using a syringe with a 19G needle. 	The 
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CsC1 was removed from the sample by dialysis against 
several changes of phage buffer over a 12 hour period at 
4°C. 
2.3.8 LARGE SCALE M13 SINGLE-STRANDED DNA PREPARATION 
DNA was prepared from the dialysed phage (see 2.3.7) 
by phenol extraction (three times) followed by ether 
extraction (twice) and finally precipitation of the phage 
DNA with ethanol. . The dried pellet was resuspended in 
TE, and DNA concentration and purity were estimated by UV 
spectrophotometry at 260nm and 280nm. 
2.3.9 	 S.I.N.G.L.E7.  
STRANDED DNA 
An overnight host bacterial culture was diluted 100-
fold in LB and imi ,of this was inoculated with a fresh 
M13 plaque (prepared as described in section 2.3.6) and 
grown for 5 hours at 37°C. The culture was transferred 
to a microfuge tube and spun for 3 minutes in a microfuge 
(11,600g). The supernatant was carefully decanted into 
a fresh microfuge tube and 200V1 of PEG/NaC1 solution 
(20% (w:v) PEG 6000, 2.5M NaCl) added. The tube was 
vortexed and then transferred to ice for 20 minutes 
before the precipitated phage particles were recovered by 
centrifugation in a microfuge (11,6000g) for 5 minutes. 
The supernatant was drained off and discarded. The tube 
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was spun again for 1 minute (as above) and any remaining 
supernatant carefully removed. The pellet was then 
resuspended in 1001i1 TE and extracted once with an equal 
volume of phenol, before the DNA was ethanol 
precipitated. 	The dried DNA pellet was redissolved in 
30p.l TE and then stored at -20° C. 
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2.4 	PLASMID.LE.cNIQU.E.S. 
2.4. 1 PREPARATION OF SMALL QUANTITIES OF PLASMID DNA 
(modified from Birnboim and Doly 1979) 
1.5m1 of an overnight culture (grown from an 
isolated colony in LB and under antibiotic selection) 
were transferred into a microfuge tube and spun for 2 
minutes in a microfuge (11,600g). The supernatant was 
removed and discarded and the pellet resuspended by 
vortex-mixing in lOOi..&l of cold lysis solution (25mM Tris-
HC1 pH8.0, 10mM EDTA pH8.0, 50mM glucose, 4mgml' 
lysozyme) and left at room temperature for 5 minutes. 
200p.l of freshly prepared alkaline - SDS solution (0.2M 
NaOH, 1% (w:v) SDS) were then added, the samples mixed by 
inversion, and placed on ice for 5 minutes to allow 
completion of cell lysis and the selective denaturation 
of chromosomal DNA. 150p.l of cold potassium acetate 
pH4.8 (3M with respect to potassium and 5M with respect 
to acetate) were added and the sample returned to ice for 
a further 5 minutes. During this time most of the 
chromosomal DNA aggregated into an insoluble network. 
It was removed, along with the co-precipitated high 
molecular weight RNA and proteins, by centrifugation in a 
microfuge (11,600g) for 5 minutes at 4°C. 400i.tl of the 
supernatant were transferred to a fresh microfuge tube 
and extracted with an equal volume of phenol: chloroform. 
Nucleic acids were ethanol precipitated and the dried 
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pellet resuspended in 301.d. of TE, containing RNase A at a 
final concentration of 20gml'. 
2.4. 2 PREPARATION .OFLA.. Q.!A.NT .IT . .S . DJDNA 
200m1 of LB (plus appropriate antibiotic) were 
inoculated with a single bacterial colony and incubated 
at 37°C overnight. Cells were harvested by 
centrifugation in a GS-A rotor at 7000 rpm (8000g) at 4°C 
for 20 minutes, and the resultant pellet washed in 0.5 
volume of cold TE buffer before being spun again, as 
before. This pellet was resuspended in 3ml of sucrose 
buffer (25% (w:v) sucrose, 50mM Tris-HC1 pH8.0) and 
placed on ice. imi of lysozyme solution (lOmgml') was 
added and the tube left on ice for 5 minutes with 
frequent agitation. lml of 0.5M EDTA (pH8.5) and 0.4ml 
of RNase A (lOmgml') were added, mixed and left on ice 
for a further 5 minutes. 5m1 of Triton solution were 
then added (0.1% (v:v) Triton X-100, 65mM EDTA pH 8.5, 
50mM Tris-HC1 pH8.0) and, after a further 10 minutes on 
ice, the debris from the lysed cells was pelleted by 
centrifugation in a SS34 rotor at 15,000 rpm (27,000g) at 
4°C for 30 minutes. 
Plasmid DNA was then isolated by equilibrium 
centrifugation in CsCl-EtBr. 9g of CsCl were added to 
the (9m1) supernatant and dissolved thoroughly before the 
further addition of 0.9m1 EtBr (5mgml 1 ). This solution 
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was transferred to a Beckman 12ml polyallomer tube which 
was sealed and centrifuged in a Beckman Ti50 rotor at 
38,000 rpm (90,000g) for approximately 60 hours at 18°C. 
After centrifugation DNA bands were clearly visible when 
the tube was observed under long wave UV light. The 
lower (plasmid DNA) band was collected through the side 
of the tube, using a syringe and 19G needle. EtBr was 
removed from the sample by extracting three times with 
0.5 volumes of isopropanol (equilibrated with saturated 
CsCl solution). The DNA solution was then dialysed 
against several changes of TE over a 24 hour period. 
The DNA was ethanol precipitated, and dried pellets 
resuspended in a desired volume of TE. DNA purity and 
concentration were estimated by measuring the UV 
absorbance at 260nm and 280nm. 
2.4. 3 PREPARATION ..Q]L  SMALL _QUANTITIES P1JN 
An overnight culture was diluted 100-fold in LB. 
2m1 of this were inoculated with a fresh M13 plaque 
(prepared as described in section 2.3.6) and grown for 4 
hours at 37°C. 	1.5ml of the infected culture were 
transferred to a microfuge tube. 	The M13 DNA was 
isolated as described in section 2.4.1. 
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2.4.4 
lml of LB, inoculated with a fresh M13 plaque, as 
well as a 5m1 cell culture, were grown overnight at 37°C. 
The cell culture was diluted 20-fold and grown to an A650 
of 0.5. 	200ml of LB was then inoculated with 2m1 of 
this culture and grown again to an A650 of 0.5. 	200.d 
of the overnight phage culture were then added and growth 
continued for a further 4 hours. The M13 DNA was 
isolated as described in section 2.4.2. 
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2.5 	RACTERIAL --- TECHNIQ B5 
2.5.1 PREPARATION OF COMPETENT CELLS 
An overnight culture, grown at 37°C in LB, was 
diluted 50-fold in prewarmed LB and grown to an A&so of 
0.5. The cells were cooled on ice for 20 minutes before 
being harvested by centrifugation in a MSE Minor 'S' 
bench-top centrifuge at 4100 rpm (2480g) for 10 minutes. 
The resultant pellet was washed in 0.5 volumes of 0.1M Mg 
C12 and spun as before. The cells were then resuspended 
in 0.5 volumes of 0.1M CaCl2 and left on ice for 30 
minutes before being centrifuged as before, resuspended 
in 0.05 volumes of 0.1M CaC12 and returned to ice for a 
minimum of 1 hour before being used. 
Competent cells were also prepared in advance and 
stored frozen for future use. In this case the final 
pellet, instead of being resuspended in 0.05 volumes of 
0.1M CaC12, was resuspended in 0.05 volumes of MOPS 
(pH6.5), 50mM CaCl2, 20% (v:v) glycerol, incubated on ice 
for 30 minutes, and stored in aliquots at -70°C. Before 
use these frozen aliquots were slowly thawed on ice. 
I,; 
2.5.2 TRANSFECTION AND TRANSFORMATION WITH DNA 
Transfections were performed by adding up to lOOng 
of M13 DNA to 2001il of competent cells and incubating on 
ice for 30 minutes (to allow non-specific adsorption of 
DNA). The cells were then heat-shocked at 42°C for 2 
minutes (to promote DNA uptake) before being returned to 
ice for a further 5 minutes. Samples were plated by 
adding 200.d. of log-phase cells, 20l IPTG (24mgml - l) 
30l X-gal (24mgm1 1 in dimethylformamide) and 3ml of 
molten BBL top agar. This was mixed and poured as 
described in section 2.3.6. 
For transformations, up to 50ng of plasmid DNA were added 
to 200.d of competent cells and incubated on ice for 30 
minutes. 	The cells were then heat-shocked at 42°C for 2 
minutes and chilled briefly on ice. 	lml of LB was then 
added and the samples incubated at 37°C for one hour, to 
allow 	expression 	of 	plasmid-encoded 	antibiotic 
resistance. 	200.tl aliquots were then spread on 
selective plates and incubated at 37°C overnight. 
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2.6 	DNA TECHKjQ1j 
2.6.1 RESTRICTION ENDONUCLEASE DIGESTION 
The restriction enzymes and buffers used during this 
work are shown in Table 2.4. Generally DNA was 
incubated with a two-fold excess of restriction 
endonuclease in the appropriate buffer as recommended by 
the enzyme's manufacturer. Incubations were generally 
of 60-90 minutes duration at the temperature recommended 
by the manufacturer. Reactions wee stopped by heat-
inactivation of the enzyme at 65°C for 10 minutes and/or 
phenol: chloroform extraction. 
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Table 2.4 RESTRICTION ENZYMES AND BUFFERS 
Restriction 	Manufacturer 	Reaction Buffer 
Endonuclease 
AccI 	 (Boehringer) 	A 
Clal 	 U 	 H 
EcoRI 	 if H 
Hindill 	 it B 
Nan 	 (New England 	(1) 
Blo labs) 
Sail 	 (Boehringer) 	H 
Smal 	 VI A 
StuI 	 ff B 
XmaI 	 (New England 	(2) 
B i o labs) 
XmnI 	 11 (3) 
Buffers A, B and H : supplied by Boehringer 
Buffers (1), (2) and (3) : made in the lab. 
Buffer A (pH7.9) (33mM Tris acetate, 10mM Mg-acetate, 
66mM K-acetate, 0.5M DTT) 
Buffer B (pH8.0) (10mM Tris-HC1, 5mM MgC12, 100mM NaCl, 
1mM 3-mercaptoethenol). 
Buffer H (pH7.5) (50mM Tris-HC1, 10mM MgCl2, 100mM NaCl, 
1mM f3-mercaptoethenol) 
(6mM Tris-HC1 pH7.4, 6mM MgC12, 100mM DTE, 0.01% 
(w:v) BSA). 
(10mM Tris-HC1 pH7.5, 10mM MgC12, 25mM NaCl, 10mM 3-
mercaptoethenol, 0.01% (w:v) BSA). 
(10mM Tris-HC1 pH8.0, 10mM MgC12, 10mM NaCl, 10mM 13 -
mercaptoethanol 0.01% (w:v) BSA). 
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2.6.2 DNA LIGATION 
Ligations were generally performed in a small volume (10 
- 20i.tl total volume) containing digested DNA (generally 
10 - 1501igml' final concentration) and 0.1 volumes 10 x 
ligase cocktail (0.75M Tris-HC1 pH7.8, 0.2M MgCl2, 0.2M 
DTT, 10mM ATP, 0.01% (w:v) BSA). T4 DNA ligase (1 - 5 
units) was added and the mixture incubated at 15°C 
overnight, or at room temperature for 4 hours. A 
portion of this reaction mix was then used directly for 
transformation of E. coil cells (see section 2.5.2). 
2.6.3 DNA SEQUENCING (Sanger et al 1977, Biggin et al 
1983) 
DNA sequencing was carried out by the dideoxy 
nucleotide chain termination method on DNA cloned into 
M13mplO, M13mp18 or M13mp19 vectors (Messing et al 1977, 
Norrander et al 1983). 
5..t1 of M13 single-stranded template DNA (prepared as 
described in section 2.3.9) were mixed with 5pl of primer 
mix (3p.l universal sequencing primer 2.5p.gml', lp.l TM 
(100mM Tris-HC1 pH8.5, 50mM MgCl2), 11 dH201 in a 
microfuge tube and annealed at 60°C for 1 hour. The 
samples were cooled by spinning briefly in a microfuge 
and were then split into 4 separate microfuge tubes 
(containing 2tl of primer : template mix per tube). 21A1 
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of the appropriate dideoxynucleotide mix (Tmix, Cmix, 
Gmix or Amix - see Table 2.5) were added to the 
appropriate tube followed by 2tl of Klenow mix (10mM 
Tris-HC1 pH8.5, 10mM DTT, 4p.Ci [ 35 S]-dATP, 1.5 units E 
coil DNA polymerase I Klenow large fragment, dH20 to 81.iJ 
- sufficient for 4 reactions), and then the reaction 
started by spinning briefly to bring all solutions to the 
bottom of the microfuge tube. The reactions were left 
at room temperature for 20 minutes before 2tl of dNTP 
chase solution (0.25M each of dTTP, dCTP, dGTP and dATP) 
were added and the reactions left for a further 20 
minutes. 21Al of formamide dye mix (lOOml deionised 
formamide, 0.1g xylene cyanol FF, 0.1g bromophenol blue, 
2ml 0.5M EDTA pH8.5) were added to each tube and the 
samples heated to 100°C for 3 minutes. Electrophoresis 
of the samples was then carried out on a buffer-gradient 
denaturing polyacrylamide gel as described in section 
2.9.8. 
As a method for rapidly screening several M13 
plaques a slight modification of this protocol can be 
used. Only one dideoxynucleotide mix was used for each 
test template DNA (generally A or T-termed A-tracking or 
T-tracking respectively). 	Thereafter the protocol 
described above was followed exactly. 	In Fig. 2.1 a 
representative autoradiograph displays results of this 
tracking technique. 
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Table 2.5 COMPOSITION OF DIDEOXYNUCLEOTIDE REACTION 
MIXES FOR 
Components Tmix Cmix Gmix Amix 
0.5mM dTTP 25 500 500 500 
0.5mM dCTP 500 25 500 500 
0.5mM dGTP 500 500 25 500 
10mM ddTTP 50 - - - 
10mMddCTP . 	 - 8 - - 
10mM ddGTP - - 16 - 
10mM ddATP - - - 1 
TE 1000 1000 1000 500 
Quantities given are in jal 
•F.g2l 
A representative autoradiograph displaying the 
results of A-track screening of candidate M13 mutants. 
Mut. is the deletion mutant M13mpl9-11, produced by site-
directed mutagenesjs of M13mp19-5, and identified by this 
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2.7.1 PREPARATION OF RNA (Salser et al 1967, Shaw and 
Guest, 1982) 
200m1 minimal cultures of the appropriate bacterial 
strains were grown to the desired A650 (generally 0.15 - 
0.3). Where appropriate, cultures were treated with 
rifampicin (at 5pgml - ' final concentration) and grown for 
a further 15, 30 or 60 minutes. Cells were then 
harvested by centrifugation in a GS-A rotor at 7000 rpm 
(8000g) at 4°C for 10 minutes, washed in 20ml TE and spun 
again, as above. After resuspension in lml of cold 10mM 
KC1, 5mM MgC12, 10mM Tris-HC1 (pH7.3) the sample was 
transferred to a microfugetube. Lysozyme was added to a 
final concentration of 300gml' and the sample frozen at 
-70°C for 30 minutes. Upon thawing, 110l of 10% (w:v) 
SDS was added and the tube incubated at 64°C until the 
turbidity of the solution dropped (usually about 10 
minutes). 40l of 3M sodium acetate (pH5.2) were then 
added and the sample split between two microfuge tubes. 
Extraction with one volume of phenol was carried out by 
agitation at 64°C for 5 minutes and the phenol:aqueous 
phases separated by centrifugation in a microcentrifuge 
(11,600g) for 4 minutes. The aqueous layer was removed 
and phenol-extracted once more, as above, before ethanol 
precipitation. 	Pelleted RNA was washed 3 - 4 times in 
70% (v:v) ethanol, 10mM Tris-HC1 pH7.5, 10mM NaCl. 	RN 
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concentration and 	purity 	were 	estimated by 	UV 
spectrophotometry at 260nm and 280nm. 
2.7.2 LABEL14..NG AND SQIA...ONOFRNh (Dunn and Studier 
1973) 
Minimal cultures of the appropriate bacterial 
strains were grown to an A650 of 0.2. At this point 
small volumes (e.g. 2m1) were labelled with (5 3 H1 
uridine at 20p.Ciml' for 5 minutes. Rifampicin was then 
added to a final concentration of 100.tgm1'. 
Immediately before, and 5 and 10 minutes after the 
addition of the drug, 0.5m1 samples of the labelled 
culture were transferred to lrnl of 0.02M NaN3 on ice. 
The cells were harvested by spinning in a microfuge 
(11,600g) for 2 minutes and resuspended in 20p.l of 50mM 
Tris-HC1 (pH6.8), 1% (w:v) SDS, 10% (v:v) glycerol, 0.14M 
f3-mercaptoethanol. They were then placed in a boiling 
water bath for 2 minutes and transferred to ice. 
Labelled rRNA, extracted by this technique, is readily 
separated by electrophoresis on agarose/acrylamide 
composite gels (see section 2.9.5) and can be detected by 
autoradiography. 
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2.7.3 JB.JN.QAN.PPREPARATIONOFRNA (Zengel et al 
1980) 
Minimal cultures of the appropriate bacterial 
strains were grown to the desired A650 (0.15 - 0.3). 
Where appropriate, cultures were treated with rifampicin 
(5.tgml' final concentration) and grown for a further 15, 
30 or 60 minutes. 20ml samples were labelled for 60 
seconds with [5- 3H] uridine at a concentration of 
20.iCimll. An equal volume of TSE1 (0.02M Tris-HC1 
pH7.4, 0.2M NaCl, 0.04M EDTA, 1% (w:v) SDS) preheated to 
100°C, was added and the samples maintained at 100°C for 
a further 2 minutes. The samples were then allowed to 
cool to 20° C, extracted three times with phenol and 
precipitated twice with ethanol. 
117 
2.8 	PROTEIN TECHNIQUES ___- 
2.8.1 PROTEIN LABELLING AND EXTRACTION 
Cultures were grown exponentially in the appropriate 
minimal medium to the desired A650 (0.15 - 0.3). 
Samples were pulse-labelled at various times thereafter, 
with or without addition of rifampicin at 5.tgml' final 
concentration. A 0.75m1 aliquot was labelled for 2.5 
minutes with L-[4,5- 3H] leucine at a concentration of 
20iCimll. Unlabelled leucine was then added to 200igml 
1 and growth continued for 3 minutes to allow completion 
of nascent labelled polypeptides. 	NaN3 was then added 
to 20mM and the sample chilled on ice. 	The cells were 
collected by microcentrifugation (11,600g) for 2 minutes, 
washed by resuspension in Matzura buffer (plus leucine): 
62.5mM Tris-HC1 pH6.8, 0.1mM DTT leucine 200.tgml' : and 
spun as before. The cells were resuspended in 10l of 
Matzura buffer (plus leucine) and lysed in 30l SDS 
sample buffer (62.5mM Tris-HC1 pH6.8, 3% (w:v) SDS, 10% 
(v:v) glycerol, 0.735M 3-mercaptoethanol, 0.02% (w:v) 
bromophenol blue) at 100°C for 3 minutes, before being 
subjected to SDS-polyacrylamide gel electrophoresis (see 
section 2.9.9). 
If required, 	cells were 	also 	labelled with 
L- [1 --14 C] - leucine 	at 0.5p.Ciml - ' for approximately two 
generations 	prior 	to 	[ 3H] -leucine 	pulse-labelling. 
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Incorporation of 14C into protein was complete within 
about one generation. 
Unlabelled 	cell 	extracts 	were 	prepared 	in 
essentially the same way as described above. 	0.75rn1 
aliquots were removed and NaN3 added to 20mM. 	Samples 
were then chilled on ice and cells collected by 
microcentrifugation (11,600g) for 2 minutes. The cells 
were washed in Matzura buffer (without added leucine) and 
centrifuged as before. They were then resuspended in 




2.9 	GEL ELECTROPHORESIS 
2.9.1 HORIZONTAL AGAROSE GEL ELECTROPHORESIS 
Horizontal 0.6 - 2.0% agarose slab gels were 
prepared by dissolving the correct concentration of 
agarose in 1 x TAE or 1 x TBE buffer in a microwave oven. 
The solution was allowed to cool to approximately 50°C 
before being poured into one of several possible gel 
formers with their combs in place (Bethesda Research 
Laboratories; 20 x 25cm (20 well); 11 x 14cm (14 well); 
50 x 75mm (8 well)). The gel was allowed to set before 
being placed in the gel apparatus containing sufficient 
buffer (1 x TAE or 1 x TBE) to just cover the gel. 0.1 
volume of loading buffer (50% (v:v) glycerol, 0.5%, (w:v) 
xylene cyanol FF, 0.5% (w:v) bromophenol blue, 10 x TAE 
or TBE) was added to the DNA sample prior to loading onto 
the submerged gel using a Gilson pipette. 	The gel was 
run at the desired voltage. 	After electrophoresis the 
gel was stained in EtBr (1tgmll) for 30 minutes, 
destained in water for 30 minutes and the DNA bands 
visualised using a short wavelength UV trans illuminator. 
If required the gel was photographed using Polaroid 667 
positive film and a suitable red filter. 
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2.9.2 RECOVERY OF DNA FROM AGAROSE GELS 
(Ground Glass Method) 
DNA fragments were recovered from excised agarose 
gel slices using the "Geneclean" kit (BlO 101 Inc) 
precisely as stated in the manufacturer's instruction 
sheet. 
2.9.3 NONDENATURING POLYACRYLAMIDE GEL ELECTROPHOSESIS 
DNA fragments of <500 bp were routinely separated on 
a 10% nondenaturing polyacrylamide gel. 	30ml of a 10% 
acrylamide solution was prepared as follows. 	lOml of 
30% acrylamide solution (29% (w:v) acrylamide, 1% (w:v) 
bisacrylamide). 3m1 10 x TBE buffer, 250i.il 10% (w:v) 
AMPS, dH20 to 30ml. 
Two glass plates separated along their edges by 
plastic spacers were clamped together to create a mould 
of dimensions 25 x 14 x 0.1cm. 	Three edges were sealed 
with water agarose (0.5% (w:v) agarose in dH20). 	251Al 
of TEMED were then added to the 10% acrylamide solution 
and immediately poured into this glass sandwich. A 15 
tooth comb was inserted and the gel left to polymerise 
for at least 60 minutes in an upright position. When 
polymerisation was complete the comb and bottom spacer 
were removed and the wells immediately rinsed out with 1 
x TBE to remove any remaining acrylamide solution. The 
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gel was attached to an electrophoresis tank containing 1 
x TBE in the upper and lower reservoirs. Care was taken 
to flush out the wells again, thoroughly and to remove 
any air bubbles trapped beneath the gel plates. 
DNA samples for analysis were ethanol precipitated, 
dried and resuspended in 20l TE. 10l of loading 
buffer (0.5 x TBE, 0.125M EDTA, 0.1% (w:v) bromophenol 
blue, 50% (v:v) glycerol) were added to each sample 
before it was carefully loaded onto the gel using a 
Hamilton microsyringe. Electrophoresis was carried out 
at 150 - 200V until the bromophenol blue had migrated the 
appropriate distance. The gel was removed from the 
electrophoresis tank and stained in a solution of EtBr 
(1.&gml') for 30 minutes, before being observed using a 
long wavelength UV transilluminator. 
2.9.4 RECOVERY OF DNA FRAGMENTS FROM POLYACRYLAMIDE GELS 
(Maniatis et al 1982) 
Once located the DNA band of interest was excised 
from the polyacrylamide gel using a razor blade, and 
placed on a glass plate. The acrylamide slice was 
chopped into fine pieces with a razor blade and the 
fragments transferred to a microfuge tube where they were 
crushed against the wall of the tube using a disposable 
pipette tip. One volume of elution buffer (0.5M 
ammonium acetate, 1mM EDTA pH8.0) was added and the tube 
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incubated at 37°C overnight on a rotating wheel. 	The 
next day the sample was spun in a microfuge (11,600g) for 
10 minutes. The supernatant was recovered and an 
additional 0.5 volume of elution buffer added to the 
pellet, which was then vortexed and recentrifuged as 
before. The two supernatants were combined, the DNA 
precipitated with ethanol and the pellet resuspended in 
200.tl TE. The DNA was precipitated once again, the 
pellet washed in 70% (v:v) ethanol and dried. 
2.9.5 COMPOSITE AGAROSE : POLYACRYLAMIDE GEL 
ELECTROPHORESIS (Dunn and Studier, 1973). 
To analyse high molecular weight RNA a 2% 
polyacrylamide gel plus 0.5% agarose was used. The 
agarose was added to strengthen the gel, making it easier 
to handle. 	A 50m1 solution of this composite gel was 
prepared as follows: 	2.5ml of 40% acrylamide solution 
(38% (w:v) acrylamide, 2% (w:v) bisacrylamide) 5m1 of 10 
x sodium phosphate buffer (1M sodium phosphate pH6.8, 1% 
(w:v) SDS, 0.02M EDTA), dH20 to 25ml. A solution of 
water agarose (1% (w:v) agarose in dH20) was made up 
separately. This water agarose was heated in a 
microwave oven and allowed to cool to 50°C before adding 
25m1 of it to the acrylamide solution and mixing both by 
swirling. 250p.l of 10% (w:v) AMPS and 25.il of TEMED 
were added to the agarose/acrylamide solution, which was 
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then poured between two glass plates as described in 
section 2.9.3. 
When polymerisation was complete the comb and bottom 
spacer were removed and the wells carefully rinsed out 
with 1 x sodium phosphate buffer. The gel was then 
attached to an electrophoresis tank containing 1 x sodium 
phosphate buffer in the upper and lower reservoirs. Any 
trapped air bubbles were removed from beneath the gel and 
the wells once more carefully flushed out with 1 x sodium 
phosphate buffer. 
Labelled extracts (prepared as described in section 
2.7.2) were loaded onto the gel using a Hamilton 
microsyringe. The gel was run at 70V for 3 hours. 
Afterwards it was impregnated with Enlightning and dried 
under vacuum. The radiolabelled rRNA bands were 
visualised after autoradiography as described in section 
2.2.8. 
2.9.6 DENATURING POLYACRYLAMIDE GEL ELECTROPHORESIS 
Denaturing polyacrylamide gel electrophoresis was 
used to fractionate the products of Sl nuclease mapping 
and primer extension analyses. 	For these purposes 6% 
polyacrylamide/7.2M urea gels were used. 	To obtain gels 
of the desired acrylamide/urea concentrations, 9/10 
volume stock solutions were prepared (e.g. 6.67% (w:v) 
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acrylamide:bisacrylamide (20:1), 8M urea for a final gel 
of 6% polyacrylamide/7.2M urea) deionised (see section 
2.2.3), filtered and stored at 4°C. Gels were prepared 
by mixing 45ml of the stock solution with 5m1 10 x TBE 
buffer, 250tl 10% (w:v) AMPS and 25pi. of TEMED and poured 
using a syringe into a 40cm x 20cm x 0.4mm mould formed 
by two glass plates separated by Plastikard strips 
(sealed at the edges with PVC tape). The flat side of a 
Sharkstooth comb (Bethesda Research Laboratories : either 
24 sample, 6mm spacing or 48 sample, 3mm spacing) was 
inserted approximately 0.5cm into the top of the gel, 
which was then left to polymerise, for at least 60 
minutes, laid at an angle a few degrees from the 
horizontal. After polymerisation was complete, the comb 
and PVC tape sealing the bottom edges of the plates were 
removed. The flat surface on top of the gel was washed 
with 1 x TBE and the Sharkstooth comb reinserted with its 
teeth just sticking into the gel surface. The gel was 
then placed in the electrophoresis tank filled with 1 x 
TBE buffer. After the gel was pre-electrophoresed. for 
40 minutes, the samples were denatured by heating to 
100° C for 3 minutes in formamide dye mix (see section 
2.6.3) or urea load buffer (10M urea, 1 x TBE, 0.2% (w:v) 
bromophenol blue, 0.2% (w:v) xylene cyanol; filter 
sterilized and stored at -20° C) and loaded using a drawn-
out glass capillary. Electrophoresis was continued at 
40W until the marker dyes had migrated the appropriate 
distance. At this point the gel plates were removed 
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from the electrophoresis tank and separated. 	The gel 
(attached to one glass plate) was covered with Saran Wrap 
and autoradiographed (see section 2.2.8). 
2.9.7 HIGH PERCENTAGE DENATURING POLYACRYLAMIDE GEL 
ELECTROPHORESIS 
20% polyacrylamide/8M urea gels were used to analyse 
radioactively labelled oligonucleotides (labelled as 
described in section 2.12.2). A 50m1 solution of 20% 
polyacrylamide/8M urea was prepared as follows: 5m1 10 x 
TEE, 25m1 40% acrylamide solution (38% (w:v) acrylamide, 
2% (w:v) bisacrylamide), 24g ultra-pure urea and dH20 to 
50m1. 250.d. 10% (w:v) AMPS and 25ii.l of TEMED were added 
and the gel poured, treated and pre-run exactly as 
described in section 2.9.6. Samples were denatured and 
loaded (as described in 2.9.6) and electrophoresis 
continued at 40W until the marker dyes had migrated the 
appropriate distance. After electrophoresis the gel was 
treated as described in section 2.9.6. 
2.9.8 BUFFER-GRADIENT DENATURING POLYACRYLAMIDE GEL 
ELECTROPHORESIS (Biggin et al 1983) 
Buffer-gradient denaturing polyacrylamide gels were 
used to fractionate the products of DNA sequencing 
reactions (see section 2.6.3). They are poured in such 
a way that there is a progressive increase in the 
I 
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concentration of buffer towards the lower part of the 
gel. Because the voltage carried through the gel 
decreases as ionic strength increases, then the DNA moves 
more slowly as it approaches the bottom of the gel. 
This lessens the spacing between adjacent DNA bands in 
this region, allowing more sequence to be read from a 
single gel. 
For each gel two solutions were prepared containing 
the following components: Solution A : 7ml 2.5 x TBE gel 
mix (150ml 40% acrylamide (38% (w:v) acrylamide, 2% (w:v) 
bisacrylamide) 200m1 10 x TBE, 460g urea, 50g sucrose, 
50mg bromophenol blue, dH20 to 1 litre), 14pi. 25% (w:v) 
AMPS, 14.il TEMED. 
Solution B : 35ml 0.5 x TBE gel mix (150ml 40% 
acrylamide (as above), 50ml 10 x TBE, 460g urea, dH20 to 
1 litre), 70pJ. 25% (w:v) AMPS, 70iil TEMED. 
Using a lOml pipette and "Pumpette", 4ml of Solution 
B was taken up, followed by Gml of Solution A. A 
gradient was established by allowing 3 - 4 air bubbles up 
into the pipette, through the interface between Solutions 
A and B. 	This mixture was then poured into a glass gel 
sandwich (see section 2.9.6). 	The rest of Solution B 
was then taken up in a 20ml syringe and used to fill the 
remaining space. 	A Sharkstooth comb was inserted and 
the gel treated as described in section 2.9.6. 	DNA 
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sequencing reaction products (section 2.6.3) were loaded 
onto the gel using a drawn-out glass capillary and the 
gel run at 40W until the marker dyes had migrated the 
appropriate distance. 
Following electrophoresis the plates were removed 
from the electrophoresis tank and separated. The gel, 
still attached to one plate, was fixed in a solution of 
10% (v:v) methanol and 10% (v:v) glacial acetic acid for 
15 minutes. It was then transferred to blotting paper, 
covered with Saran Wrap, dried using a heated vacuum gel 
drier and autoradiographed (see section 2.2.8). 
2.9.9 SDS POLYACRYLANIDE GEL ELECTROPHORESIS 
(Laemmli 1970) 
Proteins were separated on 5% linear or, more 
usually, 5 - 15% gradient SDS polyacrylamide gels. To 
prepare a 5% linear gel a 5% separating gel mix was 
prepared : 5m1 30% acrylamide solution (.29.2% (w:v) 
acrylamide, 0.8% (w:v) bisacrylamide), 7.5ml 4 x lower 
gel buffer (1.5M Tris-HC1 pH8.0, 0.4% (w:v) SDS), 25.tl 
25% (w:v) AMPS and dH20 to 30m1. 20i.il TEMED was then 
added and the solution poured into a 25 x 14 x 0.1cm 
glass sandwich, pre-sealed with plastic spacers and 0.5% 
(w:v) water agarose, to within 5cm of the top of the 
notched plate. The gel solution was gently overlaid 
with H20 - saturated butan-2-ol and left to polymerise in 
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an upright position for at least 60 minutes. 	A 5% 
stacking gel mix was then prepared : 1.5ml 30% acrylamide 
(as above) 2.25m1 4 x upper gel buffer (0.5M Tris-HC1 
pH6.8, 0.4% (w:v) SDS) 10it1 25% (w:v) AMPS and dH20 to 
9ml. 
The H20-saturated butan-2--ol was poured off the 
polymerised separating gel and the surface washed with 1 
x upper gel buffer. lOi.i.l TEMED was then added to the 
stacking gel solution and this mix was poured onto the 
separating gel . 	A 15 tooth comb was inserted and the 
gel left to polymerise as before. 	Once polymerisation 
was complete the comb and bottom plastic spacer were 
removed. The wells were washed out with 1 x Tris-
glycine running buffer plus 0.5% (w:v) SDS and the gel 
attached to the electrophoresis tank filled with this 
same 1 x Tris-glycine buffer. Any air bubbles trapped 
beneath the gel were removed before the protein samples 
(prepared as described in section 2.8.1) were loaded 
using a Hamilton microsyringe, and the gel run at 60 - 
90V overnight. 
To prepare a 5 - 15% gradient SDS polyacrylamide 
gel, two 15ml acrylamide solutions were prepared 
separately. 5% solution : 15m1 of this solution was 
prepared as described above. 	15% solution 	7.5m1 30% 
acrylamide solution (as above), 3.75m1 4 x lower gel 
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buffer, 	25pJ 15% (w:v) AMPS, 20i.il TEMED and dH20 to 
15m1. 
The solutions were poured into a two chambered 
gradient maker which was used to mix a 5 - 15% gradient 
into a 25 x 14 x 0.1cm glass sandwich (as above). 
Thereafter, this gel was treated exactly as described 
above. Generally 5 - 15% gradient gels were run at 100V 
overnight. 
Following electrophoresis, the protein gel was 
removed from the glass plates and fixed and stained in 
staining solution (50% (v:v) methanol, 10% (v:v) glacial 
acetic acid, 0.1% (w:v) Coomassie brilliant blue) at 37°C 
for 30 minutes. The staining solution was then removed 
and the gel washed in destaining solution (10% (v:v) 
methanol, 10% (v:v) glacial acetic acid) at 37°C for 
several hours. 
If the protein samples were labelled with 3H-leucine 
(or double-labelled with 3H-leucine and 14 C-leucine) 
then, at this stage, the gel was transferred to a clean 
glass plate, and the identified protein bands excised 
from the gel using a razor blade. Each piece of excised 
gel was then sliced into 1mm wide slices on a specially 
made razor blade stack. Each slice was transferred to 
3m1 	of 	solubilising 	scintillation 	fluid 	(Petri 
Scintillant) (1 litre of Petri Scintillant comprises 
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900ml toluene, 3.6g PPO, 101mg dimethyl POPOP, lOOmi 
Soluene (Packard), 0.9m1 10% (w:v) SDS and dH20 to 1 
litre) and incubated, with shaking, at 37°C overnight. 
The next day samples were counted in a Beckman 
scintillation counter. 
Once 	sufficiently 	destained, 	gels 	containing 
proteins not radioactively labelled were transferred to 
blotting paper, covered with Saran Wrap and dried using a 
heated vacuum gel dryer. 
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2.10 13GALACTOSIDASEASS AY (modified from Miller, 1972) 
Assays of 13  galactosidase activity were performed on 
AK14 strains harbouring pSKS106 (Shapira et a], 1983) or 
its derivatives constructed during this work. AK14 
carries laclq, therefore lacZ expression must be induced 
by the addition of IPTG to the growth medium. 
Assays were performed after 'long-term induction' 
(i.e. continuous growth of the culture in the presence of 
IPTG at a concentration of 10 5M, for at least 18 hours) 
and 'short-term induction' (addition of IPTG at 10M for 
45 minutes). 
Cells were grown in the appropriate medium to an 
A600 of 0.3 and then assayed for 13 galactosidase 
activity. Each assay contained 0.8m1 PM2 reducing 
buffer (0.1M sodium phosphate pH7.0, 1mM MgSO4, 0.2mM 
MnSO4, 100mM f3-mercaptoethanol), 0.2m1 0.1% (w:v) CETAB, 
0.01ml 1% (w:v) sodium deoxycholate, lml of a suitable 
dilution of cells (defined empirically) and 0.6ml ONPG 
(13.5mM in 1 x Spizizen salts). Assays were incubated 
at 28°C and the reaction stopped by the addition of 1.3m1 
1M Na2CO3 once sufficient colour had developed (generally 
A420 0.3 - 0.8). 
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2.11 	NUCLEIC ACID HYBRIDISATION 
2.11.1 LABELLING OF DNA PROBES BY RANDOM PRIMING 
(Feinberg and Vogelstein 1984) 
This method permits the labelling of isolated DNA 
fragments to high specific activity and can even be used 
to label a DNA fragment in low melting-point agarose (LMP 
agarose) without the need for purification of the DNA. 
Digested DNA was electrophoretically separated as 
described in section 2.9.1., but using 0.6% LMP agarose 
(Bethesda Research Laboratories). After staining with 
EtBr, and destaining, the gel was observed on a long 
wavelength UV transilluminator and the required band 
excised cleanly. The gel slice was weighed, dH20 added 
(3m1 per gram of gel) and the sample heated in a boiling 
water bath for 7 minutes to melt the LMP agarose and 
denature the DNA. This solution could either be used 
immediately for the labelling reaction or stored at -20° C 
(Before further use, such a stored sample was reboiled 
for 3 minutes). 
To label the DNA the following reagents were added 
in the order stated to a microcentrifuge tube : dH20 to a 
final volume of 50p.l, 10tl oligonucleotide-labelling 
buffer (A : B : C mixed in the ratios 2 : 5 : 3 (v:v) 
where A : 1.25M Tris-HC1 pH8.0, 0.125M MgC12, 0.5mM each 
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of dATP, dTTP, dGTP and 0.25mM f3-mercaptoethanol; 
B : 	2M Hepes-NaOH pH6.6; 	C : 4.5mgml - ' random 
hexadeoxynucleotide pd(N)6 mixture (in TE), 21 BSA 
(lOmgml - l), DNA in LMP agarose (up to 32.51i1 containing 
20 - lOOng DNA), 50F.lCi of a[32P]-dCTP and 2 units of 
Kienow fragment. The mixture was incubated at room 
temperature for 2.5 - 18 hours to allow polymerisation to 
occur and the reaction then stopped by the addition of 
200.t1 'stop solution' (20mM NaCl, 20mM Tris-HC1 pH7.5, 
2mM EDTA I. 0.25% (w:v) SDS, 1.tM dCTP). 
2.11.2 LABELLING OF DNA BY FILLING-IN OF RECESSED 
3' TERMINI 
DNA fragments which have been cut with restriction 
endonucleases to generate recessed 3' termini can 
subsequently be radiolabelled. If required, the cut DNA 
may be isolated and purified by a variety of techniques 
(as detailed in sections 2.9.1 - 2.9.4) although DNA can 
also be labelled directly after digestion (without any 
subsequent isolation/purification steps). 
Which dNTPs are added to the labelling reaction 
depends on the sequence of the protruding 5' termini. 
During the course of this work al 1 4 dNTPs were required. 
Routinely, approximately 300ng of digested DNA were 
labelled by mixing lp.l 10 X TM (100mM Tris-HC1 pH8.0, 
100mM MgCl2), 2j.tl of dGTP, dATP, dTTP mix (each at 1mM), 
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lOp.Ci of a-[32P]-dCTP, 1 unit of Kienow fragment and dH20 
to 1011. This mixture was incubated at 37°C for 30 
minutes, then extracted once with phenol, and ethanol 
precipitated. 
2.11.3 LABELLING OF DNA OLIGONUCLEOTIDE PROBES 
Oligonucleotide DNA was 5'-end labelled for use as a 
probe as follows: 30p.Ci [32P]-ATP was vacuum desiccated 
in a microfuge tube, to which were added 1.5l 
(10pmoltl 1 ) oligonucleotide DNA, 3i.il 10 X kinase buffer 
(500mM Tris-HC1 pH8.0, 100mM MgC12), 4il 100mM DTT and 
24i.il dH20. 2l (20 units) of T4 polynucleotide kinase 
were added and the reaction incubated at 37°C for 30 
minutes. After this, the probe was crudely purified by 
diluting with 3ml 6 x SSC and passing the solution 
through a 0.45itm Acrodisc filter (Gelman Sciences). The 
filter was then washed with lml 6 x SSC and the resulting 
4m1 of probe were stored frozen in a petri dish. This 
purification procedure is intended only to avoid the 
possibility of generating "hot-spots" on the 
hybridisation filters; it did not remove unincorporated 
label, but was nonetheless adequate for the purposes 
required. 
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2. 11 . 4 PLAQUE BLOTTING  
Transfected or duplicate stabbed plates were used as 
the source of plaques in this method. 2 - 3 day old BBL 
plates were used, and were well dried before use. The 
plates were incubated overnight in the usual way, before 
being chilled at 4°C for at least one hour to allow the 
top agar to harden. The nitrocellulose filters 
(Schleicher and Schuell, 82mm diameter, 0.45p.m pore size) 
required no preparation prior to use, but were carefully 
marked to ensure easy orientation with the parent plate 
afterwards. A dry filter was carefully laid onto the 
surface of the plate for 90 seconds and then placed on a 
pad of blotting paper soaked in 0.5M NaOH (the surface 
that had been in contact with the plaques being placed 
uppermost). After 5 minutes the filter wa transferred 
in sequence into the following solutions in a series of 
four petri dishes, allowing 20 seconds in each petri dish 
a) 0.1M NaOH, 1.5M NaC1 b) 0.5M Tris-HC1 pH7.5, 1.5M 
NaC1 c) repeat of b, d) 2 x SSC. Filters were dried at 
37°C before being baked in a vacuum over at 80°C for 2 
hours. 
2.11.5 HYBRIDISATIONLJ'L..LLPT$JLIT...LBEIJJ-'EP 
OL IGONUCLEOT IDE PROBES 
This method was used to detect mutants produced by 
site-directed mutagenesis (using the labelled mutagenic 
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oligonucleotide as a probe). 	Filters were prepared as 
described in section 2.11.4 and then prehybridised in 10 
x Denhardt's solution, 6 x SSC and 0.2% (w:v) SDS at 65°C 
for 1 hour. Each filter, treated individually, was then 
rinsed in 6 x SSC for 5 minutes and placed (plaque side 
down) into the petri dish containing the radiolabelled 
oligonucleotide probe (see section 2.11.3) and left for 
60 minutes at room temperature. Occasionally, during 
this hour, the filter was lifted and replaced in the 
probe solution, in an attempt to ensure even 
hybridisation. The hybridised filter was washed for 3 x 
5 minutes in 6 x SSC at room temperature, placed on 
blotting paper to remove excess liquid, sandwiched 
between two layers of Saran Wrap and exposed to X-ray 
film. If increased stringency washes were required then 
the washing procedure was carried out in 6 x SSC for 5 
minutes at 5°C below the calculated dissociation 
temperature (Td) of the oligonucleotide. The Td was 
calculated using the Wallace rule (which only applies to 
oligonucleotides under 6 x SSC washing conditions). 
Td (°C) = 4 (G + C) + 2(A + T) 
Under 6 x SSC washing conditions, 	increased 
stringency can be achieved by gradually increasing the 
wash temperature to the Td, with autoradiography at each 
step. 
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2. 11 .6 COLONYBLOTTING 
The screening of bacterial colonies to identify 
recombinant clones is performed by the method of 
Grunstein and Hogness (1975) as detailed by Maniatis et 
al (1982). Transformed E. coli colonies were picked, 
using sterile toothpicks, and streaked (in a grid 
pattern) on duplicate LB agar (plus selective antibiotic) 
plates and grown at 37°C overnight. One of these 
duplicate plates was stored at 4°C as the master plate. 
Colonies which carried the desired recombinant DNA 
sequences were later recovered from this plate. The 
other plate was used for blotting. 
A nitrocellulose filter (Schleicher and Schuell, 82 
mm diameter, 0.45.im pore size) was laid on top of the 
agar, causing the bacterial colonies to stick to it. 
The membrane was then removed and laid, colony side 
uppermost, onto a pad of blotting paper soaked with 1.5M 
NaCl, 0.5M NaOH for 5 minutes. This step was repeated 
with blotting paper soaked in 1M Tris-HC1 pH8.0, 1.5M 
NaCl for 5 - 10 minutes and blotting paper soaked in 2 x 
SSC for 5 minutes. The filter was then dried at 37°C 
and baked at 80°C under vacuum for 2 hours. 
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2.11.7 HYBRIDISATION OF COLONY BLOTS WITH LABELLED 
DNA PROBES 
Filters (prepared as described in section 2.11.6) 
were pre-wetted in hybridisation solution (5 x Denhardt's 
solution, 2 x SSC, 0.5% (w:v) SDS, 0.lmgml' salmon 
testes DNA (sheared by repeated passage through an 18G 
needle and boiled for 5 minutes prior to use), 50% (v:v) 
deionised formamide) and then transferred to a bag 
containing approximately 20ml of the same hybridisation 
solution. 	The bag was sealed, taped to a tray and. 
placed, shaking, 	at 37°C for 2 hours to allow 
prehybridisation of the filters. 	After this time the 
solution was discarded. 	It was replaced by 
approximately 20ml of fresh hybridisation solution 
containing the radioactive probe (see section 2.11.1) 
(The probe had been heated to 100° C for 5 minutes prior 
to use). The bag was resealed and incubated, shaking, 
at 37°C overnight. The following day the filters were 
removed and washed at 37°C as follows: 2 x 20 minutes in 
wash 1 (2 x SSC, 0.5% (w:v) SDS, 50% (v:v) deionised 
formamide), 2 x 30 minutes in wash 2 (2 x SSC, 0.5% (w:v) 
SDS) and 2 x 30 minutes in wash 3 (2 x SSC). Excess 
liquid was removed on blotting paper, after which the 
filters were sandwiched between 2 layers of Saran Wrap 
and autoradiographed (see section 2.2.8). 
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2.11 .8 DNA;RNA FILTER HYBRIDISATION (Anderson and 
Young 1985) 
Nitrocellulose filters (Schleicher and Schuell, 24 
mm diameter, 0.45m pore size) were prepared by numbering 
them with pencil and then incubating them in dH20 at 80°C 
for 10 minutes. 	The filters were then stored in 10 x 
SSPE at room temperature until required. 	They were 
loaded (using a slight negative pressure) with either 2ig 
of SS M13 DNA or 4p.g of denatured RF M13 DNA (in each 
case in a total volume of 500p.l). The BY M13 DNA was 
first denatured in 4m1 of alkaline SSPE (15 x SSPE, 0.5M 
NaOH) at 80°C for 10 minutes. The samples were 
neutralised by the addition of 600.iJ 0.5M HCl and 6001il 
of 1M Tris-HC1 pH7.4, then placed on ice prior to 
loading. The loaded filters were dried at 37°C and 
baked at 80°C under vacuum for 2 hours. 
The filters were prehybridised as described in 
section 2.11.7 and then placed in glass vials (which had 
been siliconised, DEP treated and baked prior to use). 
Hybridisation solution (see section 2.11.7) was added to 
the vials (0.75ml per vial) followed by the appropriate 
amount of labelled RNA (0.5, 0.25 and 0.125 volumes of 
the total RNA preparation - as described in section 
2.7.3). 	The vials were incubated, with gentle shaking, 
at 42°C overnight. 
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Following hybridisation, each vial was aspirated 
using a water pump fitted with a Pasteur pipette. The 
liquid was replaced with 2.5ml wash 1 (2 x SSC, 0.1% 
(w:v) SDS). 	The vials were shaken at room temperature 
for 15 minutes and the above step repeated. 	The filters 
were then transferred to a plastic sandwich-box and 
washed as follows: 2 x 1 hour at 65°C in wash 2 (0.1 x 
SSC, 0.1% (w:v) SDS), 2 x 20 minutes at 37°C in wash 3 (2 
x SSC), 1 x 2 hours at 37°C in wash 4 (2 x SSC, 251igml' 
RNase A, 10 Um1 1 RNase Ti), 2 x 20 minutes at 65°C in 
wash 5 (2 x SSC, 0.5% (w:v) SDS) and finally 2 x 20 
minutes at room temperature in wash 6 (2 x SSC). The 
filters were then placed on blotting paper and dried at 
370 C, before the retained counts were determined by 
liquid scintillation counting in 3ml (per filter) of 0.4% 
(w:v) butyl-PBD in toluene. 
A measure of the total labelled RNA was obtained by 
spotting a small volume onto a nitrocellulose filter. 
Once dried (and without any washing procedure) this can 
be counted as described above. 
2.11.9 Si NUCLEASE MAPPING OF RNA (Maniatis et al 
1982) 
20Vq of RNA (prepared as described in section 
2.7.1), approximately 10 4 cpm of labelled DNA probe (see 
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section 2.11.2) and 150.tg of E. coli tRNA (Boehringer) as 
carrier were added to a microfuge tube and precipitated 
with ethanol. The dried pellet was resuspended in 30l 
of hybridisation buffer (40mM PIPES pH6.4, 1mM EDTA 
pH8.0, 0.4M NaCl, 80% (v:v) deionised formamide). 
Optimal denaturation and hybridisation conditions must be 
determined for each separate DNA : RNA reaction. In the 
Si nuclease mapping experiments carried out during this 
work I used the conditions set out in Railing and Linn 
(1987). Samples were immersed in a water bath at 80°C 
for 10 minutes to denature the DNA, followed by 
hybridisation at 53°C for 3 hours. With the body of the 
microfuge tube still submerged in the 53°C water bath, 
0.27m1 of ice-cold Si nuclease buffer, containing Si 
nuclease, was added (0.28M NaCl, 0.05M sodium acetate 
pH4.6, 4.5mM ZnSO4, 20.igml-' carrier SS DNA, 400 Umll Si 
nuclease). The samples were then transferred to 37°C 
for 30 minutes, placed on ice and the reaction stopped by 
the addition of 501il 'STOP' mix (4M ammonium acetate, 
0.1M EDTA). 	Each sample was then extracted once with 
phenol/chloroform. 	A further 20p.g of carrier tRNA were 
added to the aqueous -phase, then precipitated with an 
equal volume of isopropanol. The dried pellet was 
resuspended in formamide dye mix (see section 2.6.3) or 
urea load buffer (see section 2.9.6), boiled for 3 
minutes, and subjected to denaturing polyacrylamide gel 
electrophoresis (see section 2.9.6). 
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2.11.10 PRIMER EXTENSION ANALYSIS OF RNA 
This technique was used to map the 5' termini and/or 
processing intermediates of mRNA. The test RNA was 
hybridised with a synthetic oligonucleotide DNA primer 
radiolabelled at its 5' terminus by phosphorylation (see 
section 2.11.3). Reverse transcriptase was then used to 
extend this primer to produce a cDNA which was 
complementary to the RNA template. The cDNA was 
analysed by denaturing polyacrylamide gel electrophoresis 
(see section 2.9.6). 
The oligonucleotjde DNA primer was 5' end-labelled 
as follows: 20pmoles oligonucleotjde, 20MC1 '[32p] ATP, 
3p.l 10 x kinase buffer (500mM Tris-HC1 pH8.0, 100mM 
MgC12), 3p.1 100mM DTT, 1.5 U T4 polynucleotide kinase and 
dH20 to 30l were mixed in a microfuge tube and incubated 
at 37°C for 15 minutes. The enzyme was heat-inactivated 
at 70°C for 10 minutes and the sample then stored at - 
20°C until required. Varying amounts of RNA (30 - 
150p.g), prepared as described in section 2.7.1, were 
mixed with varying amounts (0.5 - 2p.l) of the labelled 
oligonucleotj.de primer mix (see above) and hybridisation 
mix (50mM Tris-HCI pH7.5, 75mM KC1, 3mM MgC12) in a final 
volume of 30p.l. This was incubated for 30 minutes at 
5°C below the calculated Td of the oligonücleotjde (see 
section 2.11.5). The sample was then cooled quickly on 
ice and the following reagents added : 1&l 1M Tris - 
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HC1 	pH7.5, 1.5l 0.2M MgC12, 5l 0.1M DTT, 2.5p.l dNTP 
mix (each dNTP at 10mM), lp.l BSA 5mgml 1 , 7.5p.l dH20 and 
1.5 U M-MLV RTase (Moloney Murine Leukemia Virus Reverse 
Transcriptase, Gibco BRL). 
These components were mixed well and the sample 
incubated at 37°C for 1 hour. After this time, 12.5i.t1 
0.5M NaOH were added and the sample placed in a boiling 
water bath for 3 minutes, then transferred to ice. 
12.5.il 0.5M HC1 and 12.51 of 1M Tris-HC1 (pH7.4), were 
then added and the sample precipitated with ethanol. 
After washing in 66% (v:v) ethanol, the dried pellet was 
resuspended in urea load buffer (see section 2.9.6), 
boiled for 3 minutes and subjected to denaturing 
polyacrylamide gel electrophoresis (see section 2.9.6). 
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2. 12 OLIGONUCLEOTIDE SITE-DIRECTED MUTAGENESIS 
2.12.1 THE ECKSTEIN METHOD (Taylor et al 1985a, 1985b) 
All 	oligonucleotide 	site-directed 	mutagenesis 
reactions carried out during the course of this work used 
the 'Eckstein Method'. 	A schematic outline of this 
method is shown in Fig. 2.2. 	This procedure was 
performed using an oligonucleotide-directed in vitro 
mutagenesis kit supplied by Amersham International plc, 
and the protocol described in the booklet they provide 
was followed exactly. 
Before use, the size and purity of each custom 
synthesised oligonucleotide were checked (see section 
2.12.2). Also, prior to each mutagenesis reaction, the 
fidelity of oligonucleotide binding and optimal 
conditions for oligonucleotide : template DNA annealing 
were ascertained by using the oligonucleotide as a 
primer, at varied template-primer ratios and different 
temperatures, for dideoxy-sequencing (generally A- or T-
tracking reactions, see section 2.6.3). 
2.12.2 CHECKING THE SIZE AND PURITY OF AN 
L I GONUCLEOT IDE 
All of the oligonucleotides used in this work were 
custom synthesised by the OSWEL DNA service (Department 
Fig.2.2 
The Amersham ol igonucleot ide-directed 
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of Chemistry, Edinburgh). 	A small quantity of 
oligonucleotide was phosphorylated using [32P] ATP, by 
mixing the following components : lOi.&Ci [32P] ATP, lOp 
moles oligonucleotide, 1l 10 x kinase buffer (see 
section 2.11.10), 1l 100mM DTT, dH20 to 10l, and then 
adding 1 unit of T4 polynucleotide kinase. 	The reaction 
was incubated at 37°C for 15 minutes. 	51 of formamide 
dye mix (see section 2.6.3) were added and the sample 
boiled for 3 minutes before being loaded onto a high 
percentage denaturing polyacrylamide gel and subjected to 
electrophoresis (see section 2.9.7). 
An example of the results of this method is shown in 
Fig. 2.3. These oligonucleotides are all essentially 
pure and are all of the correct size as judged by 
comparison with a previously determined oligonucleotide 
marker. 
Fig 2.3 
Check on the size and purity of oligonucleotides 
Tracks 
1 	202A (15 mer) oligonucleotide size marker 
2 	203A (17 mer) 
3 	211A (15 mer) 
4 	218A (16 mer) 	- not used in this work 
5 	219A (25 mer) 
6 	608A (21 mer) 
LI 
Fig 2.3 
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CHAPTER 3 
COMPARATIVE .MiA.LY.I S.....QF . 
IN rnc AND rnc105 E. CULl STRAINS 
3. 1 INTRODUCTION 
The rpoBC genes are contranscrihed in an operon with 
four 50S ribosomal protein genes, rp1KAJL, included 
upstream (reviewed by Yura and Ishihama 1979). 
Approximately 80% of all transcripts which emanate from 
promoters PL1I and PL1O are terminated in the tL7 region. 
Si nuclease analysis of this readthrough mRNA reveals 
that it is normally cleaved at sites between tL7 and the 
rpoB start, and that this processing does not occur in an 
rnclOS (RNase III deficient) strain (Barry et al 1980). 
These cleavage sites have been accurately mapped to a 
region of potential mRNA secondary structure which 
resembles other known RNase III target sites (Barry et al 
1980, Fukuda and Nagasawa-Fujimori 1983, Downing and 
Dennis 1987, Ralling and Linn 1987). This and all other 
work to date (including Morgan and Hayward 1987) suggests 
that cleavage is slow or incomplete. 
Dennis (1984) showed that the lack of any detectable 
RNase III processing, in the rnc105 strain N2077, has no 
observable effect on the rates of rplJL or rpoBC mRNA 
production or of 1313' protein synthesis under steady state 
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growth conditions, when compared with the isogenic rnc 
control N2076. However, Portier et al (1987) presented 
evidence that 1313' proteins form a higher percentage of 
total protein in an rnc105 mutant (BL321) than in its 
isogenic wild type partner (BL322), although they did not 
measure the actual synthetic rates of 1313'. 
I decided to re-examine the rates of 013' synthesis 
during exponential, steady state growth in N2076 and 
N2077, and also to determine these rates in BL322 and 
BL321. 
The rpoBC genes are also subject to translational 
feedback regulation. The drug rifampicin can interfere 
with this post-transcriptional control mechanism, as has 
been clearly demonstrated by studies in vitro (Bass et al 
1979, Kajitani et al 1980, Lang-Yang and Zubay 1981, 
Fukuda and Nagasawa-Fujimori 1983) and more tentatively 
by in vivo results (Bass et al 1979). Rifampicin also 
causes increased transcriptional readthrough of the tL7 
terminator. This effect may be an artefact, since all 
tested terminators show increased readthrough in the 
presence of rifampicin (Howe et al 1982, Newman et al 
1982, Cromie and Hayward 1984). I decided to determine 
the rates of rpoBC mRNA synthesis and 13 13 ' protein 
production in rnc and rnc1O5 strains (N2076 and N2077 
respectively) following rifampicin treatment. 
3.2 INITIAL CHARACTERISATION OF rnc AND rnc1 05 
STRAINS 
It is known that RNase III deficiency leads to a 
reduction in the growth rate of E. coli (Apirion and 
Watson 1975, Studier 1975). Table 3.1 confirms that the 
rnclOS strains BL321 and N2077 grow markedly more slowly 
than their isogenic rnc partners BL322 and N2076, under 
all conditions tested. 
Table 3.1 CELL DOUBLING TIMES 
Growth Medium and Temperature 
Strain MIN30 0 C MIN 37°C ENR 37°C 
BL322 (rnc) 125 	(±3) 106 (±3) 61 (±1) 
BL321 (rnc105) 176 	(±3) 133 (±2) 90 (±1) 
N2076 (rnc) 118 	(±3) 70 (±2) 55 (±1) 
N2077 (rnc105) 177 	(±3) 118 (±1) 73 (±4) 
 The time taken for doubling of cell number is shown 
in minutes. 	The figures 	in brackets are standard 
errors; each result 	is the mean of at least three 
observations. 
 MIN is 	Spizizen 	minimal 	medium : 	ENR is the 	same, 
enriched with 	all standard 	amino acids except 
leucine. 
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One major reason for this growth defect is likely to 
be the impaired processing of the 30S ribosomal precursor 
RNA to 16S, 23S and smaller RNAs, in the absence of RNase 
III (Dunn and Studier 1973, Nikolaev et al 1973, King et 
al 1984). This phenomenon is a good diagnostic 
characteristic of rnc105 strains, which can be readily 
checked. I verified it for out stock of strain N2077. 
Cultures of N2076 and N2077 were subjected to 
[ 3H] 
uridine pulse-labelling followed by rifampicin addition 
at 100.igm1-1 and RNA extraction as described in section 
2.7.2. 	Samples were fractionated by special, composite 
agarose 	polyacrylamide gel electrophoresis (see section 
2.9.5) and the rRNA species detected by sensitive 
autoradiography, after fluorography (see section 2.2.8). 
This technique showed the presence of a 30S RNA in N2077 
which was not detectable in N2076 (see Fig. 3.1). Upon 
'chasing' with non-radioactive uridine the label in the 
30S band disappeared, almost completely after 5 minutes 
and entirely after 10 minutes, whilst that in the 16S and 
23S bands increased. This fits the expectation of 
slower processing in an RNase III deficient strain 
relative to its wild type partner and confirms that our 
stock of N2077 is indeed RNase III deficient. It is 
known that whilst maturation of 16S rRNA can proceed 
without prior RNase III cleavage, such processing is 
absolutely required to allow mature 23S rRNA production. 
RNase III deficient strains contain a variety of pre-23S 
rRNA species with additional 5' and 3' sequences. The 
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quality of the resolution of the RNA bands in Fig. 3.1 is 
too poor to permit the detection of discrete pre-23S rRNA 
species : however, there is an indication of more diffuse 
23S rRNA bands in tracks 4 and 6 (N2077) than in the 
corresponding "wild type" tracks 3 and 5 (N2076). 
Fractionation of labelled RNA preparations from 
N2076 and N2077 by composite 0.5% agarose 2% 
polyacrylamide gel electrophoresis. 
Tracks 
M 	Markers are pNA601ClaI, which should yield three 
fragments (approximately 6kb, 5kb and 3.5kb). 
These were denatured in 30% (w:v) DMSO, 1mM EDTA, 
0.05% bromophenol blue at 90°C for 2 minutes, 
chilled on ice and loaded onto the gel. Sizes are 
given in nt. 
1 	N2076 0mm., 	no rifampicin 
2 	N2077 0mm., 	no rifampicin 
3 	N2076 +5mm., rifampicin 	(100.igml-l) 
4 	N2077 +5mm., rifampicin 	(lOOj.igml - ') 
5 	N2076 +10mm., rifampicin 	(100gml - l) 
6 	N2077 +10mm., rifampicin 	(lOOp.gml - l) 
30S, 23S and 16S mark the positions of 30SrRNA, 
23SrRNA and 16SrRNA respectively. 
F ig 3.1 
M 	1 	2 	3 	4. 	5 	6 
tx 





3.3 DETERMINATION OF 3' SYNTHESIS RATES DURING 
EXPONENTIAL.._STAPTMQW111 
Since rnc and rnc105 strains display different 
growth rates (Apirion and Watson 1975, Studier 1975, see 
Table 3.1) and since it is known that 1313' production is 
growth-rate-dependent (Iwakura et al 1974) then it is 
important to study the expression of these proteins in 
rnc and rnc105 strains under a variety of growth rates. 
In this way the relative contributions of growth rate and 
mc phenotype to the level of 13(3' expression can be 
elucidated. This was achieved by growing the rnc and 
rnc105 strains in two different media (minimal and 
enriched minimal) and at two temperatures (300 C and 
37°C). This provided a set of experimental data by 
which mnc and rnc105 strains could be compared when 
growing at the same as well as when growing in the 
same •coji.ditipn..It is •interesting to note that under 
these various growth conditions the mnc strains N2076 
and BL322 never grew exponentially above A650 of 0.5, 
and the mnc105 strains N2077 and BL321 never grew 
exponentially above A650 0.35. Because of this, the 
experiments with all four strains were started at 
relatively low cell densities (e.g. A650 = 0.16). 
At this point the appropriate strains, grown under 
the correct conditions, were pulse-labelled for 2.5 
minutes with [ 3H] leucine. After a 3 minutes chase with 
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unlabelled leucine, to allow completion of nascent 
labelled polypeptides, the cells were collected, washed 
and lysed (as described in section 2.8.1). To normalise 
for any variations in the recovery of 13 and 0' from the 
different samples, the [ 3H] leucine labelled cell 
extracts were then mixed with an aliquot of a "standard" 
cell extract, prepared from a single culture which had 
been pre-labelled for two generations with [14C] leucine. 
A small volume of this 'mixed extract' was set aside to 
be used in determining the level of 'total protein' in 
each sample. This then allows one to determine 
accurately the rates of (3f3' synthesis relative to total 
protein in the different cultures. 
The labelled cell extracts were fractionated on SDS 
polyacrylamide gels (see section 2.9.9). 0 and 13 ' 
proteins are sufficiently well purified from N2076, 
N2077, BL322 and BL321 cell extracts by this method to 
allow direct assay by scintillation counting of the 
excised protein bands. The 3 H : 14C ratios in 1313' and 
total protein were determined by direct scintillation 
counting of samples. The differential rates of 13 plus 
13 ' syntheses are summarised in Tables 3.2.1 and 3.2.2. 
The amount of incorporation of [ 3H] leucine into (3 was 
virtually the same as that into 0' in all strains and in 
all conditions (data not shown). Therefore the sum of 13 
and f3' is given for greater clarity. 
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Two general conclusions can be drawn from the 
results presented in Tables 3.2.1 and 3.2.2. 	Firstly, 
the differential rate of r313' synthesis is not 
significantly affected by the mc phenotype when one 
makes a comparison between N2076 and N2077, or between 
BL322 and BL321, at similar growth rates. Secondly 
there is, as expected, a modest growth-rate--dependent 
effect on the differential rate of f3(3' synthesis in 
strains N2076 and N2077. The data for BL322 and BL321 
are compatible 	with 	a 	similar 	effect, 	but are 
insufficiently precise to allow any assertion. 
154 
Table 3.2.1 
Rate of 1313' synthesis as a percentage of total 
protein b 
N2076 




Cell Doubling Timea 
55 (± 1) 
73 (± 4) 
118 (± 3) 





0.01) 	0.72 (± 0.06) 
0.24) 	0.54 (± 0.04) 
0.48 (± 0.09) 
Table 3.2.2 
Rate of 13(3' synthesis as a percentage of total 
protein b 
Cell Doubling Timea 
61 (± 1) 
99 (± 10)1) 
128.5 (± 6.5) 2 ) 
176 (± 3) 
BL322 







0.27) 	0.62 (± 0.18) 
0.07) 	0.65 (± 0.10) 
0.52 (± 0.09) 
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1) 	BL322 and BL321, respectively, 106 (± 3) and 90 (± 
1) : see Table 3.1. 
2) 	BL322 and BL321, respectively, 125 (± 3) and 133 (± 
2) : see Table 3.1. 
Cell doubling time is shown in minutes. 	Except as 
noted (1,2) the figures in brackets are standard 
errors, and each result is the mean of at least 
three observations. 	Growth conditions are those 
shown in Table 3.1. 
13 13 ' protein levels are expressed as a percentage of 
the total protein level i.e. (3H/14C in 133') ± 
( 3H/ 14C in total protein) x 100. 	The figures in 
brackets are ranges; each result is the mean of two 
independent experiments. 
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3.4 DETERM I NAT  I.O.N....-OF BB SYNTHESIS RATES.-FOLLOWING 
RIFAMPICIN ADDITION 
As described in Chapter 1, addition of sub-
bacteriostatic quantities of the drug rifampicin, which 
binds to the 13 subunit of RNA polymerase and aborts 
initiation, leads to an increase in synthesis of 1313' and 
other RNA polymerase subunits in exponential cultures of 
sensitive E. coli. I compared the kinetics of this 13 13 ' 
response in the strains N2076 and N2077 (rnc and rnc105 
respectively). 
These experiments involved exponential growth of 
N2076 and N2077 with addition of rifampicin at A650 = 
0.16. The low drug concentration used (5p.gml - ') had no 
detectable effect on growth rate for at least 90 minutes 
after addition, and similarly no measurable effect on 
[ 3H] leucine incorporation into total protein for at 
least 60 minutes after addition (data not shown). 
Samples were pulse-labelled with [ 3H] leucine immediately 
before, and at various times after drug addition (as well 
as in parallel drug-free controls). Results were 
normalised using [14C] leucine which had been added to 
the culture two generations prior to [ 3H] leucine pulse-
labelling, to serve as an internal control. 
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Incorporation of [14C] leucine into protein had been 
complete within about one generation. 
The differential rates of 13 and 3' protein syntheses 
prior to, and following, rifampicin addition are shown 
for N2076 (Table 3.3) and N2077 (Table 3.4). Since 13 
and (3' subunits showed essentially parallel responses to 
rifampicin in both strains and all growth conditions, the 
results for 0 plus 13' are again taken together and 
expressed graphically (as (313') in Fig. 3.2. 
The drug-free control data confirm that the cultures 
were in steady state exponential growth throughout the 
experiments (and that the [ 14C] labelled control 13(3' 
proteins were stable). The rnc (N2076) strain shows 
the expected rapid increase in (3(3' synthesis following 
drug addition, the kinetics being somewhat slower at the 
lowest growth rate. The extent of the effect (a 2 - 3 
fold increase in the rate of (3(3' synthesis) is very 
similar to that seen previously for example by Nakamura 
and Yura (1976) using low rifampicin concentrations in 
the drug-sensitive strain KY1400, or by Hayward and Fyfe 
(1978a) using the rifs/rifr merodiploid RSH74. The 
rnclQ5 strain (N2077) also shows the effect, but the 
kinetics are quite different. This is particularly 
striking if one compares the two strains growing at the 
same rate (Fig. 3.2 a) and e) and eSDeciglly Fig. 3.2 b) 
and f)], but is also true if one compares the two strains 
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growing under the same conditions (marginally so in Fig. 
3.2 a) and d), but more clearly in Fig. 3.2 b) and e), 
and, particularly at early time points, in Fig. 3.2 c) 
and f)]. It is clear that the rifampicin effect is 
expressed more slowly in the rncl05 mutant, N2077, than 
in its isogenic rnc partner, N2076. 
Table 3.3 
0 	and 	(3' 	synthesis 	rates 	in 	N2076 	(rnc). 
Synthesis rates are given relative to the rate at zero 
minutes (designated 1). 	-Rif. (no rifampicin added); 
+Rif. (rifampicin added at 5qml - '). 	Growth conditions 
are : MIN 30°C (minimal medium at 30°C), MIN 37°C 
(minimal medium at 37°C), ENR 37°C (enriched medium at 
37°C). 	The drug-free control experiments were carried 
out only once (except for the zero time points). 	The 
results for N2076 ENR 37°C +Rif. are the means of 
duplicate experiments. 	All other results are the means 
of three independent experiments. 	Ranges or standard 
errors are not shown (but see Fig. 3.2). 
Table 3.3 
and ' synthesis rates in N2076 (nic.) 
Time MIN 30 C 
-Rif +Rif 
0 1 1 1 1 
5 0.97 0.99 1.07 1.02 
10 1.06 0.97 1.10 1.05 
15 0.96 1.04 1.31 1.31 
20 0.99 0.87 1.32 1.36 
30 1.02 1.08 1.5 1.6 
45 0.93 0.91 1.93 1.74 
60 0.96 0.91 1.78 1.94 
MIN 37 C 
-Rif +Rif 
1 1 1 1 
0.92 0.87 1.16 1.18 
0.90 0.87 1.47 1.64 
0.92 0.90 1.61 1.83 
0.95 0.92 1.87 2.05 
0.88 0.86 2.40 2.33 
0.85 0.93 2.43 2.57 
1.02 0.93 2.90 2.96 
ENR 37 C 
-Rif +Rif 
1 1 1 1 
0.96 0.88 1.22 1.12 
0.94 0.95 1.40 1.43 
0.88 0.93 1.64 1.55 
0.93 0.94 1.63 2.06 
1.01 1.01 1.74 1.86 
0.96 0.96 1.98 1.97 
0.98 1.00 1.95 2.21 
Table 3.4 
13 and 13' 	synthesis 	rates in N2077 	(rnclO5). 
Synthesis rates are given relative to the rate at zero 
minutes (designated 1). 	-Rif. (no rifampicin added); 
+Rif (rifampicin added at 5p.gml - l). 	Growth conditions 
are exactly as for Table 3.3. 	The drug-free control 
experiments were carried out only once (except for zero 
time points). 	The results of N2077 MIN 30°C +Rif. are 
the means of duplicate experiments. 	All other results 
are the means of three independent experiments. 	Ranges 
or standard errors are not shown (but see Fig. 3.2). 
Table 3.4 
and ' synthesis rates in N2077 (rncl05) 
Time MIN 30 C 
-Rif +Rif 
0 1 1 1 1 
5 0.90 1.02 1.07 1.03 
10 0.91 1.01 1.15 1.05 
15 0.85 0.98 1.14 1.18 
20 0.95 1.05 1.21 1.16 
30 0.95 1.08 1.33 1.31 
45 0.96 1.09 1.39 1.46 
60 0.96 1.06 1.83 1.63 
MIN 37 C 
-Rif +Rif 
1 1 1 1 
0.93 0.89 0.97 0.94 
0.92 0.88 0.92 0.99 
0.98 0.96 1.20 1.25 
0.84 0.81 1.10 1.04 
0.99 0.99 1.18 1.29 
1.04 0.97 1.47 1.54 
0.97 1.00 1.50 1.62 
ENR 37 C 
-Rif +Rif 
1 1 1 1 
1.05 1.02 1.21 1.14 
0.95 0.95 1.35 1.35 
1.13 1.12 1.39 1.34 
0.98 0.86 1.50 1.46 
1.08 1.05 1.53 1.56 
0.94 1.01 1.60 1.48 
1.04 1.02 1.88 1.83 
Fig 3. 2 
The differential rate of (3(3' synthesis in N2076 
(rnc : a,b,c) and N2077 (rnc105 : d,e,f) following the 
addition of rifampicin at 5.&gml'. Cultures were grown 
in minimal medium at 30°C (a,d) or 37°C (b,e), or in 
enriched medium at 37°C (c,f). 	Open circles : no 
rifampicin added; 	closed circles : 5g rifampicin m1 1 
added at zero minutes. 	The heights of the vertical bars 
on the latter points represent twice the standard errors 
of the mean results, all of which were derived from three 
independent experiments (except for c and d, which show 
means and ranges derived from duplicate experiments). 
Where no bars are shown, the errors were less than ± 
0.04. The drug-free control experiments were carried out 
only once (except for the zero-time points). The 
vertical arrows link the rnc (upper panels) and rnc105 
strains for comparison when growing under the same 
conditions . The diagonal arrows link them when growing 
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3.5 DETERMINATION OF rPoB AND rDoC mRNA SYNTHESES 
RATES FOLLOWING RIFAMPICIN ADDITION 
Obviously one important, initial question is whether 
this delayed response of 1313' synthesis in the rnc105 
strain reflects a transcriptional or post-transcriptional 
effect. To determine this, I monitored the rates of 
synthesis of rpoB and rpoC mRNA, as well as control rps 
and rpl mRNAs, in both strains (N2076 and N2077) using 
the DNA : RNA filter hybridisation method described in 
section 2.11.8. 	Both strains were pulse-labelled with 
[ 3H] uridine before and after rifampicin addition. 	I 
studied N2076 in Spizizen minimal medium at 30°C and 
37°C, and N2077 in minimal and enriched media at 37°C, to 
allow comparison at two different doubling times (see 
Table 3.1), as well as in the same growth condition 
(minimal medium at 37°C). The culture absorbance at the 
time of rifampicin addition, and the drug concentration 
were exactly as in the protein labelling experiments. 
The low drug concentration used (5tgml') had no 
detectable effect on [ 3H] uridine uptake into total RNA 
for at least 60 minutes after addition (data not shown). 
The labelled RNA was extracted as described in 
section 2.7.3. 	Several DNA probes were used in these 
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filter hybridisation experiments. 	These are listed in 
Table 3.5. 
Table 3.5 
DNA probes for filter hybridisation experiments 
Clone 	Gene 	DNA typea) 	Hybridisation Probe 
to mRNAb) 	sizec) 
(nt) 
M13mp8 	- 	SS 	 - 	 - 
M13mp11-5 rpsMKD SS 	 + 	 1320 
M13mp18-9 rplJL 	SS 	 + 	 916 
M13mp19-4 rplJL 	SS 	 - 	 916 
M13mp18-11 rpoB 	SS 	 + 	 1090 
M13mp18-12 rpoB 	SS 	 - 	 1090 
M13mpll-22 rpoC 	SS 	 + 	 2542 
M13mpll-23 rpoC 	SS 	 - 	 2542 
(SS) is single stranded M13 DNA 
(+) means the M13 SS DNA strand which is 
complementary to the gene's mRNA,and will hybridise. 
(-) means the M13 SS DNA strand which has the same 
sequence as the gene's mRNA, and should not 
hybridise. 
C) 	Probe size refers to the length of bacterial DNA 
inserted into the M13 vector and is given in 
nucleotides (nt). 
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As can be seen from Table 3.5, the probes were all 
single-stranded M13 DNA, prepared from clones in M13mp 
vectors. 	M13mp8 SS DNA acts as a control for non- 
specific hybridisation; 	it contains no bacterial DNA 
insert and should have no sequence complementarity to 
bacterial messenger RNA. 	Filters without any DNA were 
included as further negative controls. 	M13mp11-5 was 
constructed as described in Meek and Hayward (1986), and 
serves as a positive control responding to mRNA sequences 
outwith the rpoBC operon. 	It binds to mRNA from the a 
operon 	rpsHKD. 	I prepared the rpiJL positive- 
hybridisation probe (M13mp18-9) by cloning a 916bp EcoRI- 
Stul DNA fragment (derived from 	), DWM321) into M13mp18 
between the EcoRI and SinaI sites. 	I made the 
complementary, negative-hybridisation probe (M13mp19-4) 
by cloning the same fragment in M13mp19. 	I constructçd 
the rpoB positive- and negative-hybridisation probes by 
cloning the 1090bp Sail DNA fragment from 	), DWM321 into 
the Sail site of M13mp18, in both orientations. 	In 
JM101, M13mp18-11 was unstable and readily generated 
deletions, whilst M13mp18-12 was stable. This 
phenomenon has been observed before with rpoB DNA 
sequences (Meek and Hayward 1986), where a. 2873bp EcoRI 
rpoB insert was stable in one orientation in M13mpll, but 
highly unstable in the opposite orientation in the same 
vector. Interestingly the same 2873bp EcoRI DNA fragment 
is stable in both orientations when cloned into M13mp8 
(Railing and Linn 1987). 
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In the recA strain NM570, both M13mp18-11 and 
M13mp18-12 are stable. All my M13 SS DNA probe 
preparations were therefore made in this strain. 
The DNA probes made during this work : M13mp18-9, 
M13mp19-4, M13mp18-11 and M13mp18-12 : were all 
thoroughly checked by restriction endonuclease analysis 
(of their replicative form DNAs) to verify that, in each 
case, a single fragment of the correct size had been 
inserted; 	and by DNA sequencing, to ensure that the 
orientation of the insert was as expected. 	These 
results are presented in Figs. 3.3, 3.4 and 3.5. 
The presence of excess probe DNA (immobilised on 
nitrocellulose filters) during these hybridisation 
experiments was verified by the linear relationship 
between input and hybridised counts, using increasing 
amounts of RNA, in every experiment. This is shown in 
Fig. 3.6. 
The results of hybridisation of the labelled RNA to 
the various SS DNA probes are shown in Table 3.6 and 
graphically in Fig. 3.7. 
From these data one can conclude that the mc 
phenotype has no significant effect on the rates of 
synthesis of the rplJL, rpoB or rpoC mRNAs of the rpoBC 
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operon. 	Also, it does not significantly affect the 
efficiency of the partial terminator tL7 (lying between 
rplL and rpoB), nor the degree to which rifampicin 
increases readthrough of this terminator. Accordingly, 
the effect of rnclO5 on the response of 13(3' synthesis to 
drug addition must be post-transcriptional. 
•F.ig.33 
Restriction analysis of M13mp18-9 and M13mp19-4. 	1% 
agarose gel electrophoresis. 	The upper part shows 
partial maps of M13mp18-9 and M13mp19-4 (not to scale). 
Open boxes represent the EcoRI - StuI fragment from the 
rpoBC operon cloned into M13mp18 and M13mp19. The lower 
part shows the agarose gel photograph. 
Tracks 
M 	Markers are A/HindIII + EcoRI 
1 	M13mp18-9 - uncut 
2 	M13mp18-9 - Hindlil 
3 	M13mp19-4 - uncut 
4 	M13mp19-4 - Hindlil 
The sizes of all DNA fragments are shown in kb. 
Fig 3.3 
r.aL -  rpti 
HirIII 	 Hi 1II1 
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Restriction analysis of M13mp18-11 and M13mp18-12. 
1% agarose gel electrophoresis. The upper part shows 
partial maps of M13mp18-11 and M13mpl8-12 (not to scale). 
Open boxes represent the Sail fragment from the rpoBC 
operon cloned into M13mp18 in both orientations. The 
lower part shows the agarose gel photograph. 
Tracks 
M 	Markers are ) / Hindill + EcoRI 
1 	M13mp18-11 - uncut 
2 	it 	 - Sail 
3 	of 	 - EcoRI 
4 	M13mp18-12 - uncut 
5 	it 	 - Sail 
6 	it 	 -EcoRl 
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•F.g3.5 
DNA sequencing analysis of Ml3mp18-9, mp19-4, mp18-- 
11 and mp18-12. 	Sequences are read 5' - 3', upwards 
from left to right. 	In each case a representative 
portion of the sequence (ten nucleotides) at the junction 
of M13 and the cloned insert is highlighted to indicate 
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Hybridisation of pulse-labelled RNA to specific DNA 
probes. In every experiment the presence of excess 
probe DNA (immobilised on nitrocellulose filters) was 
verified by the linear relationship between input and 
hybridised counts, using increasing amounts of RNA. In 
each case, the RNA preparation was divided into three 
fractions (0.5, 0.25 and 0.125) and hybridised, in 
separate assays, to an excess of SS DNA probe. (1) is 
N2076 MIN 30°C (0, 15, 30 and 60 minutes after rifampicin 
addition at 5gml 1 ) ( 2) is N2077 MIN 37°C (as above) (3) 
is N2076 MIN 37°C (as above) and (4) is N2077 ENR 37°C 
(as above). Growth conditions are as described in Table 
3.6. 
Symbols:- 
o is rplJL mRNA 
is rpsMKD mRNA 
o is rpoB mRNA 
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Rates of mRNA synthesis in 	E.coli rnc 	and rncl05 
Genotype and Min after Input RNA hybridised, normalised for probe length(d) Efficiency of 
Conditions(a) rif 	(b) RNA 	(c) rpsMKD rplJL rpoB rpoC termination 	(%) 	(e) 
rnc 0 5.50 3.02 4.29 0.99 0.75 77 
1TT, 	300 15 4.45 3.11 3.65 1.45 1.06 66 
30 1.66 2.96 4.16 1.52 1.14 63 
60 2.19 3.21 4.77 1.81 1.38 62 
rnclOS 0 6.78 2.19 4.22 0.76 0.69 82 
MIN, 	370 15 8.54 1.50 3.63 1.16 1.20 68 
30 7.83 1.88 4.49 1.38 1.35 69 
60 7.16 1.54 3.51 1.50 1.49 57 
rnc 0 7.24 1.48 2.68 0.40 0.33 85 
flTT, 	370 15 8.14 1.19 2.75 0.62 0.52 77 
30 7.64 1.21 2.70 0.84 0.49 69 
60 7.16 1.56 2.71 0.94 0.64 65 
rnclOS 0 7.13 1.56 3.67 0.60 0.50 84 
rN1T37 0  15 6.90 1.57 4.02 0.88 0.70 78 
30 5.18 1.92 3.89 1.05 0.85 73 
60 4.85 2.11 	- 3.70 1.46 1.13 61 
(a) MIN is minimal medium: ENR is the same, enriched with all standard amino acids except leucine. Growth rates for 
rnc, MIN, 30 0 and rnc105, MIN, 370  were identical; as were those for rnc, MIN, 370  and rnclOS, ENR, 7O• 	
'Zero time" samples were taken 1 min before drug addition. 
Cb) Minutes after addition of rifampicin, to 5 ig m1 1 . 
The figure given is cpm[ 3H]x 10 -6 for the highest input; in all cases parallel hybridisations used 50% and 25% 
as much RNA. 
Shows the % of input counts in hybrids per nucleotide length of probe x 10 6 . 	Background counts and non-specific 
hybridisation (generally 5-20cpni) have been subtracted. 
The efficiency of termination at tL7 was 	estimated by comparing the rpoB and rplJL mRNA levels. 
Graphic illustration of the rates of mRNA syntheses 
in E. coil rnc and rnclO5 strains during rifampicin 
treatment. The date are taken from Table 3.6. 
Symbols:- 
o is N2076 MIN 30°C 
. is N2076 MIN 37°C 
0 is N2077 MIN 37°C 








•2: 1 46 
ci 
Fig 3.7 
rpsMKD 	rpu rpLL tL7 	 rpoB 	rpoC 
PROBE 	 PROBE 	 PROBE 
Time (mins) after rif addition 
164 
3.6 
REGION, FOLLOWING 	NP1.T. IO.N 
As described in Chapter 1, transcription and 
processing in the rplL - rpoB intergenic region of the 
rpoBC operon have been extensively studied in rnc and 
rnc105 strains during steady state exponential growth 
(Barry et al 1980, Downing and Dennis 1987, Morgan and 
Hayward 1987, Railing and Linn 1987). Furthermore 
Morgan and Hayward (1987) have directly demonstrated, 
using Si nuclease analysis, that following rifamicin 
addition at lOp.gml' transcriptional readthrough of tL7 
is increased approximately twofold in the rnc105 strain 
AB301-105. This level of increased transcriptional 
readthrough is equivalent to that which I observed in DNA 
RNA filter hybridisation studies of N2076 and N2077, 
using rifampicin at 5p.gml' (see section 3.5). Whilst 
the results presented in section 3.5 give a detailed 
account of the rates of rpoB and rpoC mRNA syntheses, and 
the efficiency of termination at tL7 in N2076 and N2077 
following rifampicin addition, they do not provide 
information as regards RNase III processing in this 
region under such conditions. I therefore attempted to 
extend my analysis of rpoBC expression by performing Si 
nuclease mapping of mRNA in the rplL - rpoB 
intercistronic region in N2076 and N2077 following 
addition of rifampicin at 5igml'. Previous reports 
have indicated that the pattern of hybrids formed in this 
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region during Si analysis may be too complex to allow 
quantitative assessment of the effect of rifampicin, in 
the rnc strain (see Morgan and Hayward 1987). 
Nonetheless I decided to make an attempt using both N2076 
and N2077. 
I grew both strains in Spizizen minimal medium at 
37°C to an A50 of 0.16. RNA was then prepared from 
cultures grown in the absence, or presence, of rifampicin 
(5&gmll final concentration) as described in section 
2.7.1. 
As a probe I used a 1533bp Hindlil DNA fragment 
(which spans the .rplL - rpoB intergenic space) from 
M13mp10-21. (M13mp10-21 has a 1886bp PstI rpl'JL - 
rpoB' DNA fragment cloned into the PstI site of M13mp10, 
and was constructed by Brian Morgan, in this lab.) The 
fragment was labelled at the 3' ends by the method 
described in section 2.11.2. This 1533bp Hindill DNA 
fragment contains 1524bp of DNA sequence from the rpoBC 
operon, plus 9bp of M13mp10 polylinker sequence DNA. 
The DNA strand which is complementary to rpoBC mRNA has 
the 9 nucleotides of M13mp10 polylinker DNA at its 5' 
end. After Si nuclease treatment any 'full-length' DNA 
RNA hybrids should be 1524bp long (since the unpaired 
extra 9nt of probe DNA would be degraded by Si nuclease). 
On the other hand, re-annealing of the probe DNA strands 
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(i.e. a DNA : DNA hybrid) should produce a Si nuclease 
resistant hybrid which is 1533bp long. 
I performed the Si nuclease analysis as described in 
section 2.11.9. Each DNA : RNA hybridisation reaction 
contained 20kg RNA, 150.ig tRNA and approximately 10 4 cpm 
of 3' end-labelled probe DNA in 30it1 of hybridisation 
buffer. The denaturation step was carried out at 80°C 
for 10 minutes, followed by hybridisation at 53°C for 3 
hours (Railing and Linn 1987). Si nuclease digestion 
was then performed as described in section 2.11.9. 
Transcripts were sized by resolving the single-stranded 
DNA probe fragments, which had survived Si nuclease 
treatment on a denaturing polyacrylamide gel (see section 
2.9.6). Predicted transcript sizes, and the 
experimentally observed bands, are shown in Fig. 3.8. 
Despite the very poor quality of the data presented 
in Fig. 3.8, this Si nuclease analysis indicates that the 
rnc strain N2076 4oe.s process rpoBC mRNA in the rplL - 
rpoB intergenic region,as predicted (see fragment B). 
Processing occurs in the absence, and presence, of 
rifampicin at 5.igml'. Also the .rnclQ5 strain, N2077, 
shows no indication of mRNA processing in this region, 
again as expected. 
Due to the poor quality of the Si nuclease mapping, 
any quantitative interpretation of the data must be 
limited. A summary of the densitometric analysis of 
Fig. 3.8 is given in Table 3.7. 
Fig 3 8 
Si nuclease mapping of transcript ends derived from 
the rplL - rpoB intergenic space. 	The structural 
organisation of this region is illustrated (top). 	'rplL 
is the carboxy-terminal portion of the gene which encodes 
r-protein L7/L12. 	rpoB' is the amino-terminal portion 
of the gene encoding RNA polymerase 3 subunit. 	tL7 is a 
terminator, ms is the RNase III target site. 	Predicted 
transcript sizes (A,B,C) are shown in nt. 	Closed 
circles represent the labelled 3' ends of the protected 
single-stranded 	DNA 	fragments 	after 	Si 	nuclease 
treatment. 	The experimentally observed fragments are 
marked (A,B,C). 
Tracks 
M 	Markers (in both cases) are pBR322/MspI and pBR322/ 
Aval + NheI mixed 
1 	N2076 0mm., 	no rifampicin 
2 	it  +15mm., rifampicin 5gml' 
3 	It  +30mm., rifampicin 5gml - ' 
4 	" +60mm., rifampicin 5gml - ' 
5 	N2077 0mm., 	no rifampicin 
6 	if  +15mm., rifampicin 5tgmi' 
7 +30mm., rifampicin 5gml - ' 
8 	" +60mm., rifampicin 5p.gml - ' 
The sizes of all DNA fragments are shown in nt. 
Fig3.8 













Densitometric analysis of Fig. 3.8 
Strain 	 N2076 	 N2077 
Tracka 	 1 	2 	3 	4 	5 	6 	7 	8 
Full-length 	 (Density per band)b 
transcript 
A (1524 nt) 	24.2 15.2 27.8 15.8 15.8 13.7 15.6 27.3 







11.1 13.6 12.1 9.1 - 	- 	- 	- 
23.3 37.7 42.1 61.7 	8.1 	7.5 10.6 11.0 
Numbers 1 - 8 refer to tracks 1 - 8 respectively in 
Fig. 3.8. 
Density per band is expressed as a percentage of the 
total in each (vertical) track. 
The results presented in section 3.5 and previously 
published data (discussed in Chapter 1, e.g. Blumenthal 
and Dennis 1978, Bass et al 1979) give a good indication 
of the synthesis rates of the various transcripts of the 
rpoBC operon, and the efficiency of terminator tL7, 
before and after rifampicin treatment. However the 
quantitative analysis of Fig. 3.8 presented in Table 3.7 
does not agree with these results. In particular the 
data indicate an accumulation of fragment C (tL7 
terminated transcript) in the rnc strain during 
rifampicin treatment. Other published Si nuclease 
mapping studies of this operon have also shown a large 
excess of tL7 terminated transcripts relative to 
readthrough transcripts (Downing and Dennis 1987, Ralling 
and Linn 1987, Morgan and Hayward 1987). That the 
quantitative relationship between tL7 terminated and 
full-length transcripts seen in the Si nuclease mapping 
experiments does not match the ratio observed in the DNA 
RNA filter hybridisation tests (i.e. synthetic rates), 
could, of course, be due to differential stabilities of 
the various transcripts. 
There is little published information as regards the 
stability of rpoBC transcripts. One indirect study of 
the functional half-life for E. coil mRNAs (Pedersen e1 
al 1978) estimated that rpiJL message has a half-life of 
85 - 107 seconds, while that of rpoB mRNA is 58 - 70 
seconds. However, this same study also estimated Lii 
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mRNA half-life to be 60 seconds, whereas a more recent:, 
direct analysis by Cole and Nomura (1986) concluded that 
(in normal, translationally regulated strains) Lii mRNA 
chemical half-life is 22 seconds. 
One 	plausible 	explanation 	for 	the 	apparent 
accumulation of rplJL (i.e. tL7 terminated, 566nt) 
transcripts in N2076, after rifampicin addition, is that 
it actually represents full-length message which has been 
processed at the RNase III site and then rapidly degraded 
by 3' - 5' exonucleases to the potentially stable 
secondary structure at tL7. This argument has also been 
used by Railing and Linn (1987) to explain apparent 
discrepancies in the results of their Si nuclease mapping 
and filter hybridisation experiments on rpoBC message. 
In summary, my attempts to quantitatively assess the 
effect of rifampicin on transcription of the rpoBC operon 
in the rnc strain, N2076, appear to vindicate the 
assertion of Morgan and Hayward (1987) that the pattern 
of hybrids formed during Si nuclease analysis may be too 
complex to interpret. This, allied to the poor quality 
of my own data, limits my conclusion to the qualitative 
judgement that N2076 does process rpoBC mRNA in the rplL 
- rpoB region whilst N2077 does not. 
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3.7 DISCUSSION 
The results presented in this chapter on the 
differential rates of 313' synthesis in steady state, 
exponential cultures of N2076 and N2077 confirm and 
extend those of Dennis (1984). His work (also using 
N2076 and N2077) produced clear evidence that the 
differential rates of 13 and 0' protein syntheses were 
essentially identical in the rnc and rncl05 strains, 
when grown exponentially at 37°C in M9 glucose minimal 
medium, supplemented with sixteen amino acids and 
necessary vitamins. 
In my own work, when one compares the two strains 
growing at identical rates (either in two different media 
at 37° C, or in identical media at two different 
temperatures) there is no significant difference between 
them as regards the differential rates of (3(3' syntheses 
(see Table 3.2.1). There are slight differences between 
the two strains when grown in identical conditions : the 
rate of 00' synthesis appears to be marginally higher in 
N2076 than in N2077 in each case. However, these 
differences appear to be due solely to the growth-rate-
dependent regulation of (3(3' synthesis, rather than to the 
mc phenotype. Iwakura et al (1974) derived an equation 
(to which the data of Matzura et al (1973) also fit very 
well) to express the relationship between growth rate and 
the differential synthesis rate of f3(3' in E. coli K12: a 
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0.7i. + 0. 45, where a is the differential rate of 
synthesis and ji represents growth rate as generations per 
hour. The degree to which (313' synthesis varies with 
doubling time for both strains in Table 3.2.1 is similar 
to that predicted by the equation. 
This observed growth-rate-dependent regulation of 
1313' synthesis in both N2076 and N2077 serves to highlight 
the importance of making comparisons between rnc and 
rncl05 strains at similar growth rates when analysing the 
effect of the mc phenotype on expression of rpoBC. 
In a paper primarily concerned with the effect of 
RNase III processing on the expression of the pnp operon, 
Portier et al (1987) also reported a preliminary finding 
that 13 and (3' proteins were approximately twofold more 
abundant in extracts of the rncl05 mutant BL321 than in 
the isogenic rnc control BL322. (In fact this result 
has proved difficult to reproduce - Claude Portier, 
personal communication). 	Their figure refers to total 
amounts of protein, not synthetic rates. 	When I 
measured the differential rates of 1313' synthesis in BL322 
and BL321, growing with the same doubling time, there was 
no significant difference between them. Again there were 
slight differences between the strains when they were 
grown in identical conditions (as for N2076 and N2077), 
but these were compatible with the differences in growth 
rate. 
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The major finding presented in this chapter is that 
when N2076 and N2077 are subjected to a constraint 
(namely the addition of sub-bacteriostatic levels of the 
drug rifampicin) which causes 1313' oversynthesis, the 
rnclO5 strain shows a markedly delayed response as 
compared with the isogenic wild type control. 
The rate of rpoBC mRNA synthesis increases to the 
same extent in both strains, following rifampicin 
addition. Therefore the delayed response of 3' 
synthesis in the rncl05 strain is a post-transcriptional 
effect. Since I have demonstrated that rpoBC mRNA is 
cleaved at the RNase III site between rplL and rpoB in 
N2076 (rnc) but not in N2077 (rnc105), both in the 
absence and presence of rifampicin, then I conclude that 
(contrary to the view of Dennis, 1984) processing dpes 
play an important role in the post-transcriptional 
regulation of rpoB gene expression. Since this is only 
apparent in constrained cells (i.e. after the addition of 
rifarnpicin at 5.tgml1) I suggest that during steady 
state, exponential growth, the significance of RNase III 
processing is concealed. 
Consider for instance, the possibility that cleavage 
of the rpoBC mRNA at the RNase III target site is 
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required to achieve the optimal mRNA conformation for 
efficient initiation of rpoB translation. Such 
efficient translation would then be countered by an 
appropriately strong degree of operation of the known 
feedback regulation mechanism. In the rnclO5 strain, 
however, failure to process the rpoBC mRNA would, 
according to this model, produce a message which was 
inefficient for translation initiation. This would be 
compensated for by little or no autogenous translational 
repression. Hence the outcome, during unconstrained 
growth, would be the production of similar levels of 13 
protein synthesis in rnc and rnclO5 strains, as observed 
in Tables 3.2.1 and 3.2.2, and by Dennis (1984). 
Addition of rifampicin not only increases the 
transcriptional readthrough of tL7 to the same extent in 
rnc and rnclO5 strains (see Table 3.6 and Fig. 3.7), it 
also interferes with feedback repression, as mentioned in 
Chapter 1. A combination of these two effects could 
lead to the prompt stimulation of 13 synthesis observed in 
the rnc strain after the addition of rifampicin since, 
according to this hypothesis, the extra, newly-
synthesised and processed mRNA would be intrinsically 
translationally efficient and, due to the presence of the 
drug, subject to less autogenous regulation than normal. 
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According to the above argument, feedback regulation 
would be operating weakly, or not at all, in the rnclOS 
strain. 	The addition of rifampicin should therefore 
have a less significant effect here. 	Thus the slow 
response to rifampicin in the mutant strain may reflect 
only the increased synthesis (due to increased tL7 
readthrough) of unprocessed, translationally inefficient 
mRNA. If this view is correct, then by applying an 
artificial constraint (rifampicin) upon the supply of 
active RNA polymerase, I may be observing the 
disadvantage that would apply to an E. coil strain which 
had lost the rpoB mRNA RNase III target site : an 
inability to respond as rapidly as the wild-type strain 
to a sudden demand for increased RNA polymerase output. 
An interesting feature of Tables 3.3 and 3.4 is the 
parallel behaviour between (3 and f3!  synthesis which was 
observed in both strains. Rifampicin certainly 
stimulates both rpoB and rpoC mRNA syntheses (Blumenthal 
and Dennis 1978, also Table 3.6 and Fig. 3.7), and 
opposes translational repression of 0' as well as 0 in 
vitro (Fukuda and Nagasawa-Fujimori 1983). However it 
is also clear that the two genes can be independently 
regulated post-transcriptionally (Meek and Hayward 1986). 
My results suggest that processing at the RNase III site 
between rplL and rpoB may affect rpoC translation. 
Presumably this is as a consequence of the (proposed) 
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direct affect processing has on rpoB translation. 	But 
how is this mediated? 	It may be an indication of 
"translational coupling" of rpoB and rpoC. 	For 
instance, translation of rpoB may be required to "open 
up" a translation initiation site in rpoC. Another 
possible explanation is that this reflects a shared 
component in translational regulation i.e. 13 subunit may 
be part of a repressor which regulates the translation of 
DQjjj genes. This does not exclude the possibility that 
the genes are regulated independently by separate 
repressor assemblies (e.g. a213 regulates rpoB, and 
holoenzyrne regulates rpoC (and rpoB) ?) If this were 
the case then rifampicin interaction with 13 subunit could 
interfere with the translational regulation of both genes 
(rpoB and rpoC). Work is currently underway in our 
laboratory to study the post-transcriptional regulation 
of rpoC. 
One interesting "spin off" from these results is 
that they may provide a basis for research into the 
mechanism of co-ordination of the synthesis of the major 
RNA polymerase subunits. As well as stimulating 1 3 13 ' 
synthesis, rifampicin also induces a and C70 syntheses. 
(Nakamura and Yura 1976, Hayward and Fyfe 1978b). The 
drug 	induces 	1313' 	synthesis 	di.r.e ct ly 	through 
transcriptional 	anti-termination 	and 	by 	lifting 
translational repression. 	The observed increases in a 
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and ci70 syntheses may be an indirect result of higher 13 13 ' 
levels. Rifampicin mediated readthrough of terminator 
ti in the rpoD operon (see Fig. 1.3) is a possible 
alternative explanation for increased cc70 production. 
However, 13 13 ' oversynthesis in a rpoBC merodiploid also 
leads to increased cc70 production (Hayward and Fyfe 
1978a). Moreover, there is no known transcriptional 
terminator which could mediate the effect of rifampicin 
on a synthesis. The idea of co-ordinated RNA polymerase 
subunit synthesis is therefore favoured. 
If the rifampicin-induced stimulation of a and/or 
cc 70 syntheses is dependent upon 1313' induction, then the 
markedly delayed response of 13f3 synthesis in N2077 
should consequently delay a and ci70 induction in this 
strain. This possibility is currently under 
investigation in our laboratory. 
The major interest generated by the results 
presented in this chapter was in the possibility that 
RNase III processing could play a direct role in rpoB 
gene expression. Therefore a system was devised to 
permit the detailed analysis of the role of RNase III 




CONSTRUCTION AND  
TRANSLATIONAL FUSION PLASMID AND 
DELETION MUTANT DERIVATIVES 
4. 1 INTRODUCTION 
Dennis (1984) concluded that processing per se is 
unimportant in rpoB expression and that sequences around 
the RNase III processing site, in the rplL - rpoB 
intergenic region, dictate the translational efficiency 
of rpoB mRNA. I have found that processing .dq.es play a 
role in rpoB expression and that translational regulation 
probably masks this by balancing the level of f3 
production in rnc and rnclO5 strains. Dennis (1984) 
also observed that autogenous translational regulation 
plays a major part in controlling the expression of rpoB. 
In his work four different, extensive deletions of the 
rplL - rpoB region were made in plasmids carrying a large 
EcoRI fragment of the rpoBC operon ('rplKAJL rpoBC'). 
An important feature of these plasmids is that they all 
contain the entire rpoB structural gene and thus can all 
direct the production of 0 protein. Dennis found that 
the introduction of the multicopy "parent" plasmid 
(carrying an intact rplL - rpoB intergenic region) into 
N2076 caused the relative translational efficiency of 
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rpoB mRNA to drop by 58%. 	This demonstrates the 
compensatory 	effect 	of 	autogenous 	translational 
repression. Furthermore, deletion of the attenuator tL7 
not only caused the expected increase in the levels of 
plasmid-derived rpoB messenger RNA, but also a 
compensatory decrease in the translational efficiency of 
rpoB mRNA by a further 13%. Thus translational 
repression alone can account for (at least) a 71% drop in 
the translational efficiency of rpoB mRNA. Against this 
background the reported changes in translational 
efficiency caused by deletion of sequences around the 
RNase III site (roughly a further 15% drop) are less 
striking (although still interesting). A better system 
to study these deletions would have been one in which 
variations in protein output from the plasmid-borne gene 
could not lead to confusing effects of autogenous 
translational repression. 
With this in mind I devised a strategy for the 
construction of a rpoB - lacZ translational fusion. 
This construct contains most of the rplL - rpoB 
intergenic region plus only the first 15bp of the rpoB 
structural gene and therefore does not produce 13 protein. 
Hence the plasmid protein product should not have 
any feedback effects. It now appears likely that this 
approach has also destroyed the feedback target.j on the 
mRNA, part of which resides well within the rpoB gene 
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(Passador and Linn 1989). 	This was unplanned, but is a 
welcome advantage in that variations in mRNA output from 
the plasrnid are therefore unlikely to alter the cellular 
level of rpoB feedback by competing for the repressor 
protein complex. 	The rpoB and lacZ sequences are in the 
same translational phase. 	The level of translation of 
lacZ (which can readily be determined by 13 galactosidase 
assay, see section 2.10) is dependent upon the frequency 
of translation initiation at the rpoB start. This 
provides an easy way of accurately determining the 
efficiency of translation initiation of rpoB, since this 
system should not be subject to autogenous feedback 
repression. 
Precise, defined deletions around the RNase III 
target site can then be introduced and their effect on 
rpoB translational efficiency monitored by 13 
galactosidase assay. 	Choosing exactly which deletions 
to make is a difficult task. 	There is no satisfactory 
"all encompassing", consensus RNase III target site 
therefore defining precise sequences necessary for 
processing is, as yet, impossible. 	One proposed RNase 
III target site "consensus" is shown in Fig. 4.1. 	This 
is the result of a survey by Daniels et al (1988) of 17 
known RNase III target sequences. Twelve have the boxed 
sequence (Fig. 4.1) at exactly this location relative to 
the mapped cut sites. However, no bacterial mRNA was 
used in this survey and certainly this "consensus" 
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sequence is not present in the rpoBC RNase III target 
(nor in the RNase III processing site in the pnp operon). 
Therefore with no clear indication of which small 
mutations to make at the RNase III target, I decided to 
create several large RNase III target site deletions. I 
have also noted that the triplet UUU is commonly found 
near the cut-site in RNase III target sequences. 
Therefore I decided to delete the two copies of this UUU 
triplet, present in the 5' arm of the rpoBC RNase III 
target site, which are located near the known, mapped 
cleavage sites. 
The construction and characterisation of the rpoB - 
lacZ translational fusion and its RNase III target site 
deletion derivatives are detailed in this chapter. 
Fj..g.41 
"Consensus" RNase III target site, from Daniels et 
al (1988). The boxed sequence is the conserved feature. 
It lies at exactly this location, relative to the mapped 













4.2 	CONSTRUCTION OF  
FUSION PLASMID 
4.2.1 INTRODUCTION  
This laboratory already possessed various M13 
derivatives carrying rpoB fragments. 	One such 
derivative, designated M13mp10-21 was chosen. 	(The 
construction of M13mp10-21 has already been explained, 
see section 3.6). The synthesised oligonucleotide 
(608A) has the sequence 5' CGTTTTTTCCCGGGATAGGAG 3' and 
is complementary to a sequence within the rpoB gene (see 
Fig. 4.2). Oligonucleotide 608A allows two bases to be 
changed in the rpoB sequence, thereby creating a 
SmaI/XmaI site, as shown in Fig. 4.2. The size and 
purity of oligonucleotide 608A were checked as described 
in section 2.12.2 (see Fig. 2.3) and it was then used 
initially as a sequencing primer to check that it was 
binding to the correct (and unique) location on M13mp10-
21. This also allows one to optimise the conditions for 
hybridisation 	between 	oligonucleotide 	608A and 
M13mplO-21. 	An example of the results of such a test is 
shown in Fig. 4.3. 
Oligonucleotide 	site-directed 	mutagenesis 	was 
performed as described in section 2.12.1. 	The 
oligonucleotide 608A and M13mp10-21 SS DNA were incubated 
at 70°C for 5 minutes and hybridised at 37°C for 30 
Fig. ... 4. 2 
Complementarity between oligonucleotide 608A and 
rpoB sequence. 	Upper line shows a portion of rpoB DNA 
sequence. 	Lower line shows the oligonucleotide 608A DNA 
sequence. 	X indicates positions of mutations which 608A 
introduces during the mutagenesis reaction. 	The 
initiation codon of rpoB is boxed and the target for the 
restriction enzymes SmaI/XmaI is underlined. 
Fig 4.2 
5' 	rpoB start 	 3' x 	x 
- C C C Tf_GJG T T TACT CC TAT A CC GAG A A A A A A C G TAT T - 




Smal I XmaI 
Optimisation 	of the 	conditions 	for hybridisation 
between oligonucleotide 608A and M13mplO-21 SS DNA. The 
autoradiograph 	depicts the 	results 	of 	T-tracking after 
using 	the 	annealing 	conditions detailed below. The 
ratios 	shown 	below are 	the 	molar ratios of 
oligonucleotide 608A: M13mplO-21 SS DNA. 
Tracks 
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minutes, at a 2 	1 molar ratio (608A : M13mplO-21). 
Routinely the restriction endonuclease NciI is used to 
nick the non-mutant DNA strand during the Eckstein 
mutagenesis procedure. However in this case there is a 
NciI site within the oligonucleotide 608A sequence. 
Therefore PvuI was used as an alternative nicking 
enzyme. 
One hundred candidate mutant plaques were screened 
by hybridisation (as described in section 2.11.5) using 
labelled oligonucleotide 608A as a probe. Three 
putative positive plaques were identified by this 
procedure (designated A, B and C in Fig. 4.4). These 
plaques were purified, and large scale RF M13 DNA 
preparations were made from each one (as described in 
section 2.4.4). The successful introduction of a 
SmaI/XmaI site into two of these three M13 phage (B and 
C) was verified by restriction endonuclease analysis of 
the M13 RF DNA (see Fig. 4.5). The mutant was 
designated M13mplO-22. 
4. 2.2 CREATION .QF  D.R.A.M.I. 
A 256bp Nan - Xinal fragment from M13mp10-22 was 
then cloned between the AccI and XmaI sites of M13mp19 to 
produce M13mp19-5. This was checked by restriction 
endonuclease analysis 	(see Fig. 	4.6) and by DNA 
sequencing of the entire 256bp insert to ensure that no 
Fig... 4 .4 
M13 	plaque 	hybridisation 	using 	labelled 
oligonucleotide 608A. The filter was washed in 6 x SSC 
at 59°C for 5 minutes, prior to exposure to Xray film. 
The calculated Td of oligonucleotide 608A is 64° C. 
Three putative positive plaques were identified, 


















Restriction analysis of M13mplO-22 candidates. 	1% 
agarose gel electrophoresis. 	The upper part shows a 
partial map of M13mplO-22 (not to scale). 	X SinaI shows 
the position of the newly created Smal site (introduced 
by site-directed mutagenesis). The open box represents 
the PstI fragment of rpoBC operon DNA cloned into M13mplO 
(to produce the parental M13mplO-21). The lower part 
shows the agarose gel photograph. 
Tracks 
M 	Markers are ) / Hindlil + EcoRI 
1 	Candidate A - uncut 
2 	of A - SmaI 
3 	if B - uncut 
4 	 B - SinaI 
5 	 C - uncut 
6 	11 C - SmaI 
The sizes of all DNA fragments are given in kb. 
Fiy+.5 
rpIJ-rccB 	 c -' 
SmI 	Srrxl 







other, unplanned, mutations had been introduced during 
the niutagenesj.s reaction (see Fig. 4.7). 
M13mp19-5 contains a 256bp fragment of the rpoBC 
operon (co-ordinates 2732 - 2987 inclusive, from Post et 
al 1979, as corrected by Morgan 1986). However it 
should be noted that the mutagenesis reaction, which 
introduced a SmaI/XmaI site into the rpoB gene, changed 
the nucleotide at position 2985 from A to C. This 
alters codon 6 of the rpoB structural gene from ACC to 
CCC (resulting in the substitution of a proline for a 
threonine at this position in the rpoB - lacZ fusion 
protein). It is also worth noting that (by design) 
M13mp19-5 does not contain the attenuator tL7 from the 
rpoBC operon. The important features carried on the 
256bp insert in M13mp19-5 are outlined in Fig. 4.8. 
M13mp19-5 SS DNA was then used as the template for 
further oligonucleotide site-directed mutagenesis 
reactions (see section 4.3.1). 
To construct the plasmid-borne rpoB - lacZ 
translational fusion a 277bp Hindlil.- XmaI fragment from 
Ml3mp19-5 was cloned between the same sites in pSKS106. 
The resultant plasmid was checked by restriction 
endonuclease mapping in comparison with pSKS106 and then 
designated pRAMI (see Fig. 4.9). 
Competent AK14 cells were transformed with each 
plasmid. AK14 	harbouring pSKS106 	produces 	deep blue 
colonies on LB 	plates 	(plus ampicillin, 	Xgal 	and IPTG) 
due to the high 	level 	of 	13 galactosidase 	activity from 
pSKS106. AK14 	harbouring pRAMI, 	on 	the 	other hand, 
produces pale blue colonies when grown on similar plates. 
LI 
Fig4 
Restriction analysis of M13mp19-5. 	1% agarose gel 
electrophoresis. 	The upper part shows a simple map of 
M13mp19-15 (not to scale). 	The open box represents the 
256bp Nan - XmaI fragment from M13mplO-22 which was 
cloned between the AccI - XmaI sites of M13mp19 to 
produce M13mp19-5. The lower part shows the agarose gel 
photograph. 
Tracks 
M 	Markers are ), / Hindlil 
1 	M13mp19-5 - uncut 
2 	M13mp19-5 - XmnI 








Complete DNA sequence of the 256bp NarI-XmaI insert in 
Ml 3 mpl 9-5 
'Nan 





GCGAGCTGAGGAACCCTATGGTTTACTCCTATCCC ] GGG 
XmaI 
Notes 
Brackets [ ] denote the boundaries of the 256 bp insert 
sequence 
* shows the A - C point mutation made by site-directed 
mutagenesis. 
'NarI denotes the destroyed NarI site 
	
Sequencing gel was run at 40W for: 	A 1 hour 45 minutes 
B 3 hours 30 minutes 
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Features in the 256bp Nan - XmaI insert in M13mp19- 
5. 	Co-ordinates are from Post et al (1979) as corrected 
by Morgan (1986). 	ATG is the initiation codon of rpoB. 
The A --> C point mutation was introduced by site-
directed mutagenesis, this work. 
11 
Fig4. 










Simple map of pSKS106 (not to scale). 	The 
polylinker sequence in the 5' e rid of lacZ contains 
restriction targets for Hindill, PstI, Sail, BamHI, 
SmaI/XmaI, EcoRI and HaeIII. 	The open boxes represent 




Ap r f 
lacy 
Restriction analysis of pSKS106 and pRAM1. 	0.6% 
agarose gel electrophoresis. 	Upper part shows a simple 
map of pRAM1. 	The open box represents the 277bp Hindlil 
- XmaI DNA fragment from M13mp19-5 cloned into pSKS106 
(between the same sites) to produce pRAM1. This is 
inserted into the polylinker region at the 5' end of lacZ 
(see Fig. 4.9A) - to produce a translational fusion. 
Digestion of pSKS106 with the following enzymes should 
yield these fragments : HindIll (10.1kb); 	EcoRl (9.9 + 
0.2kb); 	XmnI (8.2 + 1.9kb). Digestion of pRAM1 with the 
following enzymes 	should produce these 	fragments: 
XmnI(7.7 + 1.9 + 0.7kb); 	HindIll, XmaI(10.1 + 0.25kb) 
EcoRl (9.9 + 0.45kb). 	Lower part shows the agarose 
gels. 
Tracks 
M 	Markers (in both cases) are >, I Hindill + EcoRI 
1 	pSKS106 - uncut 5 	pRAM1 - uncut 
2 	" 	 - HindIll 6 	" - XmnI 
3 	" 	 - EcoRl 7 	it - Hindlil + XmaI 
4 	' 	 - XmnI 8 	It - EcoRI 
The sizes of all DNA fragments are given in kb. 
The 2.6kb fragment (Track 6) represents partial cutting 
of pRAM1 DNA with XmnI (1.9 + 0.7). 
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TRANSLATIONAL FUSION PLASMIDS 
4. 3. 1 OLIGONUCLEOTIDE SITE-DIRECTED MUTAGENESIS OF 
M .13m 
As described in section 4.2.2 and Fig. 4.8, M13mp19-
5 carries a short fragment of the rpoBC operon containing 
the RNase III target site, the weak promoter P, the 
translation initiation site of rpoB and the first five 
codons of the rpoB structural gene. I decided to create 
a series of RNase III target site deletion mutants. 
These were made using M13mp19-5 SS DNA and various 
custom-synthesised DNA oligonucleotides. The creation 
of each mutant is detailed below. 
M13 n.pl 9..6, .mp.9..-. 
The synthesised oligonucleotide 211A has 	the 
sequence 5' GGAACACGGCACAGC 3' and is complementary to 
sequences surrounding the RNase III target site. 
Oligonucleotide 211A allows a deletion of rpoBC operon 
sequence to be made from position 2771 - 2878 inclusive. 
This deletes the entire putative stem-loop structure of 
the RNase III target site. The size and purity of 
oligonucleotide 211A were checked as described in section 
2.12.2 (see Fig. 2.3). Optimal conditions for 
hybridisation of oligonucleotide 211A and M13mp19-5 SS 
DNA were determined. 	They were mixed and incubated at 
70°C for 5 minutes and hybridised at 37°C for 30 minutes, 
at a 2 : 1 molar ratio (211A M13mp19-5). The 
mutagenesis reaction was carried out exactly as described 
in section 2.12.1. 
Twenty plaques were screened by T-tracking. 	Of 
these, 30% were M13mp19-5, 35% appeared to have the 
planned deletion (2771 - 2878) and a further 35% 
consisted of various unplanned deletions. 
Representative plaques from each class of deletion mutant 
were purified and sequenced fully (see Fig. 4.10). Due 
to aberrant binding of oligonucleotide 211A to sequences 
in M13mp19-5, three extra mutants had been created (in 
addition to the planned deletion). These were 
designated M13mp19-6 (deletion is 2827 - 2929 inclusive) 
M13mp19-7 (deletion is 2823 - 2925 inclusive) and 
M13mp19-8 (deletion is 2771 - 2905 inclusive, plus a C to 
G point mutation at 2911). 	The planned deletion mutant 
(2771 - 2878 inclusive) was designated M13mp19-9. 	A 
schematic outline of these deletions is given in Fig. 
4.11. In this work only M13mp19-6 and M13mp19-9 were 
used for further investigation (M13mp19-7 and M13mp19-8 
were stored for use at a later date). 
•Fj.g4.lO 
DNA sequencing analysis of M13mp19-6, mp19-7, mp19- 
8, mp19-9. 	Sequences are read 5' - 3', upwards from 
left to right. 	In each case a portion of the sequence 
(twelve 	nucleotides), 	spanning 	the 	deletion, 	is 
highlighted. 	The exact position of the deletion is 
indicated, = in each case. 













- 9 G~ 
io 
.Fjg.411 
A schematic outline of the RNase III target site 
deletion mutants created during this work (not to scale). 
Co—ordinates are from Post et al (1979), as corrected by 
Morgan (1986). 	The deleted sequences are presented as 
gaps. 	Stem—loop structure represents the putative 
secondary structure of the RNase III target site. 	The 
UUU triplets are discussed in the text. 
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This deletion mutant was created by a summer visitor 
to 	the 	lab, 	Dr. 	Margarita 	Martin, 	using 	the 
oligonucleotide 	219A 	which 	has 	the 	sequence 
5' CGTCGATAGCAAGCATTGGGCACAG 3'. This ol igonucleotide 
allows the deletion of two copies of the triplet sequence 
UUU (positions 2771 - 2773 inclusive and 2783 - 2785 
inclusive) from the 5' arm of the putative stem-loop 
RNase III target structure. The size and purity of 
oligonucleotide 219A were checked as described in section 
2.12.2 (see Fig. 2.3). After determining the optimal 
conditions for oligonucleotide 219A : M13mp19-5 SS DNA 
hybridisation (incubation at 70°C for 5 minutes and 37°C 
for 30 minutes at a molar ratio of 2 : 1, 219A : M13mp19-
5) the oligonucleotide site-directed mutagenesis reaction 
was carried out as described in section 2.12.1. 
Twenty plaques were screened by A-tracking, of which 
25% appeared to have the planned deletions. DNA 
sequencing confirmed that the double deletion mutant had 
been created as planned (see Fig. 4.12). This was 
designated M13mp19-10 and is outlined schematically in 
Fig. 4.11. 
DNA sequencing analysis of M13mp19-10 and M13mp19- 
11. 	Sequences are read 5' - 3', upwards from left to 
right. 	Note that Dr. M. Martin sequenced M13mp19-10 
(and that the tracks in this case are ordered CGTA). 	A 
portion of the sequence spanning the deletions is 
highlighted in each case, and the exact positions of the 

















The synthesised oligonucleotide 	203A has 	the 
sequence 5' CGCAGTATAGGCACAGC 3 1 . This oligonucleotide 
allows a deletion from positions 2771 - 2800 inclusive 
(which deletes the 5' arm of the proposed stem-loop 
secondary structure of the RNase III target site). The 
size and purity of oligonucleotide 203A were checked (see 
section 2.12.2 and Fig. 2.3). The optimal conditions 
for hybridisation of oligonucleotide 203A and M13mp19-5 
SS DNA were determined as incubation at 70°C for 5 
minutes and 37°C for 30 minutes at a molar ratio of 10 
1 (203A : M13mp19-5). Twenty plaques were screened by 
A-tracking, of which 5% (i.e. one plaque) appeared to be 
the planned deletion. This was purified and checked by 
DNA sequencing to confirm that the deletion mutant had 
been created as planned (see Fig. 4.12). This was 
designated M13mp19-11 and is outlined in Fig. 4.11. 
4.3. 2 CREATIP1LP.AM2..., .pRAM .3..,pRAM4....an.. pMRN1 
The cloning strategy used to create pRAM1 was also 
used to construct four deleted rpoB - lacZ translational 




This plasmid was constructed by cloning the 169bp 
Hindlil - XmaI fragment from M13mp19-9 between the same 
sites in pSKS106. Transformation of competent AK14 
cells produced pale blue colonies on LB (plus ampicillin, 
Xgal and IPTG) plates. These were screened by the 
hybridisation technique detailed in section 2.11.7, using 
a labelled 1.53kb HindIll - PstI ('rplJL - rpoB') DNA 
fragment from M13mplO-21 as a probe. An identified 
putative positive clone (see Fig. 4.13) was purified and 
plasmid DNA prepared and analysed by restriction 
endonuclease mapping (see Fig. 4.14). This plasmid was 
designated pRAM2. 
pR3. 
This plasmid was made by cloning the 174bp Hindlil - 
XmaI fragment from M13mp19-6 between the same sites in 
pSKS106. Upon transformation of competent AK14 cells 
pale blue colonies were produced, which were screened as 
described above. An identified putative positive clone 
(see Fig. 4.13) was purified and plasmid DNA prepared and 
analysed by restriction endonuclease mapping (see Fig. 
4.15). This plasmid was designated pRAM3. 
Fig. 4. 13 
Detection of clones containing pRAM2 and pRAM3 by 
colony hybridisation. The DNA probe was the 1.53kb 
Hindlil - PstI ('rplJL - rpoB') DNA fragment from 
M13mplO-21. Filter was washed as described in section 
2.11.7 and exposed to Xray film at room temperature for 
60 minutes. From the top of the filter (proceeding left 
to right), the first 5 colonies were candidate AK14 
(pRAM2) clones - one of which was picked as a positive 
putative clone. The next 43 colonies were candidate 
AK14 (pRAM3) clones - one of which was picked as a 
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Fig. 4.14 
Restriction analysis of pRAM2. 	2% agarose gel 
electrophoresis. 	The upper part shows a partial map of 
pRAM2 (not to scale). 	The open box represents the 
(approximately) 0.15kb HindIll - XmaI DNA fragment from 
M13mpl9-9, inserted between the same sites in pSKS106. 
The lower part shows the agarose gel photograph. 
Tracks 
M 	Markers are ). / Hindlil + EcoRI 
1 	pRAM2 - uncut 
2 	 - Hindill + XmaI 
3 	'I 	 - EcoRI 
The sizes of all DNA fragments are shown in kb. 
Fig. 4.15 
Restriction analysis of pRAM3. 	1% agarose gel 
electrophoresis. 	The upper part shows a partial map of 
pRAM3 (not to scale). 	The open box represents the 
(approximately) 0.15kb HindIll - Xnial DNA fragment from 
M13mp19-6 inserted between the same sites in pSKS106. 
The lower part shows the agarose gel photograph. 
Dja 
M 	Markers are 
), / Hind III + EcoRI 
1 	pRAM3 - uncut 
2 	11 	- Hindlil + XmaI 
3 	it 	- EcoRI 
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This plasmid was constructed by cloning the 247bp 
HindIII-XmaI fragment from M13mp19-11 between the same 
sites in pSKS106. Pale blue colonies (see above) were 
picked and small scale plasmid DNA preparations were made 
from them. 	These were then screened by restriction 
endonuclease analysis. 	An identified positive clone was 
further purified and reanalysed as before (see Fig. 
4.16). 	This plasmid was designated pRAM4. 
P.MRXI 
Dr. M. Martin made this plasmid by cloning the 271bp 
Hindill - XmaI fragment from M13mp19-10 between the same 
sites in pSKS106. Pale blue colonies were picked and 
screened by restriction endonuclease analysis (as for 
pRAM4). 	One correct clone was identified, purified and 
analysed again (see Fig. 4.17). 	This plasmid was 
designated pMRM1. 
Fig 41 
Restriction analysis of pRAM4. 	0.6% agarose gel 
electrophoresis. 	The upper part shows a simple map of 
pRAM4 (not to scale). 	The open box represents the 
(approximately) 0.22kb HindIll - XmaI fragment from 
M13mp19-11, cloned between the same sites in pSKS106. 
Digestion of pRAM4 with the following enzymes should 
produce these fragments (sizes are approximate): Hindill 
+ XmaI (10.1 + 0.22kb), EcoRl (9.9 + 0.42kb), XmnI (7.7 + 
1.9 + 0.7kb). The lower part shows the agarose gel 
photograph 
Tracks 
M 	Markers are >. I Hindlil + EcoRI 
1 pRAM4 - uncut 
2 	it 	- Hindill + XmaI 
3 it - EcoRI 
4 	it 	-XmnI 
The sizes of all DNA fragments are shown in kb. 
F..g.4...1 
Restriction analysis of pMRM1. 	0.6% agarose gel 
13 	 electrophoresis. 	The upper part shows a simple map of 
pMRM1 (not to scale). The open box represents the 
(approximately) 0.25kb HindIll - Xrnal fragment from 
M13mp19-10 cloned between the same sites in pSKS106. 
Digestion of pMRM1 with the following enzymes should 
produce these fragments (sizes are approximate) Hindlil + 
XmaI (10.1 + 0.25kb), EcoRl (9.9 + 0.45kb), XmnI (7.7 + 
1.9 + 0.7kb). The lower part shows the agarose gel 
photograph. 
Tracks 
M 	Markers are 
). / Hindill + EcoRI 
1 pMRM1 - uncut 
2 	 - Hindlil + XmaI 
3 - EcoRI 
4 	" -XmnI 
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FUSION PLASMID AND DELETION-MUTANT DERIVATIVES 
4.4.1 PRIMER EXTENSION ANALYSIS 
Having made pRAM1, containing an intact RNase III 
target site upstream of the rpoB start, one important 
initial question was whether mRNA derived from the 
plasmid was processed faithfully at this site. Also, 
since all four mutant rpoB - lacZ fusion plasmids contain 
partial or entire deletions of the RNase III target site, 
it was important to ascertain whether mRNA derived from 
these plasmids was cleaved in this region. Primer 
extension analysis of RNA extracted from cells harbouring 
each plasmid was performed. Cultures of AK14 
(transformed with the appropriate rpoB - lacZ fusion 
plasmid) in Spizizen-glycerol minimal medium (plus 
ampicillin) were grown to an A600 of 0.3. At this point 
RNA was extracted as described in section 2.7.1. 
The synthesised oligonucleotide 083C 	(sequence 
5' CTGCAAGGCGATTAAGTTGG 3') kindly provided by John 
Morran and Dr. Jean Beggs, was labelled at its 5' end as 
described in section 2.11.3. This oligonucleotide is 
complementary to a sequence within the lacZ structural 
gene (spanning codons 21-29) and is ideal for analysing 
mRNA derived from the rpoB - lacZ fusion plasmids 
exclusively, since the host strain AK14 is j (lac - pro) 
192 
and carries F' lacZ 	M15 (a deletion extending from 
codons 11-41 inclusive) . 	Thus only lacZ mRNA derived 
from the fusion plasmids will contain sequences with 
which this oligonucleotide can hybridise. Universal 
sequencing primer (sequence 5' TCCCAGTCACGACGT 3') has 
essentially the same features as 083C : it is 
complementary to a sequence within the lacZ structural 
gene (spanning codons 12-17 inclusive) which is missing 
in (lac - pro) and .lacZ M15. Thus it too can be 
used in these primer extension experiments. 
The results of primer extension analysis of RNA 
derived from pRAM1, pRAM2, pRAM3 and pMRM1, using 
oligonucleotide 083C as the primer, are shown in Fig. 
4.18, and those of RNA from pRAM4 (using the same 
oligonucleotide primer) are shown in Fig. 4.20. pRAM1 
derived RNA was also analysed using the universal 
sequencing primer, results of which are shown in Fig. 
4.19. 
Analysis 	of 	pRAM1 	derived 	mRNA, 	using 
oligonucleotide 083C, produced four fragments (175, 185, 
270 and 278n€ in length) which map to co-ordinates 2888, 
2878, 2793 and 2785 respectively (on the scale of Post et 
al 1979) in the rpoBC operon sequence. 2785 and 2793 
are at previously mapped cleavage sites in the RNase III 
target region (see Fig. 4.21.1), thus possibly indicating 
RNase III processing of pRAM1 derived mRNA at these 
sites. However position 2888 lies outwith the proposed 
RNase III target site and 2878 has not been previously 
mapped as a cleavage site. 	These fragments may be due 
to processing of pRAM1 by an unidentified enzyme; 	may 
indicate that the transcript has an abnormal secondary 
structure thereby causing altered processing; or may 
represent previously undetected RNase III cleavage sites 
in this region. Analysis of pRAM1-derived mRNA from an 
rnc strain might help to clarify this matter (see also 
193 
P.196). 	Similarly, four major fragments were observed 
when using universal sequencing primer to analyse this 
RNA (the identical RNA preparation) . 	These fragments 
(152, 158, 170 and 172nt long) map to co-ordinates 2876, 
2870, 2858 and 2856 respectively. 	All four align to the 
3' arm of the proposed RNase III target site. 	Cleavage 
sites in this arm have been reported previously (see Fig. 
4.21.1), although not accurately defined. Processing in 
this arm may well be specific to plasmid-derived rpoBC 
transcripts. It is surprising that the analysis of a 
single RNA preparation (using two different primers) 
should yield the variety of end-points observed (see Fig. 
4.21.1). A diagram showing the position of all these 
processing sites (relative to the known mapped cut sites) 
in the context of putative stem-loop RNase III target 
site secondary structure is presented in Fig. 4.21.1. 
Primer extension analysis of RNA from the four 
deletIon mutant plasmids showed that none were processed 
in the vicinity of the RNase III target site. However 
it must be noted that the quality of the data presented 
in Fig. 4.20 (pRAM4) is very poor and hence is not 
entirely conclusive. In each case the predominant 
fragment corresponded to an uninterrupted transcript 
initiated at (or near) Plac. A less abundant, 
secondary band was observed which mapped to a position 
pstre. 	of the cloned rpoBC operon fragment in pRAM3, 
pMRM1 and pRAM4. 	It was designated S3 in pRAM3 (Fig. 
4.18), S4 in pMRM1 (Fig. 4.18) and Si in pRAM4 (Fig. 
4.20) and detailed in Fig. 4.21.2. Its origin will be 
discussed later. 
F1 	4.12 la 
Primer extension analysis of pRAM1, pRAM2, pRAM3 and 
pMRM1-derived transcripts, using oligonucleotide 083C. 
The upper part shows simple maps of the relevant region 
for each plasmid (not to scale). 	The position of the 
promoter Plac is shown by (Pr) in each case. 	Open 
boxes represent the Hindlil - XmaI fragments cloned from 
the appropriate M13s into pSKS106 to generate each 
plasmid. The position of the oligonucleotide 083C 
binding site, relative to this insert sequence, is shown 
for each plasmid. 1,2,3,4 P2,P3,S3,P4 and S3 all show 
the approximate positions of the DNA fragments produced 
by primer extension analysis. The lower part shows an 
autoradiograph of the acrylamide gel. 
Tracks 
M 	Markers are pBR322/MspI and pBR322/AvaI, NheI, mixed 
1 	70&g pRAM1 RNA : 0.3 pmoles 083C - fragments 1,2,3,4 
2 	704g pRAM2 RNA : 0.3pmoles 083C - fragment P2 
3 	70.&g pRAM3 RNA : 0.3pmoles 083C - fragments P3,53 
4 	100g pMRM1 RNA : 1.3pmoles 083C - fragments P4,S4. 
The sizes of all DNA fragments are given in nt. 
Fig4.18  
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Fig. . 4... 19 
Primer 	extension 	analysis 	of 	pRAM1-derived 
transcripts using universal sequencing primer. 	The 
upper part shows a simple map of the relevant region of 
pRAM1 (not to scale). 	The position of Plac is shown by 
(Pr). 	The open box represents the 277bp Hindlil - XmáI 
fragment from M13mp19-5 cloned into pSKS106 to generate 
pRAM1. The position of the universal sequencing primer 
binding site (U.P.) relative to this insert sequence is 
shown. 1,2,3,4 show the approximate positions of the DNA 
fragments produced by primer extension analysis. The 
lower part shows an autoradiograph of the acrylamide gel. 
Tracks 
M 	Markers are pBR3221MspI and pBR322/AvaI + NheI mixed 
1 140..&g pRAM1 RNA : 1.3pmoles UP - fragments 1,2,3,4 
2 	70ig pRANI RNA 	0.3pmoles UP - 	 to 	 If 
The sizes of all DNA fragments are shown in nt. 
i..g.4..... 
Primer 	extension 	analysis 	of 	pRAM4-derived 
transcripts using oligonucleotide 083C. The upper part 
shows a simple map of the relevant region of pRAM4 (not 
to scale). The position of Plac is shown by (Pr). The 
open box represents the 247bp Hindill - XmaI fragment 
cloned from M13mp19-11 into pSKS106 to generate pRAM4. 
The position of the oligonucleotide 083C binding site 
relative to this insert sequence is shown. P1 and Si 
show the approximate positions of the DNA fragments 
produced by primer extension analysis. The lower part 
shows an autoradiograph of the acrylamide gel. 
Tracks 
M 	Markers are pBR322/MspI and pBR322/AvaI + NheI, 
mixed 
1 	140g pRAM4 RNA : 1.3pmoles 083C - Note 
2 70g pRAM4 RNA : 0.3pmoles 083C - Pi,Si. 
The sizes of all DNA fragments are shown in nt. 
Note This RNA preparation contained sufficient salt 
(especially in Track 1) to affect the mobilities of the 
final product bands. 
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0 I 	-309(S1) 
Analysis of primer extension data. 	Positions of 
RNase III cut sites. 
Open boxes (a)-(e) show the previously reported 
RNase III cut sites in this region (mapped using Si 
nuclease mapping). 
 2770 (±3) 	(Railing and Linn 1987) 
 2776 (±1) 	(Downing and Dennis 1987) 
 2785 (±3) 	(Fukuda and Nagasawa-Fujimori 	1983, 
Downing and Dennis 1987, 	Railing and Linn 1987) 
 2864 (Fukuda and Nagasawa-Fujimori 1983) 
 2860 (Barry et al 1980) 
083C 1-4, show the positions of the fragment termini (see 
Fig. 4.18, Track 1) in the context of the RNase III 
target stem-loop. UP 1-4, show the positions of the 
fragment ends (see Fig. 4.19, Tracks 1 and 2) in the 
context of the RNase III target stem-loop. 
F.jg .... 4 
Analysis of primer extension data. 	Position of the 
secondary band terminus (S3,S4,Sl). 	The sequences at 
the junction of lacZ and the M13mp19 polylinker region 
are shown in each case. The arrow marks the position of 
the end of each fragment (see Fig. 4.18 and Fig. 4.20) 
within this region. 
Fiq4. 21.1 
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Fig 4. 21.2 
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Since pRAM1 is processed faithfully at its RNase III 
target site (see Fig. 4.18, Fig. 4.19 and Fig. 4.21.1), 
whilst the messenger RNAs of all four deletion mutant 
derivatives are not cleaved at this site then the effect 
of processing on the expression of the rpoB - lacZ fusion 
proteins can be judged. This, was done by measuring the 
level of 3 galactosidase activity produced from each 
plasmid in the host strain AK14. This strain carries 
1acI; 	therefore transcription from Plac 	must be 
induced with IPTG. Spizizen-glycerol minimal cultures 
of AK14 (alone or transformed with the appropriate 
plasmid) were grown in the absence or presence of IPTG 
(10 - 5M). The next day these were diluted and grown in 
the same medium (plus or minus IPTG) to an A500 of 0.3. 
Assays were then performed as described in section 2.10. 
Results were calculated using the following equation: 
Miller Units = 1000 x At2j - 1.75XA550 
t x v x A600 
(per ml of 
culture at A500 
of 1.0) 
where t is the duration of incubation of the sample at 
28°C (in minutes) 
v is the volume of cell culture in the sample 
(in ml) 
A600 is the culture absorbance at time of sampling 
(i.e. approximately 0.3). 
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(ONPG does not absorb at 550nm. 	Thus the A550 reading 
only measures light-scattering by cell debris. 	For E. 
coil light-scattering at 420nm is 1.75 times that at 
550nm) 
The levels of 13 galactosidase activity for pSKS106, pRAM1 
and the deletion mutant derivatives are shown in Table 
4.1. 
Table 4.1 
13 Galactosidase Levels 
Strain 	-IPTG 1 ) 	 + IPTG 2 ) 
AK14 	 0 	 0 
it 	 pSKS106 	3 	 5506 (±283) 
It 	 pRAM1 	0 	 53 (±7) 
if 	 pRAM2 	2 	 510 (±19) 
pRAM3 	1 	 341 (±16) 
pRAM4 	1 	 378 (+6) 
pMRM1 	0 	 15 (±0.3) 
13 galactosidase levels are expressed in Miller Units. 
Figures are the result of a single observation. 
Each result is the mean of at least three observ-
ations; figures in brackets are standard errors. 
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The results presented in Table 4.1 show that, in the 
absence of IPTG, laclq (carried on F') strongly represses 
transcription from P1ac, leading to little or no 0 
galactosidase activity. Under IPTG induction, the 
results show that the introduction of the 277bp Hindlil - 
XmaI fragment of rpoBC operon sequence (from M13mp19-5) 
between the same sites in pSKS106 has a profound effect 
on 13 galactosidase expression : pRAM1 13 galactosidase 
levels are approximately 100 fold lower than those of the 
"parent", pSKS106. The reason for this is not clear. 
Perhaps the alteration of codon 6 of the rpoB structural 
gene (see p.183) has affected the translational 
efficiency of this message (e.g. due to altered codon 
usage?). An investigation of this region using site-
directed mutagenesis to change specific nucleotides may 
yield some useful information. Large deletions in the 
rplL - rpoB intergenic region of this plasmid result in 
increased 13 galactosidase levels of approximately 6 - 10 
fold (pRAM2, pRAM3 and pRAM4). Intriguingly the small 
deletions in pMRM1 caused the level of 0 galactosidase 
activity to drop below that of pRAM1 	(by about 
threefold). 	In order to relate the effects of all these 
deletions on 13 galactosidase expression to the role of 
RNase III processing of rpoBC mRNA one could transfer 
this series of plasmids into a suitable host strain an 
isogenic rnclO5 derivative of AK14, generated by P1 
transduction. In this way the effects of RNase III 
processing and of the deletions could be independently 
monitored (by 13 galactosidase assays, as above), thereby 
clarifying their contributions to the levels of rpoB-lacZ 
expression. 
4.4.3 CRUDE ESTIMATION OF lacZ AND FUSION PROTEIN LEVELS 
In order to ensure that the differences in 13 
galactosidase enzyme activity shown in Table 4.1 
reflected differential gene expression rather than low 
enzymatic activity of the hybrid 13 galactosidase, the 
level of lacZ or fusion protein produced from each 
plasmid was crudely determined. Thus a comparison could 
be made between lacZ/fusion protein levels and 13 
galactosidase enzyme activities in the series of 
plasmids. 
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AK14 (alone or transformed with the appropriate 
plasmid) was grown in the absence or presence of IPTG 
(10 5M) exactly as described in section 4.4.2. At an 
A600 of 0.3 unlabelled cell extracts were made as 
described in section 2.8.1, and fractionated on SDS 
polyacrylamide gels as described in section 2.9.9. The 
gels were stained, destained and dried as described in 
section 2.9.9, and then photographed. Fig. 4.22.1 shows 
an "uninduced gel" (i.e. no IPTG added) and Fig. 4.22.2 
shows an "induced gel" (IPTG at 10 5M). The rpoB - .lacZ 
fusion proteins are virtually identical in size to the 
lacZ protein encoded by pSKS106 (just four amino acids 
shorter) and are approximately 116,000 Daltons in size. 
The uninduced protein gel (Fig. 4.22.1) shows no protein 
of this size, which is in agreement with the 13 
galactosidase enzyme assays showing very little or no 
activity in the absence of IPTG. In the presence of the 
inducer (Fig. 4.22.2) the levels of fusion protein 
observed correlate well with the levels of (3 
galactosidase enzyme activity shown in Table 4.1. Thus 
it appears that the differences in (3 galactosidase 
activities do reflect differences in rpoB - lacZ 
expression by the various plasmid.s. 
Crude estimation of lacZ and fusion protein levels 
by SDS polyacrylarnide gel electrophoresis of cell 
extracts. Extracts were prepared from cultures grown in 
the absence of IPTG. 
Tracks 
M 	Markers are from the MW-SDS-200 kit (Sigma) which 
contains six proteins of known molecular weights. 
Two of these [phosphorylase B, rabbit muscle - 
97,400 Daltons and (3-galactosidase, E.coli - 116,000 
Daltons) are shown. 
1 	AK14 pRAM4 - IPTG (1) 
2 it  pSKS106 	(3) 
3 	It  pRAM2 " 	(2) 
4 of  pRAM3 	if (1) 
5 	if  pRAM1 of 	(0) 
6 to pMRM1 	to (0) 
7 	AK14 	 It 	(0) 
Figures in brackets are the observed levels of (3-
galactosidase activity (in Miller Units) - taken from 
Table 4.1. 
4.....2.... 
Crude estimation of lacZ and fusion protein levels 
by SDS polyacrylamide gel electrophoresis of cell 
extracts. 	Extracts were prepared from cultures grown in 
the presence of IPTG (10 -5M). 	The location of the 
fusion proteins (and lacZ from pSKS106) is marked by F.P. 
Tracks 
M 	Markers are the same as in Fig. 4.22.1 
1 AK14 pRAM4 + IPTG (378±6) 
2 	" pSKS106 " 	(5506±283) 
3 of 	pRAM2 	to (510+19) 
4 	it  pRAM3 if 	(341+16) 
5 of  pRAM1 	If (53+7) 
6 	if 	pMRM1 if 	 (15±0.3) 
7 AK14 " (0) 
Figures 	in brackets are 	the 	levels 	of (3 - 
galactosidase activity (in Miller Units) taken from Table 
4.1. 
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4.4.4 DETERMINATION OF mRNA SYNTHESIS RATES DURING 
IPTG INDUCTION 
The differential expression of the various rpoB - 
lacZ fusions may be due to transcriptional or post-
transcriptional effects. Obviously since each plasmid 
has the same promoter (Plac) one would expect that the 
level of transcription of the lacZ or rpoB - lacZ fusion 
genes should be similar in each case, and would therefore 
conclude that post-transcriptional events are responsible 
for determining the level of expression from the various 
plasmids. However, the possibility that the deletion 
mutants are responsible for specific modulations in the 
rate of transcription of the rpoB - lacZ fusion genes 
cannot be entirely excluded. Therefore I determined the 
mRNA synthesis rates of lacZ and the rpoB - lacZ fusion 
genes in pSKS106, pRAM1 and the four deletion-mutant 
plasmids. 
AK14 (alone, or transformed with the appropriate plasmid) 
was grown as described in section 4.4.2 in the presence 
of IPTG (10 5M) to an A600 of 0.3. At this point the 
cultures were pulse-labelled with [ 3H] uridine for one 
minute and the RNA extracted as described in section 
2.7.3. 
M13mp8 was used as the source of both the positive 
and negative hybridisation probes. 	It contains no 
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bacterial DNA insert in the polylinker region, but does 
have the lacZ a complementation region. M13mp8 SS DNA 
was used as the "negative-hybridisation" probe since it 
has no sequence complementarity to any bacterial 
messenger RNA. 	Filters without any DNA were included as 
further negative controls. 	Denatured M13mp8 RF DNA was 
used as the source of the "positive-hybridisation" probe 
(obviously it includes both negative and positive 
hybridisation probe DNA). It contains a sequence 
(altered only at the polylinker region) which is 
complementary to 372nt of lacZ mRNA extending from Plac 
through the a complementation region of ?acZ. This 
probe will hybridise with 372nt (again with some 
deviations at the polylinker) of lacZ mRNA from plasmids 
pSKS106, pRAM1, pRAM2, pRAM3, pRAM4 and pMRM1. It will 
also hybridise with 279nt of lacZ mRNA derived from the 
lacZ A M15 fragment carried on F', which is present in 
strain AI(14. The level of hybridisation determined in 
untransformed AK14 must be subtracted from the levels 
determined in transformed AK14 strains to achieve an 
accurate measure of the transcription rate for each 
plasmid. 
DNA : RNA filter hybridisation experiments were 
performed as described in section 2.11.8. The presence 
of excess probe DNA (immobilised on nitrocellulose 
filters) during these experiments was verified by the 
linear relationship between input and hybridised counts, 
Hybridisation of pulse-labelled RNA to specific DNA 
probe. In every experiment, the presence of excess 
probe. DNA (immobilised on nitrocellulose filters) was 
verified by the linear relationship between input and 
hybridised counts, using increasing amounts of RNA. In 
each case the RNA preparation was divided into three 
fractions (0.5, 0.25 and 0.125) and hybridised in 
separate assays to excess probe DNA. 
Fig 4.23 















using increasing levels of RNA, in every experiment (see 
Fig. 4.23). The results of hybridisation of the 
labelled RNAs to the M13mp8 "positive-hybridisation" 
probe are shown in Table 4.2. 
Table 4.2 
RATES OF mRNA SYNTHESIS 
Strain 	 % of input RNA 














a) 	This value has been subtracted from all the other 
results. 	It is the level of hybridisation due to 
F' derived lacZ mRNA. 
Background counts and non-specific hybridisation 
(generally 5-20cpm) have been subtracted. 
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The results presented in Table 4.2 show that the 
rates of mRNA synthesis from the various plasmids used in 
this work are, broadly speaking, similar. There is an 
approximately three-fold difference between the lowest 
and highest rates of synthesis. This compares with an 
approximately three h.u.nd-red fold difference between the 
lowest and highest levels of (3 galactosidase activity 
amongst the plasmids. More importantly, there is no 
correlation between these small variations in rate of 
mRNA synthesis and the big variations in level of 0 
galactosidase activity. In particular pSKS106 has the 
lowest mRNA synthesis rate but yields by far the highest 
level of (3 galactosidase activity. Clearly the 
differences in (3 galactosidase activity between the 
various plasmids shown in Table 4.1 are not due to 
differential rates of mRNA synthesis. 
4.4.5ARE THE 	 cZ..1J).S..1.0..SU.BJEL T0 .0 
TRANSLATIONAL CONTROL? 
The rpoB - lacZ translational fusion proteins only 
contain the first five amino acids of the (3 subunit. 
Thus it is almost certain that they are incapable of 
acting as autogenous translational repressor molecules 
(or components thereof). However, although the results 
of Passador and Linn (1989) suggest that the target for 
feedback repression is not fully intact on the rpoB - 
lacZ fusion mRNA, the site may be partially retained. 
202 
The repressor complex might well be present in high 
enough molarity to affect it, even when being transcribed 
from the multiple copies of the Plac promoter. 
Using the knowledge that rifampicin can alleviate 
translational repression of rpoB in vitro (Lang-Yang and 
Zubay 1981, Fukuda and Nagasawa-Fujimori 1983) I decided 
to test whether any of the rpoB - lacZ fusion genes were 
subject to translational repression in vivo, by comparing 
the kinetics of 13 galactosidase induction (with IPTG) in 
the absence and presence of rifampicin. If 
translational repression were in operation then 
rifampicin might interfere with this, and consequently 
increase the level of 13 galactosidase expression during 
IPTG induction. If not, then rifampicin should not 
alter the kinetics of induction with IPTG. 
Rifampicin was used at a concentration of 3igml1. 
At this level the drug caused a 2 - 3 fold increase in 
the differential rate of 1313' synthesis after 45 minutes 
in AK14, AK14 (pSKS106) and AK14 (pRAM1) (data not 
shown), as expected from previous observations. For 1 3 
galactosidase induction experiments, AK14 (transformed 
with the appropriate plasmid) was grown to an A600 of 0.3 
in Spizizen-glycerol minimal medium (plus ampicillin). 
At this point IPTG (10 -3M) and/or rifampicin (3gml') 
were added and growth continued. Samples were taken 15, 
30 and 45 minutes later and f3 galactosidase activity 
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measured as described in section 2.10. 	The results of 
these tests are shown graphically in Fig. 4.24. 	In 
every case it is clear that there is no increase in the 
level of f3 galactosidase induction (with IPTG 10 -3M) in 
the presence of rifampicin compared to that without the 
drug. If anything, the addition of rifampicin (3.&qmll) 
4ecreasesthe rate of f3 galactosidase induction with 
IPTG. Thus, from this series of tests, it would appear 
that the rpoB - lacZ fusion genes are not subject to 
translational repression. 
A.2 24 
Induction of (3-galactosidase expression from the 
various plasmids, in the absence and presence of 
rifampicin. 	Time (after induction) is shown in minutes 
on the X-axis, in each case. 	The level of (3 
galactosidase activity from each plasmid is shown in 
Miller Units. IPTG induction, in the absence of 
rifampicin, is shown by open circles, and induction in 
the presence of the drug, by closed circles. 
Fig 4.24. 
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The combination of sequence and structural elements 
which make up a RNase III target site is, as yet, not 
fully understood. 	Therefore it was interesting that all 
four RNase III site deletions, created during this work, 
completely abolished processing. 	This was expected for 
the deletion in pRAM2 which has lost the RNase III site 
entirely. 	The total abolition of processing in pRAM3 
and pRAM4 (both of which contain partial RNase III site 
deletions) demonstrates the absolute requirement for 
secondary structure in this cleavage event, as previously 
observed by e.g. Srivastava and Schiessinger (1989b) in 
the RNase III processing of 16SrRNA. 	The relatively 
"subtle" deletion of two copies of the triplet UUU (the 
deletion in pMRM1) from the RNase III target site results 
in the entire loss of processing. 	This may be due to 
disruption of the secondary structure caused by the 
deletions, an explanation which has been used previously 
to explain the effects of point mutations in the sib 
region, downstream of the inI gene in bacteriophage 
(Guarneros et al 1982). 	However, the locations of the 
UUU triplets are such that their loss need not 
necessarily cause the collapse of the RNase III target 
site secondary structure (see Fig. 4.11). 	Accordingly 
it may be that failure to process rpoBC mRNA after the 
deletion of the UUU triplets reflects a loss of some 
primary sequence information required for cleavage. 	The 
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elucidation of pMRM1 derived mRNA secondary structure in 
this region would be interesting. 
The secondary fragments observed during primer 
extension analysis, designated S3 in pRAM3, S4 in pMRM1 
and Si in pRAM4, all map to a region upstream of the 
rpoBC insert fragment, either in Ml3mp19 polylinker 
sequence or in the start of the lacZ sequence. 
Cannistraro and Kennell (1985b) observed "ragged" 5' ends 
of lacZ mRNA, which they assumed were the products of 
degradation to the beginning of the ribosome-protected 
region of lacZ message. The secondary bands seen in the 
primer extension analysis may be due to a similar 
phenomenon; or could represent the formation of a novel 
cleavage site; or, of course, could reflect premature 
termination during the reverse transcription reaction. 
The set of rpoB - lacZ translational fusion plasrnids 
constructed during this work has provided an extremely 
useful, and relatively easy, way of monitoring the 
effects of the RNase III target site deletions on the 
expression of rpoB. The deletions were all made in a 
short rpoBC operon fragment (which lacks the tL7 
attenuator) and then cloned downstream of Plac. This 
arrangement ensured that the rate of mRNA synthesis was 
similar from plasmid to plasmid. These rates were 
determined using an amino-terminal DNA probe (M13mp8 RF 
DNA) which allows the detection of lacZ mRNA proximal to 
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the 	known 	site(s) 	of 	rho-mediated 	transcription 
termination. This site(s) is certainly distal to 
nucleotide position 200 of the coding region (Stanssens 
et al 1986), and could be near the middle of the lacZ 
gene (de Crombrugghe et al 1973). As described in 
Chapter 1, termination here is related to the efficiency 
of. translation initiation. Therefore it was important 
to avoid this complication when attempting to monitor the 
rate of mRNA synthesis from the various plasmids, since 
they had already shown a wide range of 13 galactosidase 
enzyme activities (i.e. varied translation initiation 
efficiencies). The deliberate omission of the 
attenuator tL7 from these plasmid constructs also 
eliminated a possible source of variation at the 
transcriptional level. 
One of the major difficulties in interpreting 
previous studies of rpoB expression has been assessing 
the contribution of autogenous translational repression. 
The "in frame" fusion of a very short amino-terminal 
portion of rpoB to the lacZ reporter gene appears to have 
overcome this problem. It seems certain that the fusion 
will not be susceptible to "full-blown" translational 
feedback regulation, because the target for this control 
has been, at least partially, deleted. Passador and 
Linn (1989) presented evidence which suggests that part 
of the translational regulation site may lie between 126 
and 403bp inside the rpoB gene. It should be stressed 
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that this is probably just part of the regulatory site, 
since weakened translational control was still observed 
in a construct containing rp1KAJL and only the first 
126bp of the rpoB structural gene (Passador and Linn 
1989). Regulation was also noted by Dennis (1984) in a 
very similar construct (containing the same length of 
rpoB) (Hui et al 1982). 	In the fusions used in the 
present work, however, only 15bp of rpoB remain; 	thus 
the feedback target structure might well have been 
totally lost. The fact that the presence of rifampicin 
did not enhance (3 galactosidase expression from the 
fusion plasmids, during IPTG induction, serves to 
reinforce the view that these rpoB - lacZ fusion plasmids 
are not subject to translational regulation. 
This allows a clearer interpretation of the results 
of the 0 galactosidase assays presented in Table 4.1. 
One conclusion which can- be drawn is that any effect 
RNase III processing might have on rpoB - lacZ mRNA 
stability is neither the sole nor predominant means of 
controlling rpoB - lacZ expression. Similar quantities 
of non-processed transcript produce higher (pRAM2, pRAM3, 
pRAM4) and lower (pMRM1) levels of 0 galactosidase than 
processed mRNA (pRAM1). Thus there is no systematic way 
in which RNase III processing (or the lack of it) could, 
solely by affecting messenger stability, account for 
these (3 galactosidase assay results. 
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Instead, it is likely that the variations in 13 
galactosidase activities are due to differences in the 
efficiency of translation initiation at rpoB in the 
various plasmids. Echoing the argument proposed in 
section 3.7, I suggest that the efficient initiation of 
translation at rpoB is dependent upon attaining an 
optimal. mRNA conformation, and that RNA processing is 
required to reach this state. 	An outline of this model 
is presented in Fig. 4.25. The secondary structure 
shown between positions 2879 and 2977 is the optimal one 
for this sequence using the "RNA fold" programme of Zuker 
(1981). It is possible that by "helix-stacking", one 
large extended secondary structure is formed from 
position 2770 - 2977. It is proposed that RNA processing 
(presumably by RNase III, although this has yet to be 
rigorously tested - see p. 192) is required to destroy 
the "closed" structure in Fig. 4.25 (1) and convert this 
to the "open" structure Fig. 4.25 (3). In particular it 
should be noted that the novel cleavage site mapped at 
position 2888 (this work) which lies outwith the proposed 
RNase III target stem-loop structure could destabilise 
the lower stem-loop structure. "Closed" and "open" 
refer to the accessibility of the rpoB Shine and Dalgarno 
sequence and translation initiation site for interaction 
with 16SrRNA of the small ribosomal subunit, and the 
initiator tRNA respectively. Thus processing would be 
required to achieve the optimal mRNA conformation for 
efficient translation initiation. According to this model 
the deletions in pRAM2, pRAM3 and pRAM4 all destabilise 
the "closed" structure and thus achieve an "open" con-
formation without the need for RNase III processing.The 
mRNA derived from these plasmids is therefore 
intrinsically translationally efficient, and thus each 
one produces a high level of 13 galactosidase activity 
relative to wild-type mRNA, which must first be processed 
•Fjg..4.25 
A model for the role of processing in rpoB 
expression. 
Shows the proposed secondary structure of rpJL - 
rpoB mRNA. 	2770-2879 is the putative stem-loop of 
the RNase III target. 	Nucleotides 2879-2977 are 
shown in the predicted optimal conformation (Zuker 
1981). 	The closed box shows the Shine and Dalgarno 
sequence. 	The open box is the rpoB structural 
gene. 	ATG shows the rpoB initiation codon. 	This 
is the "closed" conformation. 
Arrows show the positions of mapped RNase III cut 
sites (this work, and previously published data). 
Other symbols as in (1). 
Symbols 	as 	in 	(1). 
conformation, achieved 
(stage (2)). 
This 	is 	the 	"open" 
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by RNase III. 	This requirement for cleavage may partly 
explain the low levels of 3 galactosidase activity in 
pRAM1 relative to pSKS106. 	The deletions in pMRM1 also 
abolish processing but, it is argued, allow the 
maintenance of the "closed" conformation, resulting in 
translationally inefficient mRNA and explaining the low 
levels of 0 galactosidase activity in pMRM1. 
Such a role of RNase III processing in determining 
translational efficiency is not without precedent. 
Processing greatly stimulates translation of gene 0.3 
mRNA of phage T7, in vivo and in vitro (Dunn and Studier 
1975). 	It can also play a role in the regulation of 
genes 1.1 and 1.2 of the same phage. 	Incomplete 
processing at a RNase III site downstream of gene 1.2 in 
a particular T7 mutant produces an aberrant transcript 
which is 29nt longer than in wild-type T7. Apparently 
this extra sequence can hybridise to the gene 1.1 
ribosome binding site and exclude ribosomes. Since the 
translation of genes 1.1 and 1.2 is coupled, both are 
regulated by this mechanism (Saito and Richardson 1981). 
More recently it has been shown that RNase III stimulates 
the translation of the cIII gene of bacteriophage X. 
Intriguingly it appears that RNase III bin...-ig, not 
necessarily processing, at a site upstream of the dli 
gene is responsible for the translational enhancement 
(Altuvia et al 1987), possibly by favouring an mRNA 
structure which increases the translational efficiency of 
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clii mRNA (Kornitzer et a] 1989). 	These models, in 
which RNase III or RNase III processing shift the 
equilibrium between two mRNA conformations to increase 
ciii mRNA translational efficiency are very similar to 
the one which I have outlined in Fig. 4.25 to explain the 
role of RNase III processing in the expression of rpoB. 
Further mutational analysis is currently underway in this 
laboratory in order stringently to test the model. 
A possible alternative explanation of the data is 
that RNase III bing (as with the c III gene) is 
responsible for altering the secondary structure and 
translatability of the rpoB - lacZ transcript. This 
could be tested by producing transcripts from each of the 
deletion-plasmids in vitro and elucidating their mRNA 
secondary structures in the presence and absence of 




An important factor in rpoB gene expression is the 
contribution made by autogenous translational repression. 
This mechanism is probably responsible for balancing the 
expression of rpoB (and rpoC) between rnc and rnc105 
strains. Only when translational control is lifted, for 
example by rifampicin treatment (as detailed in Chapter 
3) or by the creation of a plasmid-borne rpoB - lacZ 
fusion system (as detailed in Chapter 4), is the effect 
of RNase III processing revealed. However an important 
question remains : if translational control ultimately 
dictates the level of 1313' synthesis, what is the 
physiological significance of RNase III processing at 
this site? It may be that any sudden demand for 
increased RNA polymerase output can only be met by the 
increased translational efficiency of rpoB mRNA which 
RNase III cleavage can provide. Alternatively RNase III 
processing and translational control may themselves be 
intimately related : processing at the RNase III site, 
upstream of rpoB, may begJj.e..d for translational 
regulation (perhaps to create a target structure for 
translational repression?) 
The rpoB - lacZ fusion which I have constructed 
seems well suited to a study of the sequence requirements 
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for RNase III processing at the rpoB site, and of the 
effect of such processing on the translatability of rpoB 
mRNA. Further studies along these lines are intended. 
The fusion is probably not susceptible to feedback 
regulation of translation. 	This could be more 
rigorously tested by in vitro methods. 	Alternatively 
the fusion could be transferred from a multicopy to a 
single copy system, in case the observed loss of 
regulation is due (at least in part) to an overproduction 
of target sites relative to repressor complexes. If, as 
expected, the fusion cannot be translationally regulated 
(due to the loss of part of all of the target site), then 
the fusion of longer stretches of rpoB to the lacZ 
reporter gene seems the best way ahead in attempting to 
locate the target site for translational repression. 
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